Form990
Click to see attachment
Department of the TreasuryInternal Revenue Service
Return of Organization Exempt From Income Tax
Under section 501(c), 527, or 4947(a)(1) of the Internal Revenue Code (except private foundations)
MediumBullet Do not enter social security numbers on this form as it may be made public.
MediumBullet Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2019
Open to Public Inspection
A For the 2019 calendar year, or tax year beginning 01-01-2019 , and ending 12-31-2019
BCheck if applicable:
CName of organization
PATH
 
 
Doing business as
 
 
Number and street (or P.O. box if mail is not delivered to street address)
2201 WESTLAKE AVENUE NO 200
 
Room/suite
City or town, state or province, country, and ZIP or foreign postal code
SEATTLE, WA98121
D Employer identification number

91-1157127
E Telephone number

G Gross receipts $ 383,749,661
F Name and address of principal officer:
BRIAN NEVILLE
2201 WESTLAKE AVENUE NO 200
SEATTLE,WA98121
I
Tax-exempt status: (   ) LeftBullet (insert no.) or
J
Website:MediumBullet
WWW.PATH.ORG
H(a)
Is this a group return for
subordinates?
H(b)
Are all subordinates
included?
If "No," attach a list. (see instructions)
H(c)
Group exemption number MediumBullet  
K Form of organization:  
L Year of formation: 1981
M State of legal domicile: WA
Part I
Summary
Activities & Governance 1 Briefly describe the organization’s mission or most significant activities: SEE PART III, LINE 1.
2 Check this box MediumBullet
3 Number of voting members of the governing body (Part VI, line 1a) ........ 3 15
4 Number of independent voting members of the governing body (Part VI, line 1b) ..... 4 15
5 Total number of individuals employed in calendar year 2019 (Part V, line 2a) ...... 5 737
6 Total number of volunteers (estimate if necessary) ............. 6 0
7a Total unrelated business revenue from Part VIII, column (C), line 12 ........ 7a 0
b Net unrelated business taxable income from Form 990-T, line 39 ......... 7b 0
Revenues Prior Year Current Year
8 Contributions and grants (Part VIII, line 1h) ......... 305,315,221 286,808,545
9 Program service revenue (Part VIII, line 2g) ......... 1,500 2,038
10 Investment income (Part VIII, column (A), lines 3, 4, and 7d ) .... 3,037,130 6,723,428
11 Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e) 980,560 836,870
12 Total revenue—add lines 8 through 11 (must equal Part VIII, column (A), line 12) 309,334,411 294,370,881
Expenses; 13 Grants and similar amounts paid (Part IX, column (A), lines 1–3 )... 62,762,146 55,619,080
14 Benefits paid to or for members (Part IX, column (A), line 4)..... 0 0
15 Salaries, other compensation, employee benefits (Part IX, column (A), lines 5–10) 139,545,675 131,590,498
16a Professional fundraising fees (Part IX, column (A), line 11e) ..... 0 0
b Total fundraising expenses (Part IX, column (D), line 25) MediumBullet2,679,350    
17 Other expenses (Part IX, column (A), lines 11a–11d, 11f–24e).... 110,458,648 105,099,261
18 Total expenses. Add lines 13–17 (must equal Part IX, column (A), line 25) 312,766,469 292,308,839
19 Revenue less expenses. Subtract line 18 from line 12....... -3,432,058 2,062,042
Net Assets or Fund Balances; Beginning of Current Year End of Year
20 Total assets (Part X, line 16)............. 237,501,233 243,064,155
21 Total liabilities (Part X, line 26)............. 202,931,874 204,045,574
22 Net assets or fund balances. Subtract line 21 from line 20..... 34,569,359 39,018,581
Part II
Signature Block
Under penalties of perjury, I declare that I have examined this return, including accompanying schedules and statements, and to the best of my knowledge and belief, it is true, correct, and complete. Declaration of preparer (other than officer) is based on all information of which preparer has any knowledge.
Sign Here
JumboBullet
Signature of officer Date
JumboBullet
Type or print name and title
Paid Preparer Use Only
Print/Type preparer's name
Preparer's signature
Date
PTIN
Firm's name MediumBullet

Firm's EIN MediumBullet
Firm's address MediumBullet



Phone no.
May the IRS discuss this return with the preparer shown above? (see instructions) ..........
For Paperwork Reduction Act Notice, see the separate instructions.
Cat. No. 11282Y Form 990 (2019)
Form 990 (2019)
Page 2
Part III
Statement of Program Service Accomplishments
Check if Schedule O contains a response or note to any line in this Part III..............
1
Briefly describe the organization’s mission: PATH'S MISSION IS TO ADVANCE HEALTH EQUITY THROUGH INNOVATION AND PARTNERSHIPS. (CONTINUED ON SCHEDULE O)
2
Did the organization undertake any significant program services during the year which were not listed on
the prior Form 990 or 990-EZ? .....................
If "Yes," describe these new services on Schedule O.
3
Did the organization cease conducting, or make significant changes in how it conducts, any program
services? ...........................
If "Yes," describe these changes on Schedule O.
4
Describe the organization’s program service accomplishments for each of its three largest program services, as measured by expenses. Section 501(c)(3) and 501(c)(4) organizations are required to report the amount of grants and allocations to others, the total expenses, and revenue, if any, for each program service reported.
4a (Code:   ) (Expenses $ 122,045,425 including grants of $ 18,889,335 ) (Revenue $ 38 )
GLOBAL HEALTH PROGRAMS: PATH'S GLOBAL HEALTH PROGRAMS DIVISION IS RESPONSIBLE FOR PATH'S SCIENTIFIC EXPERTISE IN MALARIA AND NEGLECTED TROPICAL DISEASES; HIV AND TUBERCULOSIS; MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION; SEXUAL AND REPRODUCTIVE HEALTH; AND NONCOMMUNICABLE DISEASES. THE DIVISION ALSO OVERSEES PATH'S WORK IN HEALTH SYSTEMS INNOVATION AND DELIVERY, AND MANAGES OUR COUNTRY OFFICES.(SEE SCHEDULE O)MALARIA AND NEGLECTED TROPICAL DISEASES:PATH PARTNERS WITH GOVERNMENTS, THE PRIVATE SECTOR, AND FUNDERS ACROSS THE GLOBE TO BRING THE WORLD CLOSER TO MALARIA ERADICATION. MORE THAN 200 PATH STAFF MEMBERS WORK ON MALARIA IN MORE THAN 30 COUNTRIES. OUR STRATEGY INCLUDES OPTIMIZING THE DELIVERY OF CURRENT TOOLS AND APPROACHES TO ENSURE THEY REACH THE PEOPLE WHO NEED THEM, DEVELOPING NEW STRATEGIES FOR ELIMINATION, DEVELOPING NEXT-GENERATION TOOLS TO OVERCOME EMERGING CHALLENGES, AND CREATING INNOVATIVE PARTNERSHIPS AND FUNDING MODELS TO ENSURE OUR PROGRAMS ARE SUSTAINABLE AND EFFECTIVE. PATH-PIONEERED APPROACHES HAVE CONTRIBUTED TO REMARKABLE PROGRESS IN MALARIA, WITH NEARLY 7 MILLION LIVES SAVED SINCE 2000.IN 2019, OUR MALARIA CONTROL AND ELIMINATION PARTNERSHIP IN AFRICA (MACEPA) PROGRAM, FUNDED BY THE BILL & MELINDA GATES FOUNDATION, CONTINUED TO SUPPORT THE GOVERNMENTS OF ETHIOPIA, SENEGAL, AND ZAMBIA TOWARD THEIR MALARIA ELIMINATION GOALS. MACEPA'S WORK INCLUDED SCALING UP PREVENTION AND TREATMENT; EVALUATING THE LATEST, MOST SENSITIVE DIAGNOSTIC TESTS; ESTABLISHING RAPID REPORTING SYSTEMS; AND CONTINUING TO SUPPORT POPULATION-WIDE, DRUG-BASED STRATEGIES SUCH AS MASS DRUG ADMINISTRATION. THROUGH OUR PROGRAM FOR THE ADVANCEMENT OF MALARIA OUTCOMES (PAMO), FUNDED BY THE US PRESIDENT'S MALARIA INITIATIVE, PATH CONTINUED TO ASSIST THE GOVERNMENT OF ZAMBIA IN ITS EFFORTS TO ELIMINATE LOCAL MALARIA INFECTION AND DISEASE. IN 2019, PAMO PROVIDED TECHNICAL SUPPORT AND MENTORSHIP TO MORE THAN 1,200 HEALTH CARE WORKERS ACROSS FOUR PROVINCES TO IMPROVE THE QUALITY OF CARE. PAMO ALSO SUPPORTED THE DISTRIBUTION OF 115,416 INSECTICIDE-TREATED BEDNETS, ORGANIZED SOCIAL BEHAVIOR CHANGE ACTIVITIES (INCLUDING ENGAGING SCHOOLS AND PRINTING EDUCATIONAL MATERIALS), AND PROVIDED TECHNICAL AND MATERIAL SUPPORT FOR DATA QUALITY AUDITS IN HEALTH FACILITIES.ALSO IN ZAMBIA, THE VISUALIZE NO MALARIA PROJECT CONTINUED TO EXPAND. THIS PROJECT, A GROUNDBREAKING PARTNERSHIP BETWEEN PATH AND A COALITION OF TECHNOLOGY COMPANIES, EQUIPS HEALTH WORKERS AND OFFICIALS WITH REAL-TIME DATA VISUALIZATION TO SEE AND UNDERSTAND WHERE MALARIA IS APPEARING SO THEY CAN DEPLOY APPROPRIATE RESOURCES TO HALT ITS SPREAD.PATH CONTINUED TO DEVELOP AND EVALUATE NEW VECTOR CONTROL TOOLS IN 2019 WITH OUR PARTNERS IN VECTORLINK, THE US AGENCY FOR INTERNATIONAL DEVELOPMENT'S (USAID'S) FLAGSHIP VECTOR CONTROL PROJECT. SIMILARLY, UNDER THE NEW NETS PROJECT FUNDED BY UNITAID AND THE GLOBAL FUND, WE HELPED GENERATE EVIDENCE FOR THE ADOPTION OF BEDNETS EFFECTIVE AGAINST PYRETHROID-RESISTANT MOSQUITOES. AND WE CONTINUED TO DEVELOP AND EVALUATE ATTRACTIVE TARGETED SUGAR BAITS, WHICH LURE MOSQUITOES TO A MEAL LACED WITH INSECTICIDE.IN 2019, THE MALARIA TEAM PARTNERED WITH PATH'S DIAGNOSTICS PROGRAM ON EVALUATIONS OF RAPID TESTS FOR MALARIA AS WELL AS CLINICAL STUDIES FOR POINT-OF-CARE TESTS TO DETECT AN ENZYME DEFICIENCY THAT CAN COMPLICATE TREATMENT OF PLASMODIUM VIVAX MALARIA. PATH ALSO SUPPORTED THE COMMERCIALIZATION OF A DIAGNOSTICS ARRAY THAT CAN BE USED FOR MALARIA RESEARCH AND SURVEILLANCE. MOREOVER, WE LED A VALIDATION OF THE RESULTS OF MALARIA TESTS TAKEN DURING ANTENATAL CARE AS A ROUTINE MEASURE OF PARASITE PREVALENCE. FOR MORE INFORMATION, SEE THE DIAGNOSTICS SECTION. FINALLY, PATH WORKED WITH THE WORLD HEALTH ORGANIZATION (WHO) AND OTHER PARTNERS, INCLUDING THE MINISTRIES OF HEALTH IN GHANA, KENYA, AND MALAWI, TO INTRODUCE THE WORLD'S FIRST MALARIA VACCINE, KNOWN AS RTS,S, IN SELECTED AREAS OF THOSE COUNTRIES.PATH'S EFFORTS TO ELIMINATE NEGLECTED TROPICAL DISEASES CONTINUED IN 2019 IN THE DEMOCRATIC REPUBLIC OF THE CONGO (DRC), WHERE WE WORKED WITH THE COUNTRY'S NATIONAL PROGRAM TO COMBAT HUMAN AFRICAN TRYPANOSOMIASIS (HAT, OR "SLEEPING SICKNESS"). WE SUPPORTED THE PROGRAM IN ACTIVE AND PASSIVE SCREENING FOR HAT CASES IN THREE KEY PROVINCES, AND WE ASSISTED THE LIVERPOOL SCHOOL OF TROPICAL MEDICINE TO DEPLOY CONTROL MEASURES FOR THE HAT VECTOR, TSETSE FLIES, USING THE "TINY TARGET" INNOVATIVE TECHNOLOGY. OUR WORK ALSO INCLUDED ADVOCACY TO RAISE AWARENESS OF HAT AT NATIONAL, PROVINCIAL, AND COMMUNITY LEVELS.IN INDIA, PATH CONTINUED TO PROVIDE STRATEGIC TECHNICAL ASSISTANCE AT THE NATIONAL, STATE (UTTAR PRADESH), AND SUB-STATE LEVELS FOR ELIMINATION OF VISCERAL LEISHMANIASIS (KALA-AZAR) AND LYMPHATIC FILARIASIS (ELEPHANTIASIS). ADDITIONALLY, WE SUPPORTED INDIA'S VECTOR-BORNE DISEASE CONTROL PROGRAM AT THE STATE LEVEL TO COMBAT MALARIA, DENGUE, AND CHIKUNGUNYA.HIV AND TUBERCULOSIS:IN 2019, PATH CONTINUED CONTRIBUTIONS TO HIV PREVENTION AND EPIDEMIC CONTROL, AS WELL AS TUBERCULOSIS (TB) DETECTION AND CONTROL. OUR PROGRAMMING REACHED GENERAL POPULATIONS AS WELL AS THE KEY POPULATIONS OF ADOLESCENT GIRLS AND YOUNG WOMEN, PEOPLE WITH BOTH HIV AND TB, SEX WORKERS AND THEIR CLIENTS, MEN WHO HAVE SEX WITH MEN, PEOPLE WHO INJECT DRUGS, AND TRANSGENDER INDIVIDUALS. WE CONTINUED TO FIND AND DIAGNOSE, LINK TO TREATMENT, AND RETAIN PEOPLE ON TREATMENT AS WE ADVANCED PROGRAMMING ACROSS TECHNOLOGY AND SERVICE DELIVERY PLATFORMS. PATH SCALED DIFFERENTIATED PARTNER NOTIFICATION SERVICES, PROVIDING NEWLY DIAGNOSED PEOPLE LIVING WITH HIV (PLHIV) WITH A SUITE OF OPTIONS FOR DISCLOSING THEIR POSITIVE STATUS AND PROVIDING HIV TESTING SERVICES TO THEIR PARTNERS AND FAMILIES. ACROSS OUR USAID-FUNDED PROGRAMS IN THE DRC, KENYA, UKRAINE, AND VIETNAM, WE TESTED MORE THAN 744,775 PEOPLE, INCLUDING 48,366 PARTNERS AND FAMILY MEMBERS OF PLHIV, AND ENROLLED MORE THAN 24,680 NEWLY DIAGNOSED PLHIV ON TREATMENT. AMBASSADOR DEBORAH BIRX HIGHLIGHTED OUR APPROACH AS THE MODEL THAT ALL COUNTRIES INVOLVED IN THE US PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR) SHOULD FOLLOW. OUR APPROACH ALSO LED TO A COLLABORATION WITH WHO TO DEVELOP GLOBAL GUIDELINES FOR SAFE PARTNER NOTIFICATION SERVICES FOR SEX WORKERS.IN THE DRC, PATH CONTINUED TO LEAD USAID-FUNDED EFFORTS TO CONTROL THE HIV EPIDEMIC. IN 2019, THIS WORK FOCUSED ON TWO HIGH-PREVALENCE PROVINCES UNDER THE INTEGRATED HIV/AIDS PROJECT IN HAUT-KATANGA/LUALABA. PATH PROVIDED TECHNICAL ASSISTANCE TO 162 HEALTH FACILITIES, 18 HEALTH ZONES, AND FIVE NONGOVERNMENTAL ORGANIZATIONS (NGOS) TO INCREASE TARGETED TESTING EFFORTS, ENROLL ALL IDENTIFIED HIV-POSITIVE INDIVIDUALS ON TREATMENT, PROVIDE VIRAL LOAD TESTING, AND ROLL OUT DIFFERENTIATED CARE MODELS. PATH TESTED APPROXIMATELY 250,000 PEOPLE IN THE DRC, LINKED AROUND 14,000 NEWLY IDENTIFIED PLHIV TO TREATMENT, AND SUPPORTED A COHORT OF 40,000 PEOPLE TO CONTINUE TREATMENT. THROUGH THE AIDS, POPULATION, AND HEALTH INTEGRATED ASSISTANCE PROGRAM PLUS (APHIAPLUS) PROJECT IN 2019, PATH OPERATIONALIZED ELECTRONIC MEDICAL RECORDS SYSTEMS AT HEALTH FACILITIES IN WESTERN KENYA. BUILDING ON APHIAPLUS, WE ALSO LED THE USAID AND PEPFAR-FUNDED AFYA ZIWANI PROJECT. WE TESTED APPROXIMATELY 500,000 PEOPLE FOR HIV, LINKED AROUND 8,000 NEWLY IDENTIFIED PLHIV TO TREATMENT, AND SUPPORTED A COHORT OF 50,000 PEOPLE TO CONTINUE TREATMENT. TO DO THIS, WE DEVELOPED INNOVATIVE TOOLS FOR ELIGIBILITY SCREENING AND TRACKING MISSED APPOINTMENTS, AS WELL AS DATA DASHBOARDS. ALSO AS PART OF AFYA ZIWANI, PATH IMPLEMENTED THE DREAMS INITIATIVE, INTENSIFYING EFFORTS TO REACH NEARLY 80,000 ADOLESCENT GIRLS AND YOUNG WOMEN IN KENYA WITH INTERVENTIONS TO REDUCE THEIR VULNERABILITY TO HIV AND IMPROVE THEIR ACCESS TO SERVICES.
4b (Code:   ) (Expenses $ 85,821,408 including grants of $ 27,113,038 ) (Revenue $ 1,000 )
ESSENTIAL MEDICINES: PATH'S ESSENTIAL MEDICINES DIVISION DEVELOPS AND DELIVERS LIFESAVING VACCINES AND DRUGS FOR WOMEN, CHILDREN, AND COMMUNITIES AROUND THE GLOBE. (CONTINUED ON SCHEDULE O)CENTER FOR VACCINE INNOVATION AND ACCESSPATH'S CENTER FOR VACCINE INNOVATION AND ACCESS (CVIA) ALIGNS EXPERTISE ACROSS EVERY STAGE OF VACCINE RESEARCH, DEVELOPMENT, AND INTRODUCTION TO MAKE VACCINES AVAILABLE TO MORE COMMUNITIES, PARTICULARLY IN LOW- AND MIDDLE-INCOME COUNTRIES. OUR PORTFOLIO INCLUDES MORE THAN TWO DOZEN VACCINE PRODUCTS IN DEVELOPMENT OR ALREADY IN USE, WITH AN EMPHASIS ON THE LEADING INFECTIOUS CAUSES OF CHILD DEATH AND DISEASE WORLDWIDE.FOR EXAMPLE, IN 2019 PATH CONTINUED TO PARTNER WITH COUNTRIES TO EXPAND COVERAGE OF JAPANESE ENCEPHALITIS (JE) VACCINATION AND CARRIED OUT A CAMPAIGN TO CELEBRATE PROGRESS TOWARD COMBATING JE. THE GOVERNMENT OF THE PHILIPPINES CONDUCTED JE VACCINATION CAMPAIGNS IN FOUR HIGH-RISK PROVINCES, WHICH PATH SUPPORTED THROUGH PLANNING, VACCINE PROVISION, AND COST-EFFECTIVENESS ANALYSIS. AS PATH'S 16-YEAR GLOBAL JE PARTNERSHIP PREPARED TO CLOSE, WE HOSTED A MEETING WITH KEY STAKEHOLDERS IN HANOI TO DISCUSS AND CAPTURE LESSONS LEARNED FOR COUNTRY VACCINATION PROGRAMS AND INTERNATIONAL VACCINE PARTNERS. PATH DEVELOPED AND LAUNCHED A WEB PAGE, INFOGRAPHIC, AND REPORT OUTLINING THESE LESSONS AND THE STORY OF JE VACCINATION EFFORTS. ALSO IN 2019, WE BEGAN A PIVOTAL, PHASE 3 STUDY OF A POLYVALENT MENINGOCOCCAL MENINGITIS VACCINE. THE VACCINE, DEVELOPED BY SERUM INSTITUTE OF INDIA PVT. LTD., BUILDS ON THE SUCCESS OF MENAFRIVAC, A VACCINE AGAINST MENINGOCOCCAL MENINGITIS SEROGROUP A THAT WAS LICENSED AND INTRODUCED IN 2010. THE POLYVALENT VACCINE TARGETS SEROGROUPS A, C, W, X, AND Y. THE VACCINE IS DESIGNED FOR USE IN AFRICA'S "MENINGITIS BELT" REGION AND, AS THE FIRST VACCINE TO TARGET SEROGROUP X, HAS THE POTENTIAL TO ELIMINATE MENINGITIS EPIDEMICS FROM THIS REGION. TO PREVENT MALARIA, PATH IS ACCELERATING THE DEVELOPMENT OF A WIDE VARIETY OF MALARIA VACCINE CANDIDATES AND APPROACHES. IN 2019, WE WORKED WITH WHO AND OTHER PARTNERS, INCLUDING THE MINISTRIES OF HEALTH IN GHANA, KENYA, AND MALAWI, TO BEGIN PILOT IMPLEMENTATION OF THE RTS,S VACCINE IN SELECTED AREAS OF THOSE COUNTRIES. WITH OUR PARTNERS, PATH CONTINUED TO ADVANCE RESEARCH INTO WHETHER REDUCING THE DOSE LEVEL OF RTS,S AND DELAYING THE ADMINISTRATION OF DOSES HAS THE POTENTIAL TO FURTHER AID MALARIA ELIMINATION EFFORTS BY STRETCHING LIMITED VACCINE SUPPLIES AND PROTECTING AS MANY PEOPLE AS POSSIBLE. PILOT INTRODUCTION IN KENYA OF THE DELAYED FRACTIONAL-DOSE REGIMEN BEGAN IN 2019. ADDITIONALLY, WORK CONTINUED ON EFFORTS TO IDENTIFY IMMUNE CORRELATES OF PROTECTION FOR MALARIA VACCINES AND ON THE USE OF MONOCLONAL ANTIBODIES TO COMBAT MALARIA.IN 2019, THE DEFEAT DIARRHEAL DISEASE (DEFEATDD) INITIATIVE, HOUSED WITHIN CVIA, CONTINUED ITS ROLE AS A DIGITAL HUB FOR KEY INFORMATION AROUND PREVENTING AND TREATING CHILDHOOD DIARRHEAL DISEASE. IN PARTNERSHIP WITH PATH'S DRUG DEVELOPMENT PROGRAM, DEFEATDD LAUNCHED A CAMPAIGN TO PROMOTE THE ADDITION OF CO-PACKAGED ORAL REHYDRATION SOLUTION (ORS) AND ZINC TO THE WHO ESSENTIAL MEDICINES LIST FOR CHILDREN. DEFEATDD ALSO LAUNCHED A CAMPAIGN FOR WORLD TOILET DAY AROUND THE ROLE OF SANITATION IN HEALTH CARE ALONGSIDE VACCINES, NUTRITION, AND ACCESS TO MEDICINES. THROUGHOUT THE YEAR, DEFEATDD'S CHANNELS HELPED DISSEMINATE POLICY UPDATES AND RESEARCH ON THE PROJECTED HEALTH AND ECONOMIC IMPACTS OF NEW AND EXISTING ENTERIC VACCINES, INCLUDING ROTAVIRUS, CHOLERA, ENTEROTOXIGENIC ESCHERICHIA COLI, SHIGELLA, AND TYPHOID. DEFEATDD ALSO MAINTAINED, UPDATED, AND EXPANDED UPON ITS ONLINE STATE-OF-THE-FIELD REPORT, STOP THE CYCLE OF DIARRHEA. PATH CONDUCTED A PHASE 3 BRIDGING STUDY IN VIETNAM TO COMPARE A NEW LIQUID FORMULATION OF THE ROTAVIRUS VACCINE, ROTAVIN, WITH AN EARLIER LICENSED FROZEN FORMULATION, ROTAVIN-M1. WE CONDUCTED A PHASE 1 STUDY IN THE UNITED STATES TO ASSESS THE SAFETY OF A SUBUNIT SHIGELLA VACCINE CANDIDATE. ADDITIONALLY, PATH HELPED INTRODUCE AND ADVANCE ACCESS TO CURRENTLY AVAILABLE ENTERIC VACCINES, INCLUDING THE RECENTLY WHO-PREQUALIFIED ROTAVAC AND ROTASIIL ROTAVIRUS VACCINES.TO PREVENT TYPHOID, PATH, AS PART OF THE TYPHOID VACCINE ACCELERATION CONSORTIUM, IS WORKING TO ACCELERATE INTRODUCTION OF TYPHOID CONJUGATE VACCINES (TCVS) IN LOW-INCOME COUNTRIES. IN 2019, PATH SUPPORTED COUNTRIES THROUGHOUT THE VACCINE DECISION-MAKING AND INTRODUCTION PROCESS. WITH SUPPORT FROM PATH, PAKISTAN BECAME THE FIRST COUNTRY TO INTRODUCE TCV INTO ITS ROUTINE CHILDHOOD IMMUNIZATION PROGRAM. WE ALSO WORKED WITH THE GOVERNMENTS OF LIBERIA AND ZIMBABWE TO DETERMINE APPROPRIATE TCV INTRODUCTION STRATEGIES, SUCCESSFULLY APPLY FOR GAVI FINANCING, AND PREPARE FOR TCV INTRODUCTION. PATH CONTINUED TO CALL ATTENTION TO TYPHOID AND THE NEED FOR INTEGRATED SOLUTIONS THROUGH A RANGE OF ADVOCACY AND COMMUNICATIONS ACTIVITIES. PATH CONTINUED TO ADVANCE PRECLINICAL DEVELOPMENT OF A VACCINE AGAINST GROUP B STREPTOCOCCUS, THE LEADING CAUSE OF BACTERIAL SEPSIS AND MENINGITIS IN YOUNG INFANTS WORLDWIDE. PATH IS SUPPORTING INVENTPRISE, A BIOTECHNOLOGY COMPANY, AS IT WORKS TO DEVELOP A MULTIVALENT, CONJUGATE VACCINE FOR LOW- AND MIDDLE-INCOME COUNTRIES. THE INTENDED RECIPIENTS ARE PREGNANT WOMEN-PART OF A STRATEGY THAT BOOSTS IMMUNITY AGAINST THE BACTERIUM AND TRANSFERS PROTECTIVE ANTIBODIES TO THE DEVELOPING BABY. ALSO IN 2019, PATH CONTINUED TO COORDINATE A CONSORTIUM OF NINE INDEPENDENT RESEARCH INSTITUTIONS TO ANALYZE EVIDENCE ON THE POTENTIAL FOR SINGLE-DOSE HPV VACCINATION. ALTHOUGH MANY COUNTRIES HAVE INTRODUCED HPV VACCINES INTO THEIR NATIONAL IMMUNIZATION SCHEDULES, SOME HAVE DELAYED INTRODUCTION BECAUSE OF FINANCIAL, LOGISTICAL, OR OTHER BARRIERS. FOR THESE COUNTRIES, A SINGLE-DOSE REGIMEN COULD ACCELERATE INTRODUCTION. PATH PROVIDES TECHNICAL ASSISTANCE TO GAVI-ELIGIBLE COUNTRIES IN PLANNING, IMPLEMENTING, AND EVALUATING NATIONAL HPV VACCINATION PROGRAMS AIMED AT VACCINATING YOUNG WOMEN. IN 2019, OUR GLOBAL TEAM AND PARTNERS ASSISTED THE GAMBIA, KENYA, AND THE SOLOMON ISLANDS WITH NATIONAL INTRODUCTIONS.
4c (Code:   ) (Expenses $ 27,230,902 including grants of $ 4,675,897 ) (Revenue $ 1,000 )
TECHNOLOGY, ANALYTICS, AND MARKET INNOVATION: PATH'S TECHNOLOGY, ANALYTICS, AND MARKET INNOVATION (TAMI) DIVISION IS AN INTEGRATED GLOBAL PLATFORM FOR END-TO-END ADVANCEMENT OF HIGH-IMPACT MEDICAL DEVICES, HEALTH TECHNOLOGIES, DIAGNOSTICS, AND IN-COUNTRY "IMPACT LABS" THAT ADDRESS GLOBAL, REGIONAL, AND COUNTRY HEALTH NEEDS. TAMI ALSO MANAGES PATH'S WORK IN MARKET DYNAMICS AND DIGITAL AND DATA EXCELLENCE.(CONTINUED ON SCHEDULE O)MEDICAL DEVICES AND HEALTH TECHNOLOGIES:THE MEDICAL DEVICES AND HEALTH TECHNOLOGIES PROGRAM WITHIN TAMI IS PATH'S INNOVATIVE PRODUCT DEVELOPMENT ARM. THE PROGRAM WORKS WITH PUBLIC- AND PRIVATE-SECTOR PARTNERS AROUND THE WORLD TO DEVELOP, TEST, REFINE, INTRODUCE, AND SCALE AFFORDABLE TECHNOLOGIES TO IMPROVE THE HEALTH OF PEOPLE IN LOW- AND MIDDLE-INCOME COUNTRIES.IN 2019, THE PROGRAM REACHED SEVERAL KEY MILESTONES; FOR EXAMPLE, THE ELLAVI UTERINE BALLOON TAMPONADE, A MEDICAL PRODUCT ADVANCED BY PATH TO MANAGE POSTPARTUM HEMORRHAGE, RECEIVED A CE MARK, AND THE FIRST SOLAR-POWERED "ENERGY HARVESTING CONTROL" VACCINE REFRIGERATORS, FOR WHICH PATH HAS BEEN CONDUCTING IN-COUNTRY ASSESSMENTS, PASSED PREQUALIFICATION TESTING IN SENEGAL FOR WHO PERFORMANCE, QUALITY, AND SAFETY APPROVAL. (ENERGY HARVESTING CONTROL ALLOWS EXTRA SOLAR POWER TO BE USED FOR OTHER PURPOSES AT A HEALTH FACILITY.) IN ADDITION, WE TRANSFERRED A FORMULATION AND LYOPHILIZATION PROCEDURE TO DERMBIONT FOR A TOPICAL GEL FORMULATION OF JANTHINOBACTERIUM LIVIDUM BACTERIA FOR TREATING FUNGAL INFECTIONS.PATH ALSO WORKED IN 2019 TO EVALUATE AND ADVANCE DEVICES FOR LONG-TERM ANTIRETROVIRAL DELIVERY OF PREP AND HIV TREATMENT. THESE DEVICES INCLUDE MICROARRAY PATCHES FOR TRANSDERMAL DELIVERY. STAFF PRODUCED 17 JOURNAL ARTICLES AND REPORTS ON RESEARCH FINDINGS, INCLUDING 2 FOR INACTIVATED POLIOVIRUS VACCINE: ONE EVALUATING THE TECHNICAL PRODUCT ATTRIBUTES OF AN ORAL ENTERIC VACCINE CURRENTLY UNDER DEVELOPMENT FOR INFANTS, THE OTHER EVALUATING THE COST PER CHILD VACCINATED WITH FULL VERSUS FRACTIONAL-DOSE VACCINE.DIAGNOSTICS:PATH ADVANCES EQUITABLE AND SUSTAINABLE ACCESS TO QUALITY-ASSURED, PURPOSE-DRIVEN DIAGNOSTICS FOR BETTER TESTING AND TREATMENT OF DISEASES IN LOW-RESOURCE SETTINGS.IN 2019, OUR PIONEERING WORK IN DIAGNOSTICS INCLUDED QUALIFYING, VALIDATING, EVALUATING, AND COMMERCIALIZING TESTS, REFERENCE ASSAYS, AND TOOLS; CONDUCTING PERFORMANCE EVALUATIONS AND CLINICAL TRIALS TO INFORM PATIENT CARE; AND PUBLISHING 20 PEER-REVIEWED JOURNAL ARTICLES.IN PARTNERSHIP WITH PATH'S MALARIA AND NEGLECTED TROPICAL DISEASES PROGRAM, THE DIAGNOSTICS TEAM INITIATED SIX CLINICAL STUDIES FOR POINT-OF-CARE TESTS FOR GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) DEFICIENCY, A CONDITION THAT CAN COMPLICATE TREATMENT OF PLASMODIUM VIVAX MALARIA. BY THE END OF 2019, WE HAD COMPLETED ENROLLMENT IN FIVE OF THE STUDIES. PATH ALSO SUPPORTED COMMERCIALIZATION OF THE QUANSYS Q-PLEX HUMAN MALARIA ARRAY, WHICH CAN BE USED FOR MALARIA RESEARCH AND SURVEILLANCE. ADDITIONALLY, WE EVALUATED THE PERFORMANCE OF SEVERAL MALARIA RAPID DIAGNOSTIC TESTS, WHICH CAN NOW PROCEED TO CLINICAL EVALUATIONS. THE DIAGNOSTICS TEAM ALSO ESTABLISHED A COMMUNITY OF PRACTICE FOR G6PD OPERATIONAL RESEARCH AND HOSTED THREE INFORMATION-SHARING WEBINARS. IN PARTNERSHIP WITH THE UNIVERSITY OF WASHINGTON, PATH DEVELOPED AND COMMERCIALIZED A BAG-MEDIATED FILTRATION SYSTEM FOR THE ENVIRONMENTAL SURVEILLANCE OF WILD POLIOVIRUS IN SEWAGE. THIS SYSTEM SIMPLIFIES COLLECTION OF THE MATERIAL TO BE TESTED. IN 2019, THE DIAGNOSTICS TEAM CELEBRATED THE LAUNCH OF AN ENZYME-LINKED IMMUNOSORBENT ASSAY KIT THAT WE HELPED DEVELOP AND EVALUATE TO DETECT EXPOSURE TO ONCHOCERCA VOLVULUS, THE PARASITE THAT CAUSES ONCHOCERCIASIS (RIVER BLINDNESS). THE KIT SUPPORTS SEROLOGICAL SURVEILLANCE FOR RIVER BLINDNESS IN CONTROL AND ELIMINATION PROGRAMS IN AFRICA.PATH DIAGNOSTICS ALSO QUALIFIED AND VALIDATED A REFERENCE ASSAY FOR LIPOARABINOMANNAN (LAM), A VIRULENCE FACTOR ASSOCIATED WITH TB. THIS REFERENCE ASSAY IS NOW AVAILABLE FOR THE TB DIAGNOSTIC COMMUNITY TO INDEPENDENTLY EVALUATE EMERGING DIAGNOSTIC LATERAL FLOW ASSAYS FOR THE DETECTION OF URINARY LAM. FURTHER, PATH COMPLETED A FIELD PERFORMANCE EVALUATION STUDY OF A NEW PREECLAMPSIA TEST WITH PARTNERS IN GHANA. AN AFRICAN-BASED MANUFACTURER LAUNCHED THE PRODUCT IN LATE 2019. IT IS NOW BEING USED TO INFORM PATIENT CARE. FINALLY, IN COLLABORATION WITH A PRIVATE-SECTOR PARTNER, PATH WORKED TO DEVELOP A SEROTYPE-SPECIFIC URINE ANTIGEN DETECTION ASSAY ON A PLATFORM SUITABLE FOR USE IN LOW- AND MIDDLE-INCOME COUNTRIES. THE ASSAY PROVIDES HIGH-PERFORMANCE DETECTION ACROSS AN EXPANDED PANEL OF COMMON PNEUMOCOCCAL CONJUGATED VACCINE SEROTYPES. THIS ENHANCED CAPACITY INCREASES ITS UTILITY AS A TOOL FOR BOTH CLINICAL AND EPIDEMIOLOGIC STUDIES TO SUPPORT DEVELOPMENT OF A PNEUMONIA VACCINE.IMPACT LABS:PATH'S IMPACT LABS IN INDIA AND SOUTH AFRICA HELP ADVANCE THE MOST PROMISING HEALTH TECHNOLOGIES. THESE COUNTRIES HAVE RICH INNOVATION ECOSYSTEMS WITH UNIVERSITIES, PRIVATE-SECTOR FIRMS, AND A GROWING NUMBER OF ENTREPRENEURS FOCUSED ON DEVELOPING PRODUCTS AND SERVICES THAT MAKE HEALTH CARE MORE AFFORDABLE, ACCESSIBLE, AND EFFECTIVE.THE INDIA IMPACT LAB, A PARTNERSHIP WITH TATA TRUSTS AND THE INDIAN INSTITUTE OF TECHNOLOGY DELHI, IS A PLATFORM TO ENABLE LATE-STAGE MEDICAL TECHNOLOGY (MEDTECH) INNOVATIONS TO ACHIEVE MARKET ENTRY, ADOPTION, AND SCALE. THE IMPACT LAB ALSO PARTNERS WITH TOP INDIAN TECHNOLOGY AND BUSINESS INCUBATORS IN THE LIFE SCIENCE AND HEALTH CARE INDUSTRIES TO FURTHER DEVELOP THE INNOVATION ECOSYSTEM. IN 2019, THE IMPACT LAB BEGAN ENGAGEMENT WITH TEN SELECTED MEDTECH START-UPS UNDER THE QUEST FOR HEALTHCARE INNOVATIONS PROGRAM, A JOINT INITIATIVE WITH SOCIAL ALPHA. THE PROGRAM FEATURES A SYSTEMATIC, COHORT-BASED ENGAGEMENT MODEL, PROVIDING THE SELECTED START-UPS WITH CONTEXTUAL SUPPORT, GUIDANCE, AND MENTORSHIP IN PRODUCT DEVELOPMENT, CLINICAL EVIDENCE GENERATION, REGULATIONS, QUALITY MANAGEMENT, MARKET UNDERSTANDING, AND PROCUREMENT CHANNELS. ACTIVITIES INCLUDED A DEEP AND EXPANSIVE REQUIREMENT MAPPING FOR EACH START-UP AS WELL AS SUPPORT FOR THEIR CLINICAL VALIDATION JOURNEY AND GO-TO-MARKET NEEDS. THE IMPACT LAB CONDUCTED TWO CURATED CONVENINGS FOR THE COHORT: ONE WITH DOMAIN EXPERTS IN CLINICAL AND REGULATORY COMPLIANCE, THE OTHER WITH EXPERTS IN PUBLIC AND PRIVATE MEDICAL DEVICE TECHNOLOGY ASSESSMENT AND PROCUREMENT. ADDITIONALLY, THE IMPACT LAB DELIVERED FIVE FOCUSED KNOWLEDGE PLATFORMS, INCLUDING WORKSHOPS AND ROUNDTABLES FOR THE WIDER MEDTECH ECOSYSTEM. FOR THESE, THE IMPACT LAB ENGAGED WITH EXPERTS FROM NUMEROUS LARGE AND SMALL MEDTECH COMPANIES, PARTNER INCUBATORS, INDUSTRY, AND ACADEMIA, AS WELL AS KEY NATIONAL AND GLOBAL STAKEHOLDERS. THE KNOWLEDGE PLATFORMS COVERED A RANGE OF TOPICS-FROM TESTING AND CALIBRATING MEDICAL DEVICES TO MEDTECH REGULATIONS, LATE-STAGE PRODUCT DEVELOPMENT, AND MARKET ACCESS- AND INCLUDED ROUNDTABLE DISCUSSION OF PERTINENT ISSUES IN TB DETECTION, TREATMENT, AND ADHERENCE TO MEDICATION. THE IMPACT LAB, A CROSS-CUTTING INITIATIVE WITHIN PATH, PROVIDED SUPPORT TO PATH'S PROGRAM VERTICALS, FOR EXAMPLE IN THE DEVELOPMENT OF A MENSTRUAL HEALTH APPLICATION FOR WOMEN IN LOW- AND MIDDLE-INCOME COUNTRIES, DEVELOPMENT OF A TARGET PRODUCT PROFILE FOR MICROARRAY PATCHES FOR RABIES VACCINE DELIVERY, AND OPERATIONAL VALIDATION OF TRUENAT, A MOLECULAR DIAGNOSTIC DEVICE FOR DETECTION OF TB. THROUGH THE SOUTH AFRICA IMPACT LAB, PATH ACCELERATED OUR ASSISTANCE TO THE SOUTH AFRICAN MEDICAL RESEARCH COUNCIL (SAMRC) THROUGH THE JOINT GLOBAL HEALTH INNOVATION ACCELERATOR (GHIA) PARTNERSHIP. GHIA, WHICH IS PRIMARILY FUNDED BY A GRANT FROM THE BILL & MELINDA GATES FOUNDATION TO SAMRC, CONTINUES TO SUPPORT THE DEVELOPMENT AND COMMERCIALIZATION OF MEDICAL TECHNOLOGIES DESIGNED FOR RESOURCE-LIMITED SETTINGS IN SOUTH AFRICA AND BEYOND. IN 2019, PATH HOSTED STAFF FROM SAMRC FOR A WEEKLONG EXCHANGE IN SEATTLE, WASHINGTON. THE FOCUS WAS ON SHARING INTERNAL PATH PROCESSES FOR TECHNOLOGY EVALUATION, PRODUCT DEVELOPMENT, AND GO-TO-MARKET STRATEGIES, AND IDENTIFYING AREAS OF SUPPORT ON CERTAIN GHIA PROJECTS. ADDITIONAL CAPACITY-BUILDING EFFORTS INCLUDED A "BOOTCAMP" SESSION IN CAPE TOWN TO DISCUSS PRODUCT INTRODUCTION TOPICS SUCH AS PROCUREMENT, MARKET SIZING, AND COUNTRY DOWN-SELECTION APPROACHES. TO INCREASE GHIA'S VISIBILITY, PATH AND SAMRC CO-WROTE AND PUBLISHED AN ARTICLE REFLECTING ON THE LAST FIVE YEARS.
(Code:   ) (Expenses $ 22,615,272 including grants of $ 4,940,809 ) (Revenue $   )
ADVOCACY AND PUBLIC POLICYPATH'S ADVOCACY AND PUBLIC POLICY TEAM WORKS IN THE UNITED STATES, AT THE GLOBAL LEVEL WITH MULTILATERAL AGENCIES, AND IN COUNTRIES AND COMMUNITIES AROUND THE WORLD. WE HELP POLICYMAKERS UNDERSTAND ISSUES AND MOTIVATE THEM TO COMMIT FUNDING, CRAFT POLICIES, AND SPONSOR INITIATIVES TO STRENGTHEN GLOBAL HEALTH EFFORTS. IN 2019, PATH LED EFFORTS TO ENSURE SUPPORT AMONG POLICYMAKERS IN THE UNITED STATES, EUROPE, AND MULTILATERAL AGENCIES TO MAINTAIN AND STRENGTHEN WORK IN RESEARCH AND DEVELOPMENT (R&D), MATERNAL AND CHILD HEALTH, IMMUNIZATION, AND GLOBAL HEALTH SECURITY. OUR SUCCESSES IN 2019 INCLUDED PROTECTING KEY US GOVERNMENT FUNDING FOR OUR PRIORITY HEALTH AREAS AND SUCCESSFULLY INFLUENCING LANGUAGE CALLING FOR NEW R&D FUNDING AND STRONG REGULATORY SYSTEMS IN THE OUTCOME STATEMENT OF THE UNITED NATIONS HIGH-LEVEL MEETING ON UNIVERSAL HEALTH COVERAGE. WORKING WITH PARTNERS IN AFRICAN COUNTRIES, WE HELPED ADVANCE POLICIES TO IMPROVE THE HEALTH OF WOMEN AND CHILDREN. AMONG MANY ACHIEVEMENTS DURING 2019, IN THE DRC, A NATIONAL IMMUNIZATION FORUM WE ORGANIZED IN PARTNERSHIP WITH THE HEAD OF STATE LED TO AN UNPRECEDENTED COMMITMENT BY NATIONAL AND PROVINCIAL LEADERS TO IMPROVE ROUTINE IMMUNIZATION AND POLIO ERADICATION EFFORTS. IN UGANDA, PATH'S ONGOING IMMUNIZATION ADVOCACY RESULTED IN THE GOVERNMENT NEARLY DOUBLING ITS BUDGET FOR ROUTINE IMMUNIZATION. IN KENYA, YEARS OF ADVOCACY BY PATH RESULTED IN PASSAGE OF THE FIRST COMPREHENSIVE POLICY IDENTIFYING PRIORITIES FOR HEALTH R&D, AND IN SOUTH AFRICA, PATH'S ADVOCACY AND COALITION-BUILDING EFFORTS CONTINUED TO STRENGTHEN SUPPORT FOR HEALTH R&D.SPECIAL INITIATIVESPATH IS ENGAGED IN A VARIETY OF SPECIAL INITIATIVES THAT GALVANIZE OUR EXPERTISE AND RESOURCES AND THOSE OF OUR GLOBAL PARTNERS TO SAVE MORE LIVES, MORE QUICKLY. BY THE END OF 2019, WE HAD ACTIVE HEALTH IMPACT TEAMS IN SEVEN HEALTH AREAS. EACH HEALTH IMPACT TEAM HAS BEEN ONGOING FOR AT LEAST TWO YEARS, WORKING TO BUILD STRUCTURED COLLABORATION ACROSS PROGRAMS AND GEOGRAPHIES TO INCREASE PATH'S IMPACT.
4d Other program services (Describe in Schedule O.)
(Expenses $ 22,615,272 including grants of $ 4,940,809 ) (Revenue $   )
4e Total program service expensesMediumBullet257,713,007
Form 990 (2019)
Form 990 (2019)
Page 3
Part IV
Checklist of Required Schedules
Yes
No
1
Is the organization described in section 501(c)(3) or 4947(a)(1) (other than a private foundation)? If "Yes," complete Schedule AClick to see attachment.....................
1
Yes
 
2
Is the organization required to complete Schedule B, Schedule of Contributors (see instructions)? Click to see attachment...
2
Yes
 
3
Did the organization engage in direct or indirect political campaign activities on behalf of or in opposition to candidates for public office? If "Yes," complete Schedule C, Part IClick to see attachment.............
3
 
No
4
Section 501(c)(3) organizations. Did the organization engage in lobbying activities, or have a section 501(h) election in effect during the tax year? If "Yes," complete Schedule C, Part IIClick to see attachment.........
4
Yes
 
5
Is the organization a section 501(c)(4), 501(c)(5), or 501(c)(6) organization that receives membership dues, assessments, or similar amounts as defined in Revenue Procedure 98-19? If "Yes," complete Schedule C, Part IIIClick to see attachment..
5
 
No
6
Did the organization maintain any donor advised funds or any similar funds or accounts for which donors have the right to provide advice on the distribution or investment of amounts in such funds or accounts? If "Yes," complete Schedule D, Part IClick to see attachment.........................
6
 
No
7
Did the organization receive or hold a conservation easement, including easements to preserve open space,
the environment, historic land areas, or historic structures? If "Yes," complete Schedule D, Part IIClick to see attachment....
7
 
No
8
Did the organization maintain collections of works of art, historical treasures, or other similar assets? If "Yes,"
complete Schedule D, Part IIIClick to see attachment..............
8
 
No
9
Did the organization report an amount in Part X, line 21 for escrow or custodial account liability; serve as a custodian for amounts not listed in Part X; or provide credit counseling, debt management, credit repair, or debt negotiation services? If "Yes," complete Schedule D, Part IVClick to see attachment..............
9
 
No
10
Did the organization, directly or through a related organization, hold assets in temporarily restricted endowments, permanent endowments, or quasi endowments? If "Yes," complete Schedule D, Part V......
10
Yes
 
11
If the organization’s answer to any of the following questions is "Yes," then complete Schedule D, Parts VI, VII, VIII, IX, or X as applicable.
a
Did the organization report an amount for land, buildings, and equipment in Part X, line 10? If "Yes," complete
Schedule D, Part VI. Click to see attachment...................
11a
Yes
 
b
Did the organization report an amount for investments—other securities in Part X, line 12 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part VIIClick to see attachment.......
11b
 
No
c
Did the organization report an amount for investments—program related in Part X, line 13 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part VIIIClick to see attachment.......
11c
 
No
d
Did the organization report an amount for other assets in Part X, line 15 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part IXClick to see attachment............
11d
 
No
e
Did the organization report an amount for other liabilities in Part X, line 25? If "Yes," complete Schedule D, Part XClick to see attachment
11e
 
No
f
Did the organization’s separate or consolidated financial statements for the tax year include a footnote that addresses the organization’s liability for uncertain tax positions under FIN 48 (ASC 740)? If "Yes," complete Schedule D, Part XClick to see attachment
11f
 
No
12a
Did the organization obtain separate, independent audited financial statements for the tax year? If "Yes," complete
Schedule D, Parts XI and XIIClick to see attachment......................
12a
 
No
b
Was the organization included in consolidated, independent audited financial statements for the tax year? If "Yes," and if the organization answered "No" to line 12a, then completing Schedule D, Parts XI and XII is optional Click to see attachment
12b
Yes
 
13
Is the organization a school described in section 170(b)(1)(A)(ii)? If "Yes," complete Schedule E
13
 
No
14a
Did the organization maintain an office, employees, or agents outside of the United States? .....
14a
Yes
 
b
Did the organization have aggregate revenues or expenses of more than $10,000 from grantmaking, fundraising, business, investment, and program service activities outside the United States, or aggregate foreign investments valued at $100,000 or more? If "Yes," complete Schedule F, Parts I and IV.........Click to see attachment
14b
Yes
 
15
Did the organization report on Part IX, column (A), line 3, more than $5,000 of grants or other assistance to or for any foreign organization? If “Yes,” complete Schedule F, Parts II and IV.....Click to see attachment
15
Yes
 
16
Did the organization report on Part IX, column (A), line 3, more than $5,000 of aggregate grants or other assistance to or for foreign individuals? If “Yes,” complete Schedule F, Parts III and IV...Click to see attachment
16
 
No
17
Did the organization report a total of more than $15,000 of expenses for professional fundraising services on Part IX, column (A), lines 6 and 11e? If "Yes," complete Schedule G, Part I(see instructions) ....
17
 
No
18
Did the organization report more than $15,000 total of fundraising event gross income and contributions on Part VIII, lines 1c and 8a? If "Yes," complete Schedule G, Part II............
18
 
No
19
Did the organization report more than $15,000 of gross income from gaming activities on Part VIII, line 9a? If "Yes," complete Schedule G, Part III...................
19
 
No
20a
Did the organization operate one or more hospital facilities? If "Yes," complete Schedule H....
20a
 
No
b
If "Yes" to line 20a, did the organization attach a copy of its audited financial statements to this return?
20b
 
 
21
Did the organization report more than $5,000 of grants or other assistance to any domestic organization or domestic government on Part IX, column (A), line 1? If “Yes,” complete Schedule I, Parts I and II.....Click to see attachment
21
Yes
 
Form 990 (2019)
Form 990 (2019)
Page 4
Part IV
Checklist of Required Schedules (continued)
Yes
No
22
Did the organization report more than $5,000 of grants or other assistance to or for domestic individuals on Part IX, column (A), line 2? If “Yes,” complete Schedule I, Parts I and III........Click to see attachment
22
Yes
 
23
Did the organization answer "Yes" to Part VII, Section A, line 3, 4, or 5 about compensation of the organization’s current and former officers, directors, trustees, key employees, and highest compensated employees? If "Yes," complete Schedule J....................... Click to see attachment
23
Yes
 
24a
Did the organization have a tax-exempt bond issue with an outstanding principal amount of more than $100,000 as of the last day of the year, that was issued after December 31, 2002? If “Yes,” answer lines 24b through 24d and complete Schedule K. If “No,” go to line 25a...............
24a
 
No
b
Did the organization invest any proceeds of tax-exempt bonds beyond a temporary period exception?...
24b
 
 
c
Did the organization maintain an escrow account other than a refunding escrow at any time during the year
to defease any tax-exempt bonds? ...............
24c
 
 
d
Did the organization act as an "on behalf of" issuer for bonds outstanding at any time during the year?...
24d
 
 
25a
Section 501(c)(3), 501(c)(4), and 501(c)(29) organizations. Did the organization engage in an excess benefit transaction with a disqualified person during the year? If "Yes," complete Schedule L, Part I ....
25a
 
No
b
Is the organization aware that it engaged in an excess benefit transaction with a disqualified person in a prior year, and that the transaction has not been reported on any of the organization’s prior Forms 990 or 990-EZ? If "Yes," complete Schedule L, Part I.......................
25b
 
No
26
Did the organization report any amount on Part X, line 5 or 22 for receivables from or payables to any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or 35% controlled entity or family member of any of these persons? If "Yes," complete Schedule L, Part II...........
26
 
No
27
Did the organization provide a grant or other assistance to any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or employee thereof, a grant selection committee member, or to a 35% controlled entity (including an employee thereof) or family member of any of these persons?
If "Yes," complete
Schedule L, Part III.........................
27
 
No
28
Was the organization a party to a business transaction with one of the following parties (see Schedule L, Part IV instructions for applicable filing thresholds, conditions, and exceptions):
a
A current or former officer, director, trustee, key employee, creator or founder, or substantial contributor? If "Yes," complete Schedule L, Part IV......................
28a
 
No
b
A family member of any individual described in line 28a? If "Yes," complete Schedule L, Part IV.....
28b
 
No
c
A 35% controlled entity of one or more individuals and/or organizations described in lines 28a or 28b? If "Yes," complete Schedule L, Part IV.....................
28c
 
No
29
Did the organization receive more than $25,000 in non-cash contributions? If "Yes," complete Schedule M..Click to see attachment
29
Yes
 
30
Did the organization receive contributions of art, historical treasures, or other similar assets, or qualified conservation contributions? If "Yes," complete Schedule M .................Click to see attachment
30
 
No
31
Did the organization liquidate, terminate, or dissolve and cease operations? If "Yes," complete Schedule N, Part I
31
 
No
32
Did the organization sell, exchange, dispose of, or transfer more than 25% of its net assets? If "Yes," complete Schedule N, Part II........................
32
 
No
33
Did the organization own 100% of an entity disregarded as separate from the organization under Regulations sections 301.7701-2 and 301.7701-3? If "Yes," complete Schedule R, Part I............Click to see attachment
33
 
No
34
Was the organization related to any tax-exempt or taxable entity? If "Yes," complete Schedule R, Part II, III, or IV, and Part V, line 1.........................Click to see attachment
34
Yes
 
35a
Did the organization have a controlled entity within the meaning of section 512(b)(13)?
35a
Yes
 
b
If ‘Yes’ to line 35a, did the organization receive any payment from or engage in any transaction with a controlled entity within the meaning of section 512(b)(13)? If "Yes," complete Schedule R, Part V, line 2 ...Click to see attachment
35b
Yes
 
36
Section 501(c)(3) organizations. Did the organization make any transfers to an exempt non-charitable related organization? If "Yes," complete Schedule R, Part V, line 2............. Click to see attachment
36
 
No
37
Did the organization conduct more than 5% of its activities through an entity that is not a related organization and that is treated as a partnership for federal income tax purposes? If "Yes," complete Schedule R, Part VIClick to see attachment
37
 
No
38
Did the organization complete Schedule O and provide explanations in Schedule O for Part VI, lines 11b and 19? Note. All Form 990 filers are required to complete Schedule O. ............
38
Yes
 
Part V
Statements Regarding Other IRS Filings and Tax Compliance
Check if Schedule O contains a response or note to any line in this Part V...........
Yes
No
1a
Enter the number reported in Box 3 of Form 1096. Enter -0- if not applicable ..
1a
248
b
Enter the number of Forms W-2G included in line 1a. Enter -0- if not applicable .
1b
0
c
Did the organization comply with backup withholding rules for reportable payments to vendors and reportable gaming (gambling) winnings to prize winners? ..................
1c
Yes
 
Form 990 (2019)
Form 990 (2019)
Page 5
Part V
Statements Regarding Other IRS Filings and Tax Compliance (continued)
2a
Enter the number of employees reported on Form W-3, Transmittal of Wage and
Tax Statements, filed for the calendar year ending with or within the year covered by this return ..................
2a
737
b
If at least one is reported on line 2a, did the organization file all required federal employment tax returns?
Note. If the sum of lines 1a and 2a is greater than 250, you may be required to e-file (see instructions)
2b
Yes
 
3a
Did the organization have unrelated business gross income of $1,000 or more during the year?...
3a
 
No
b
If “Yes,” has it filed a Form 990-T for this year? If “No” to line 3b, provide an explanation in Schedule O...
3b
 
 
4a
At any time during the calendar year, did the organization have an interest in, or a signature or other authority over, a financial account in a foreign country (such as a bank account, securities account, or other financial account)? ..
4a
Yes
 
b
If "Yes," enter the name of the foreign country: MediumBulletBE , CH , CG , ET , GH , IN , KE , BM , MZ , PE , SG , SF , SZ , TZ , UG , UK , UP , VM , ZA
See instructions for filing requirements for FinCEN Form 114, Report of Foreign Bank and Financial Accounts (FBAR).
5a
Was the organization a party to a prohibited tax shelter transaction at any time during the tax year? ..
5a
 
No
b
Did any taxable party notify the organization that it was or is a party to a prohibited tax shelter transaction?
5b
 
No
c
If "Yes," to line 5a or 5b, did the organization file Form 8886-T? ............
5c
 
 
6a
Does the organization have annual gross receipts that are normally greater than $100,000, and did the organization solicit any contributions that were not tax deductible as charitable contributions? ...
6a
 
No
b
If "Yes," did the organization include with every solicitation an express statement that such contributions or gifts were not tax deductible? ......................
6b
 
 
7
Organizations that may receive deductible contributions under section 170(c).
a
Did the organization receive a payment in excess of $75 made partly as a contribution and partly for goods and services provided to the payor? ....................
7a
 
No
b
If "Yes," did the organization notify the donor of the value of the goods or services provided? .....
7b
 
 
c
Did the organization sell, exchange, or otherwise dispose of tangible personal property for which it was required to file Form 8282? .........................
7c
 
No
d
If "Yes," indicate the number of Forms 8282 filed during the year ....
7d
 
e
Did the organization receive any funds, directly or indirectly, to pay premiums on a personal benefit contract?
7e
 
No
f
Did the organization, during the year, pay premiums, directly or indirectly, on a personal benefit contract? ..
7f
 
No
g
If the organization received a contribution of qualified intellectual property, did the organization file Form 8899 as required? ......................
7g
 
 
h
If the organization received a contribution of cars, boats, airplanes, or other vehicles, did the organization file a Form 1098-C? ..........................
7h
 
 
8
Sponsoring organizations maintaining donor advised funds. Did a donor advised fund maintained by the sponsoring organization have excess business holdings at any time during the year? ........
8
 
 
9
Sponsoring organizations maintaining donor advised funds.
a
Did the sponsoring organization make any taxable distributions under section 4966?........
9a
 
 
b
Did the sponsoring organization make a distribution to a donor, donor advisor, or related person?...
9b
 
 
10
Section 501(c)(7) organizations. Enter:
a
Initiation fees and capital contributions included on Part VIII, line 12 ...
10a
 
b
Gross receipts, included on Form 990, Part VIII, line 12, for public use of club facilities
10b
 
11
Section 501(c)(12) organizations. Enter:
a
Gross income from members or shareholders .........
11a
 
b
Gross income from other sources (Do not net amounts due or paid to other sources against amounts due or received from them.) ..........
11b
 
12a
Section 4947(a)(1) non-exempt charitable trusts. Is the organization filing Form 990 in lieu of Form 1041?
12a
 
 
b
If "Yes," enter the amount of tax-exempt interest received or accrued during the year.
12b
 
13
Section 501(c)(29) qualified nonprofit health insurance issuers.
a
Is the organization licensed to issue qualified health plans in more than one state? .........
Note. See the instructions for additional information the organization must report on Schedule O.
13a
 
 
b
Enter the amount of reserves the organization is required to maintain by the states in which the organization is licensed to issue qualified health plans ....
13b
 
c
Enter the amount of reserves on hand ............
13c
 
14a
Did the organization receive any payments for indoor tanning services during the tax year?.....
14a
 
No
b
If "Yes," has it filed a Form 720 to report these payments? If "No," provide an explanation in Schedule O..
14b
 
 
15
Is the organization subject to the section 4960 tax on payment(s) of more than $1,000,000 in remuneration or excess parachute payment(s) during the year? ....................
If "Yes," see instructions and file Form 4720, Schedule N.
15
 
No
16
Is the organization an educational institution subject to the section 4968 excise tax on net investment income? ..
If "Yes," complete Form 4720, Schedule O.
16
 
No
Form 990 (2019)
Form 990 (2019)
Page 6
Part VI
Governance, Management, and Disclosure For each "Yes" response to lines 2 through 7b below, and for a "No" response to lines 8a, 8b, or 10b below, describe the circumstances, processes, or changes in Schedule O. See instructions.
Check if Schedule O contains a response or note to any line in this Part VI..............
Section A. Governing Body and Management
Yes
No
1a
Enter the number of voting members of the governing body at the end of the tax year
1a
15
If there are material differences in voting rights among members of the governing body, or if the governing body delegated broad authority to an executive committee or similar committee, explain in Schedule O.
b
Enter the number of voting members included in line 1a, above, who are independent
1b
15
2
Did any officer, director, trustee, or key employee have a family relationship or a business relationship with any other officer, director, trustee, or key employee? .................
2
 
No
3
Did the organization delegate control over management duties customarily performed by or under the direct supervision of officers, directors or trustees, or key employees to a management company or other person? .
3
 
No
4
Did the organization make any significant changes to its governing documents since the prior Form 990 was filed? .
4
 
No
5
Did the organization become aware during the year of a significant diversion of the organization’s assets? .
5
 
No
6
Did the organization have members or stockholders? ................
6
 
No
7a
Did the organization have members, stockholders, or other persons who had the power to elect or appoint one or more members of the governing body? ....................
7a
 
No
b
Are any governance decisions of the organization reserved to (or subject to approval by) members, stockholders, or persons other than the governing body? ...................
7b
 
No
8
Did the organization contemporaneously document the meetings held or written actions undertaken during the year by the following:
a
The governing body? .......................
8a
Yes
 
b
Each committee with authority to act on behalf of the governing body? ............
8b
Yes
 
9
Is there any officer, director, trustee, or key employee listed in Part VII, Section A, who cannot be reached at the organization’s mailing address? If "Yes," provide the names and addresses in Schedule O.......
9
 
No
Section B. Policies (This Section B requests information about policies not required by the Internal Revenue Code.)
Yes
No
10a
Did the organization have local chapters, branches, or affiliates? ............
10a
 
No
b
If "Yes," did the organization have written policies and procedures governing the activities of such chapters, affiliates, and branches to ensure their operations are consistent with the organization's exempt purposes?
10b
 
 
11a
Has the organization provided a complete copy of this Form 990 to all members of its governing body before filing the form? ............................
11a
Yes
 
b
Describe in Schedule O the process, if any, used by the organization to review this Form 990. .....
12a
Did the organization have a written conflict of interest policy? If "No," go to line 13.......
12a
Yes
 
b
Were officers, directors, or trustees, and key employees required to disclose annually interests that could give rise to conflicts? ..........................
12b
Yes
 
c
Did the organization regularly and consistently monitor and enforce compliance with the policy? If "Yes," describe in Schedule O how this was done...................
12c
Yes
 
13
Did the organization have a written whistleblower policy? ...............
13
Yes
 
14
Did the organization have a written document retention and destruction policy? .........
14
Yes
 
15
Did the process for determining compensation of the following persons include a review and approval by independent persons, comparability data, and contemporaneous substantiation of the deliberation and decision?
a
The organization’s CEO, Executive Director, or top management official ...........
15a
Yes
 
b
Other officers or key employees of the organization ................
15b
Yes
 
If "Yes" to line 15a or 15b, describe the process in Schedule O (see instructions).
16a
Did the organization invest in, contribute assets to, or participate in a joint venture or similar arrangement with a taxable entity during the year? ......................
16a
 
No
b
If "Yes," did the organization follow a written policy or procedure requiring the organization to evaluate its participation in joint venture arrangements under applicable federal tax law, and take steps to safeguard the organization’s exempt status with respect to such arrangements? ............
16b
 
 
Section C. Disclosure
17
List the states with which a copy of this Form 990 is required to be filedMediumBullet
AL , AR , CA , CT , FL , IL , KS , KY , MA , MD , MI , MN , MS , NC , NH , NJ , NM , NY , OK , OR , PA , RI , SC , TN , UT , VA , WI , WV
18
Section 6104 requires an organization to make its Form 1023 (or 1024-A if applicable), 990, and 990-T (501(c)(3)s only) available for public inspection. Indicate how you made these available. Check all that apply.
19
Describe in Schedule O whether (and if so, how) the organization made its governing documents, conflict of interest policy, and financial statements available to the public during the tax year.
20
State the name, address, and telephone number of the person who possesses the organization's books and records:
MediumBulletBRIAN NEVILLE VP ACCOUNTINGFINANCIAL OPERATIONS2201 WESTLAKE AVE SUITE 200   SEATTLE,WA98121 (206) 285-3500
Form 990 (2019)
Form 990 (2019)
Page 7
Part VII
Compensation of Officers, Directors,Trustees, Key Employees, Highest Compensated Employees, and Independent Contractors
Check if Schedule O contains a response or note to any line in this Part VII..............
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees
1a Complete this table for all persons required to be listed. Report compensation for the calendar year ending with or within the organization’s tax year.
RoundBullet List all of the organization’s current officers, directors, trustees (whether individuals or organizations), regardless of amount
of compensation. Enter -0- in columns (D), (E), and (F) if no compensation was paid.

RoundBullet List all of the organization’s current key employees, if any. See instructions for definition of "key employee."
RoundBullet List the organization’s five current highest compensated employees (other than an officer, director, trustee or key employee)
who received reportable compensation (Box 5 of Form W-2 and/or Box 7 of Form 1099-MISC) of more than $100,000 from the
organization and any related organizations.

RoundBullet List all of the organization’s former officers, key employees, or highest compensated employees who received more than $100,000
of reportable compensation from the organization and any related organizations.

RoundBullet List all of the organization’s former directors or trustees that received, in the capacity as a former director or trustee of the
organization, more than $10,000 of reportable compensation from the organization and any related organizations.

See instructions for the order in which to list the persons above.
Check this box if neither the organization nor any related organization compensated any current officer, director, or trustee.
(A)
Name and title 		(B)
Average hours per week (list any hours for related organizations below dotted line) 		(C)
Position (do not check more than one box, unless person is both an officer and a director/trustee) 		(D)
Reportable compensation from the organization (W-2/1099-MISC) 		(E)
Reportable compensation from related organizations (W-2/1099-MISC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; OfficerInd; Key Employee; Highest compensated employee; FormerOfcrDirectorTrusteeInd;
(1) DAVID KING......................................................................
CHAIR
 2.00
.................
  		X   X       0 0 0
(2) BETH GALETTI......................................................................
VICE CHAIR
 2.00
.................
  		X   X       0 0 0
(3) YEHONG ZHANG......................................................................
SECRETARY
 2.00
.................
  		X   X       0 0 0
(4) BRUCE MCNAMER......................................................................
TREASURER
 2.00
.................
  		X   X       0 0 0
(5) FELIX OLALE......................................................................
DIRECTOR
 2.00
.................
  		X           0 0 0
(6) JO ADDY......................................................................
DIRECTOR
 2.00
.................
  		X           0 0 0
(7) IREENA VITTAL......................................................................
DIRECTOR
 2.00
.................
  		X           0 0 0
(8) DEANNA OPPENHEIMER......................................................................
DIRECTOR
 2.00
.................
  		X           0 0 0
(9) JOHN-ARNE ROTTINGEN......................................................................
DIRECTOR
 2.00
.................
  		X           0 0 0
(10) JOEL HOLSINGER......................................................................
DIRECTOR
 2.00
.................
  		X           0 0 0
(11) HELENA WAYTH......................................................................
DIRECTOR
 2.00
.................
  		X           0 0 0
(12) SANFORD MELZER......................................................................
DIRECTOR
 2.00
.................
  		X           0 0 0
(13) ABAYOMI SULE......................................................................
DIRECTOR (BEGAN 6/2019)
 2.00
.................
  		X           0 0 0
(14) LISA ANDERSON......................................................................
DIRECTOR (BEGAN 6/2019)
 2.00
.................
  		X           0 0 0
(15) RACHEL SIBANDE......................................................................
DIRECTOR (BEGAN 6/2019)
 2.00
.................
  		X           0 0 0
(16) STEPHEN BROWN DAVIS......................................................................
PRESIDENT AND CEO
 39.00
.................
1.00 		    X       560,672 0 64,002
(17) OLIVIA D POLIUS......................................................................
CHIEF FINANCIAL OFFICER
 39.00
.................
1.00 		    X       348,833 0 31,967
Form 990 (2019)
Form 990 (2019)
Page 8
Part VII
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees (continued)
(A)
Name and title 		(B)
Average hours per week (list any hours for related organizations below dotted line) 		(C)
Position (do not check more than one box, unless person is both an officer and a director/trustee) 		(D)
Reportable compensation from the organization (W-2/1099-MISC) 		(E)
Reportable compensation from related organizations (W-2/1099-MISC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; OfficerInd; Key Employee; Highest compensated employee; FormerOfcrDirectorTrusteeInd;
(18) JERRY KUO........................................................................
CHIEF OF STRATEGIC FINANCE
 39.00
.......................1.00 		    X       215,587 0 55,953
(19) BRIAN N NEVILLE........................................................................
CHIEF OF ACCOUNTING
 39.00
.......................1.00 		    X       223,677 0 34,710
(20) PRAVEEN RAJA........................................................................
CHIEF OPERATING OFFICER
 39.00
.......................1.00 		      X     408,540 0 39,837
(21) DAVID C KASLOW........................................................................
VP - ESSENTIAL MEDICNES
 39.00
.......................1.00 		      X     383,540 0 66,181
(22) JEFFREY D BERNSON........................................................................
VP - TECH, ANALYTICS, & MRKT INNOV.
 40.00
.......................   		      X     373,374 0 57,347
(23) DAVID W FLEMING........................................................................
VP - PUBLIC HEALTH
 40.00
.......................   		      X     301,683 0 48,312
(24) ELAINE L GIBBONS........................................................................
VP - GLOBAL ENGAGEMENT
 40.00
.......................   		      X     250,039 0 72,215
(25) MOLLI M BARNES........................................................................
CHIEF PEOPLE OFFICER
 40.00
.......................   		      X     216,837 0 47,872
(26) ERICA JANE SESSLE........................................................................
CHIEF OF STAFF
 40.00
.......................   		      X     214,896 0 36,881
(27) SABRINA L POWERS........................................................................
GENERAL COUNSEL
 40.00
.......................   		      X     161,635 0 31,739
(28) TRAD M HATTON........................................................................
COUNTRY DIRECTOR
 40.00
.......................   		        X   333,412 0 49,783
(29) JAMES B MCKENNA........................................................................
DEPUTY DIRECTOR
 40.00
.......................   		        X   290,281 0 77,625
(30) ASHLEY J BIRKETT........................................................................
GLOBAL HEAD, MALARIA VACCINES
 40.00
.......................   		        X   310,040 0 59,402
(31) BRUCE LAMONT INNIS........................................................................
GLOBAL HEAD, RESPIRATORY INFECTIONS
 40.00
.......................   		        X   320,624 0 32,892
(32) JOHN O KONZ........................................................................
GLOBAL HEAD, FINANCIAL MANAGEMENT
 40.00
.......................   		        X   312,968 0 61,168
1b Sub-Total................MediumBullet
c Total from continuation sheets to Part VII, Section A....MediumBullet
d Total (add lines 1b and 1c)...........MediumBullet 5,226,638 0 867,886
2
Total number of individuals (including but not limited to those listed above) who received more than $100,000 of reportable compensation from the organization MediumBullet318
Yes
No
3
Did the organization list any former officer, director or trustee, key employee, or highest compensated employee on line 1a? If "Yes," complete Schedule J for such individual ..............
3
 
No
4
For any individual listed on line 1a, is the sum of reportable compensation and other compensation from the organization and related organizations greater than $150,000? If "Yes," complete Schedule J for such
individual...........................
4
Yes
 
5
Did any person listed on line 1a receive or accrue compensation from any unrelated organization or individual for services rendered to the organization? If "Yes," complete Schedule J for such person ........
5
 
No
Section B. Independent Contractors
1
Complete this table for your five highest compensated independent contractors that received more than $100,000 of compensation from the organization. Report compensation for the calendar year ending with or within the organization’s tax year.
(A)
Name and business address 		(B)
Description of services 		(C)
Compensation
WMBE PAYROLLING DBA TARGETCW

9475 CHESAPEAKE DR
SAN DIEGO,CA92123 		GENERAL CONTRACTOR 726,012
AIRCRUISE TRAVELS PVT LTD

C 101 - 102 LAJPAT NAGAR 1
NEW DELHI   110024
IN 		TRAVEL SERVICES 522,166
UNIT4 BUSINESS SOFTWARE INC

3 BURLINGTON WOODS SUITE 201
BURLINGTON,MA01803 		SYSTEMS CONTRACTOR 414,490
RANDSTAD INDIA PVT LTD

SUIT NO 001 002 COPIA
NEW DELHI   110025
IN 		STAFFING SERVICES 391,145
CLARK NUBER & CO PS

10900 NE 4TH ST SUITE 1400
BELLEVUE,WA98004 		ACCOUNTING SERVICES 375,309
2
Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 of compensation from the organization MediumBullet46
Form 990 (2019)
Form 990 (2019)
Page 9
Part VIII
Statement of Revenue
Check if Schedule O contains a response or note to any line in this Part VIII.............
(A)
Total revenue 		(B)
Related or
exempt
function
revenue 		(C)
Unrelated
business
revenue 		(D)
Revenue
excluded from
tax under sections
512 - 514
Contributions, Gifts, GrantAmt and OtherAmt Similar Amounts 1a Federated campaigns..1a  
b Membership dues..1b  
c Fundraising events..1c  
d Related organizations1d 4,265,711
e Government grants (contributions)1e 106,320,456
f All other contributions, gifts, grants, and similar amounts not included above1f 176,222,378
g Noncash contributions included in lines 1a - 1f:$ 1g 4,343,453
h Total. Add lines 1a-1f.......MediumBullet 286,808,545
Program Service RevenueAmt Business Code
2a CONSULTANCIES 541900 2,038 2,038    
b
c
d
e
f All other program service revenue.        
g Total. Add lines 2a–2f .....MediumBullet 2,038
OtherAmtRevenueAmt 3 Investment income (including dividends, interest, and othersimilar amounts) ......MediumBullet 6,310,221     6,310,221
4 Income from investment of tax-exempt bond proceedsMediumBullet        
5 Royalties...........MediumBullet        
(ii) Personal (i) Real
6a Gross rents     6a
b Less: rental expenses     6b
c Rental income or (loss)     6c
d Net rental income or (loss).......MediumBullet        
(ii) Other (i) Securities
7a Gross amount from sales of assets other than inventory 38,000 89,753,987 7a
b Less: cost or other basis and sales expenses 188,547 89,190,233 7b
c Gain or (loss) -150,547 563,754 7c
d Net gain or (loss).........MediumBullet 413,207     413,207
8a Gross income from fundraising events (not including $   of contributions reported on line 1c). See Part IV, line 18 ....
8a  
b Less: direct expenses ... 8b  
c Net income or (loss) from fundraising events..MediumBullet      
9a Gross income from gaming activities.
See Part IV, line 19 ...
9a  
b Less: direct expenses ... 9b  
c Net income or (loss) from gaming activities..MediumBullet        
10a Gross sales of inventory, less
returns and allowances ..
10a  
b Less: cost of goods sold .. 10b  
c Net income or (loss) from sales of inventory..MediumBullet        
Business Code Miscellaneous Revenue
11a OTHER 900099 806,343     806,343
b REIMBURSEMENTS 900099 30,527     30,527
c            
d All other revenue ....        
e Total. Add lines 11a–11d ...... MediumBullet 836,870
12 Total revenue. See instructions.....MediumBullet 294,370,881 2,038 0 7,560,298
Form 990 (2019)
Form 990 (2019)
Page 10
Part IX
Statement of Functional Expenses
Section 501(c)(3) and 501(c)(4) organizations must complete all columns. All other organizations must complete column (A).Check if Schedule O contains a response or note to any line in this Part IX..............
Do not include amounts reported on lines 6b,
7b, 8b, 9b, and 10b of Part VIII. 		(A)
Total expenses 		(B)
Program service expenses 		(C)
Management and general expenses 		(D)
Fundraising
expenses
1 Grants and other assistance to domestic organizations and domestic governments. See Part IV, line 21 .... 16,151,505 16,151,505
2 Grants and other assistance to domestic individuals. See Part IV, line 22 ........... 10,313 10,313
3 Grants and other assistance to foreign organizations, foreign governments, and foreign individuals. See Part IV, lines 15 and 16. ............. 39,457,262 39,457,262
4 Benefits paid to or for members .......    
5 Compensation of current officers, directors, trustees, and key employees ........... 4,246,329 659,952 3,555,676 30,701
6 Compensation not included above, to disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B) .........        
7 Other salaries and wages........ 95,165,062 85,092,916 8,828,907 1,243,239
8 Pension plan accruals and contributions (include section 401(k) and 403(b) employer contributions) .... 10,334,465 8,600,526 1,597,257 136,682
9 Other employee benefits ....... 15,489,969 13,144,164 2,160,891 184,914
10 Payroll taxes ........... 6,354,673 5,288,484 982,144 84,045
11 Fees for services (non-employees):        
a Management ......        
b Legal ......... 551,399 374,203 177,196  
c Accounting ........... 483,910 91,666 392,244  
d Lobbying ........... 2,986 2,986    
e Professional fundraising services. See Part IV, line 17    
f Investment management fees ...... 186,964   186,964  
g Other (If line 11g amount exceeds 10% of line 25, column (A) amount, list line 11g expenses on Schedule O) 15,623,175 11,637,627 3,756,218 229,330
12 Advertising and promotion .... 198,936 179,102 5,043 14,791
13 Office expenses ....... 6,900,163 5,434,596 1,382,874 82,693
14 Information technology ...... 1,363,777 450,053 899,342 14,382
15 Royalties .. 46,984 46,984    
16 Occupancy ........... 12,090,090 228,951 11,861,139  
17 Travel ............ 18,810,123 17,257,403 1,525,961 26,759
18 Payments of travel or entertainment expenses for any federal, state, or local public officials .        
19 Conferences, conventions, and meetings .... 8,225,745 8,102,741 66,093 56,911
20 Interest ........... 1,901 2 1,899  
21 Payments to affiliates .......        
22 Depreciation, depletion, and amortization .. 3,202,950 12,403 3,190,547  
23 Insurance ... 669,187 212,403 456,784  
24 Other expenses. Itemize expenses not covered above (List miscellaneous expenses in line 24e. If line 24e amount exceeds 10% of line 25, column (A) amount, list line 24e expenses on Schedule O.)
a SUBCONTRACTORS 25,505,228 25,366,038 139,190  
b EQUIP RENT & MAINT 3,622,319 2,157,809 1,461,681 2,829
c DIRECT AID TO BENEFICIA 3,034,623 3,034,623    
d FACILITIES ALLOC 0 13,042,418 -13,264,007 221,589
e All other expenses 4,578,801 1,675,877 2,552,439 350,485
25 Total functional expenses. Add lines 1 through 24e 292,308,839 257,713,007 31,916,482 2,679,350
26 Joint costs. Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation. Check here MediumBullet if following SOP 98-2 (ASC 958-720).        
Form 990 (2019)
Form 990 (2019)
Page 11
Part X
Balance Sheet
Check if Schedule O contains a response or note to any line in this Part IX..............
(A)
Beginning of year 		(B)
End of year
Assets 1 Cash–non-interest-bearing ........ 7,576,050 1 8,845,877
2 Savings and temporary cash investments ......... 14,017,223 2 17,517,988
3 Pledges and grants receivable, net ...... 35,571,476 3 44,215,907
4 Accounts receivable, net ............. 10,652,789 4 16,731,594
5 Loans and other payables to any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or 35% controlled entity or family member of any of these persons .......
  5  
6 Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), and persons described in section 4958(c)(3)(B) ...
  6  
7 Notes and loans receivable, net ...........   7  
8 Inventories for sale or use ............   8  
9 Prepaid expenses and deferred charges ...... 5,307,245 9 7,170,218
10a Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D 10a 36,971,911
b Less: accumulated depreciation 10b 26,980,281 11,047,905 10c 9,991,630
11 Investments—publicly traded securities . 153,328,545 11 138,590,941
12 Investments—other securities. See Part IV, line 11 .....   12  
13 Investments—program-related. See Part IV, line 11 ..   13  
14 Intangible assets ...............   14  
15 Other assets. See Part IV, line 11 ...........   15  
16 Total assets. Add lines 1 through 15 (must equal line 33)... 237,501,233 16 243,064,155
Liabilities 17 Accounts payable and accrued expenses ..... 202,736,996 17 204,045,574
18 Grants payable ...   18  
19 Deferred revenue .........   19  
20 Tax-exempt bond liabilities .........   20  
21 Escrow or custodial account liability. Complete Part IV of Schedule D   21  
22 Loans and other payables to any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or 35% controlled entity or family member of any of these persons .........
  22  
23 Secured mortgages and notes payable to unrelated third parties .. 194,878 23  
24 Unsecured notes and loans payable to unrelated third parties ..   24  
25 Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17 - 24). Complete Part X of Schedule D   25  
26 Total liabilities. Add lines 17 through 25.. 202,931,874 26 204,045,574
Net Assets or Fund Balance Organizations that follow FASB ASC 958, check here MediumBullet and complete lines 27, 28, 32, and 33.
27 Net assets without donor restrictions .......... 19,811,400 27 20,518,990
28 Net assets with donor restrictions ........... 14,757,959 28 18,499,591
Organizations that do not follow FASB ASC 958, check here MediumBullet and complete lines 29 through 33.
29 Capital stock or trust principal, or current funds .....   29  
30 Paid-in or capital surplus, or land, building or equipment fund ...   30  
31 Retained earnings, endowment, accumulated income, or other funds   31  
32 Total net assets or fund balances ........... 34,569,359 32 39,018,581
33 Total liabilities and net assets/fund balances ........ 237,501,233 33 243,064,155
Form 990 (2019)
Form 990 (2019)
Page 12
Part XI
Reconcilliation of Net Assets
Check if Schedule O contains a response or note to any line in this Part XI..............
1
Total revenue (must equal Part VIII, column (A), line 12) ............
1
294,370,881
2
Total expenses (must equal Part IX, column (A), line 25) ............
2
292,308,839
3
Revenue less expenses. Subtract line 2 from line 1 ..............
3
2,062,042
4
Net assets or fund balances at beginning of year (must equal Part X, line 32, column (A)) ..
4
34,569,359
5
Net unrealized gains (losses) on investments ...............
5
2,387,180
6
Donated services and use of facilities .................
6
 
7
Investment expenses .....................
7
 
8
Prior period adjustments .....................
8
 
9
Other changes in net assets or fund balances (explain in Schedule O) ........
9
0
10
Net assets or fund balances at end of year. Combine lines 3 through 9 (must equal Part X, line 32, column (B))
10
39,018,581
Part XII
Financial Statements and Reporting
Check if Schedule O contains a response or note to any line in this Part XII.............
Yes
No
1
Accounting method used to prepare the Form 990:  
If the organization changed its method of accounting from a prior year or checked "Other," explain in
Schedule O.
2a
Were the organization’s financial statements compiled or reviewed by an independent accountant?
2a
 
No
If ‘Yes,’ check a box below to indicate whether the financial statements for the year were compiled or reviewed on a separate basis, consolidated basis, or both:
b
Were the organization’s financial statements audited by an independent accountant?
2b
Yes
 
If ‘Yes,’ check a box below to indicate whether the financial statements for the year were audited on a separate basis, consolidated basis, or both:
c
If "Yes," to line 2a or 2b, does the organization have a committee that assumes responsibility for oversight of the audit, review, or compilation of its financial statements and selection of an independent accountant?
2c
Yes
 
If the organization changed either its oversight process or selection process during the tax year, explain in Schedule O.
3a
As a result of a federal award, was the organization required to undergo an audit or audits as set forth in the Single Audit Act and OMB Circular A-133?
3a
Yes
 
b
If "Yes," did the organization undergo the required audit or audits? If the organization did not undergo the required audit or audits, explain why in Schedule O and describe any steps taken to undergo such audits.
3b
Yes
 
Form 990 (2019)
Form 990 (2019)
Additional Data


Software ID:  
Software Version:  
Form 990, Special Condition Description:
Special Condition Description
SCHEDULE A
(Form 990 or 990EZ)

Department of the Treasury
Internal Revenue Service
Public Charity Status and Public Support
Complete if the organization is a section 501(c)(3) organization or a section 4947(a)(1) nonexempt charitable trust.
right arrow Attach to Form 990 or Form 990-EZ.
right arrow Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2019
Open to Public
Inspection
Name of the organization
PATH
 
Employer identification number

91-1157127
Part I
Reason for Public Charity Status (All organizations must complete this part.) See instructions.
The organization is not a private foundation because it is: (For lines 1 through 12, check only one box.)
1
2
3
4
5
6
7
8
9
10
11
12
a
b
c
d
e
f
Enter the number of supported organizations ...............................  
g
Provide the following information about the supported organization(s).
(i) Name of supported organization (ii) EIN (iii) Type of organization (described on lines 1- 10 above (see instructions)) (iv) Is the organization listed in your governing document? (v) Amount of monetary support (see instructions) (vi) Amount of other support (see instructions)
Yes No
Total
 
   
For Paperwork Reduction Act Notice, see the Instructions for
Form 990 or 990-EZ.
Cat. No. 11285F
Schedule A (Form 990 or 990-EZ) 2019

Schedule A (Form 990 or 990-EZ) 2019
Page 2
Part II
Support Schedule for Organizations Described in Sections 170(b)(1)(A)(iv) and 170(b)(1)(A)(vi)
(Complete only if you checked the box on line 5, 7, or 8 of Part I or if the organization failed to qualify under Part III. If the organization failed to qualify under the tests listed below, please complete Part III.)
Section A. Public Support
Calendar year (or fiscal year beginning in) right arrow (a) 2015 (b) 2016 (c) 2017 (d) 2018 (e) 2019 (f) Total
1 Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. 243,499,792 298,315,988 347,844,394 305,316,107 286,808,545 1,481,784,826
2 Tax revenues levied for the organization's benefit and either paid to or expended on its behalf....            
3 The value of services or facilities furnished by a governmental unit to the organization without charge..            
4 Total. Add lines 1 through 3 243,499,792 298,315,988 347,844,394 305,316,107 286,808,545 1,481,784,826
5 The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. 635,757,173
6 Public support. Subtract line 5 from line 4. 846,027,653
Section B. Total Support
Calendar year (or fiscal year beginning in) right arrow (a) 2015 (b) 2016 (c) 2017 (d) 2018 (e) 2019 (f) Total
7 Amounts from line 4.. 243,499,792 298,315,988 347,844,394 305,316,107 286,808,545 1,481,784,826
8 Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... 1,471,233 1,797,794 2,050,888 2,963,587 6,310,221 14,593,723
9 Net income from unrelated business activities, whether or not the business is regularly carried on..            
10 Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. 2,551,502 4,668,393 5,225,302 980,560 836,870 14,262,627
11 Total support. Add lines 7 through 10 1,510,641,176
12
12
230,357
13
First five years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a section 501(c)(3) organization, check this box and stop here........................................right arrow
Section C. Computation of Public Support Percentage
14
14
56.000 %
15
15
55.410 %
16a
b
17a
b
18
Private foundation. If the organization did not check a box on line 13, 16a, 16b, 17a, or 17b, check this box and see
instructions ..................................................... right arrow
Schedule A (Form 990 or 990-EZ) 2019

Schedule A (Form 990 or 990-EZ) 2019
Page 3
Part III
Support Schedule for Organizations Described in Section 509(a)(2)
(Complete only if you checked the box on line 10 of Part I or if the organization failed to qualify under Part II. If the organization fails to qualify under the tests listed below, please complete Part II.)
Section A. Public Support
Calendar year (or fiscal year beginning in) right arrow (a) 2015 (b) 2016 (c) 2017 (d) 2018 (e) 2019 (f) Total
1 Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .            
2 Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose            
3 Gross receipts from activities that are not an unrelated trade or business under section 513 .....            
4 Tax revenues levied for the organization's benefit and either paid to or expended on its behalf...            
5 The value of services or facilities furnished by a governmental unit to the organization without charge            
6 Total. Add lines 1 through 5            
7a Amounts included on lines 1, 2, and 3 received from disqualified persons            
b Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year.            
c Add lines 7a and 7b..            
8 Public support. (Subtract line 7c from line 6.)  
Section B. Total Support
Calendar year (or fiscal year beginning in) right arrow (a) 2015 (b) 2016 (c) 2017 (d) 2018 (e) 2019 (f) Total
9 Amounts from line 6...            
10a Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources..            
b Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975.            
c Add lines 10a and 10b.            
11 Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on.            
12 Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) ..            
13 Total support. (Add lines 9, 10c, 11, and 12.)..            
14
Section C. Computation of Public Support Percentage
15
15
 
16
16
 
Section D. Computation of Investment Income Percentage
17
17
 
18
18
 
19a
b
20
Schedule A (Form 990 or 990-EZ) 2019

Schedule A (Form 990 or 990-EZ) 2019
Page 4
Part IV
Supporting Organizations
(Complete only if you checked a box on line 12 of Part I. If you checked 12a of Part I, complete Sections A and B. If you checked 12b of Part I, complete Sections A and C. If you checked 12c of Part I, complete Sections A, D, and E. If you checked 12d of Part I, complete Sections A and D, and complete Part V.)
Section A. All Supporting Organizations
Yes
No
1
Are all of the organization’s supported organizations listed by name in the organization’s governing documents?
If "No," describe in Part VI how the supported organizations are designated. If designated by class or purpose,
describe the designation. If historic and continuing relationship, explain.
1
 
 
2
Did the organization have any supported organization that does not have an IRS determination of status under section 509(a)(1) or (2)? If "Yes," explain in Part VI how the organization determined that the supported organization was described in section 509(a)(1) or (2).
2
 
 
3a
Did the organization have a supported organization described in section 501(c)(4), (5), or (6)? If "Yes," answer (b) and (c) below.
3a
 
 
b
Did the organization confirm that each supported organization qualified under section 501(c)(4), (5), or (6) and satisfied the public support tests under section 509(a)(2)? If "Yes," describe in Part VI when and how the organization made the determination.
3b
 
 
c
Did the organization ensure that all support to such organizations was used exclusively for section 170(c)(2)(B) purposes? If "Yes," explain in Part VI what controls the organization put in place to ensure such use.
3c
 
 
4a
Was any supported organization not organized in the United States ("foreign supported organization")? If “Yes” and if you checked 12a or 12b in Part I, answer (b) and (c) below.
4a
 
 
b
Did the organization have ultimate control and discretion in deciding whether to make grants to the foreign supported organization? If “Yes,” describe in Part VI how the organization had such control and discretion despite being controlled or supervised by or in connection with its supported organizations.
4b
 
 
c
Did the organization support any foreign supported organization that does not have an IRS determination under sections 501(c)(3) and 509(a)(1) or (2)? If “Yes,” explain in Part VI what controls the organization used to ensure that all support to the foreign supported organization was used exclusively for section 170(c)(2)(B) purposes.
4c
 
 
5a
Did the organization add, substitute, or remove any supported organizations during the tax year? If “Yes,” answer (b) and (c) below (if applicable). Also, provide detail in Part VI, including (i) the names and EIN numbers of the supported organizations added, substituted, or removed; (ii) the reasons for each such action; (iii) the authority under the organization's organizing document authorizing such action; and (iv) how the action was accomplished (such as by amendment to the organizing document).
5a
 
 
b
Type I or Type II only. Was any added or substituted supported organization part of a class already designated in the organization's organizing document?
5b
 
 
c
Substitutions only. Was the substitution the result of an event beyond the organization's control?
5c
 
 
6
Did the organization provide support (whether in the form of grants or the provision of services or facilities) to anyone other than (i) its supported organizations, (ii) individuals that are part of the charitable class benefited by one or more of its supported organizations, or (iii) other supporting organizations that also support or benefit one or more of the filing organization’s supported organizations? If “Yes,” provide detail in Part VI.
6
 
 
7
Did the organization provide a grant, loan, compensation, or other similar payment to a substantial contributor (defined in section 4958(c)(3)(C)), a family member of a substantial contributor, or a 35% controlled entity with regard to a substantial contributor? If “Yes,” complete Part I of Schedule L (Form 990 or 990-EZ) .
7
 
 
8
Did the organization make a loan to a disqualified person (as defined in section 4958) not described in line 7? If “Yes,” complete Part I of Schedule L (Form 990 or 990-EZ).
8
 
 
9a
Was the organization controlled directly or indirectly at any time during the tax year by one or more disqualified persons as defined in section 4946 (other than foundation managers and organizations described in section 509(a)(1) or (2))? If “Yes,” provide detail in Part VI.
9a
 
 
b
Did one or more disqualified persons (as defined in line 9a) hold a controlling interest in any entity in which the supporting organization had an interest? If “Yes,” provide detail in Part VI.
9b
 
 
c
Did a disqualified person (as defined in line 9a) have an ownership interest in, or derive any personal benefit from, assets in which the supporting organization also had an interest? If “Yes,” provide detail in Part VI.
9c
 
 
10a
Was the organization subject to the excess business holdings rules of section 4943 because of section 4943(f) (regarding certain Type II supporting organizations, and all Type III non-functionally integrated supporting organizations)? If “Yes,” answer line 10b below.
10a
 
 
b
Did the organization have any excess business holdings in the tax year? (Use Schedule C, Form 4720, to determine whether the organization had excess business holdings).
10b
 
 
Schedule A (Form 990 or 990-EZ) 2019

Schedule A (Form 990 or 990-EZ) 2019
Page 5
Part IV
Supporting Organizations (continued)
Yes
No
11
Has the organization accepted a gift or contribution from any of the following persons?
a
A person who directly or indirectly controls, either alone or together with persons described in (b) and (c) below, the governing body of a supported organization?
11a
 
 
b
A family member of a person described in (a) above?
11b
 
 
c
A 35% controlled entity of a person described in (a) or (b) above? If “Yes” to a, b, or c, provide detail in Part VI.
11c
 
 
Section B. Type I Supporting Organizations
Yes
No
1
Did the directors, trustees, or membership of one or more supported organizations have the power to regularly appoint or elect at least a majority of the organization’s directors or trustees at all times during the tax year? If “No,” describe in Part VI how the supported organization(s) effectively operated, supervised, or controlled the organization’s activities. If the organization had more than one supported organization, describe how the powers to appoint and/or remove directors or trustees were allocated among the supported organizations and what conditions or restrictions, if any, applied to such powers during the tax year.
1
 
 
2
Did the organization operate for the benefit of any supported organization other than the supported organization(s) that operated, supervised, or controlled the supporting organization? If “Yes,” explain in Part VI how providing such benefit carried out the purposes of the supported organization(s) that operated, supervised or controlled the supporting organization.
2
 
 
Section C. Type II Supporting Organizations
Yes
No
1
Were a majority of the organization’s directors or trustees during the tax year also a majority of the directors or trustees of each of the organization’s supported organization(s)? If “No,” describe in Part VI how control or management of the supporting organization was vested in the same persons that controlled or managed the supported organization(s).
1
 
 
Section D. All Type III Supporting Organizations
Yes
No
1
Did the organization provide to each of its supported organizations, by the last day of the fifth month of the organization’s tax year, (i) a written notice describing the type and amount of support provided during the prior tax year, (ii) a copy of the Form 990 that was most recently filed as of the date of notification, and (iii) copies of the organization’s governing documents in effect on the date of notification, to the extent not previously provided?
1
 
 
2
Were any of the organization’s officers, directors, or trustees either (i) appointed or elected by the supported organization(s) or (ii) serving on the governing body of a supported organization? If "No," explain in Part VI how the organization maintained a close and continuous working relationship with the supported organization(s).
2
 
 
3
By reason of the relationship described in (2), did the organization’s supported organizations have a significant voice in the organization’s investment policies and in directing the use of the organization’s income or assets at all times during the tax year? If "Yes," describe in Part VI the role the organization’s supported organizations played in this regard.
3
 
 
Section E. Type III Functionally-Integrated Supporting Organizations
1
Check the box next to the method that the organization used to satisfy the Integral Part Test during the year (see instructions):
a
b
c
2
Activities Test. Answer (a) and (b) below.
Yes
No
a
Did substantially all of the organization’s activities during the tax year directly further the exempt purposes of the supported organization(s) to which the organization was responsive? If "Yes," then in Part VI identify those supported organizations and explain how these activities directly furthered their exempt purposes, how the organization was responsive to those supported organizations, and how the organization determined that these activities constituted substantially all of its activities.
2a
 
 
b
Did the activities described in (a) constitute activities that, but for the organization’s involvement, one or more of the organization’s supported organization(s) would have been engaged in? If "Yes," explain in Part VI the reasons for the organization’s position that its supported organization(s) would have engaged in these activities but for the organization’s involvement.
2b
 
 
3
Parent of Supported Organizations. Answer (a) and (b) below.
a
Did the organization have the power to regularly appoint or elect a majority of the officers, directors, or trustees of each of the supported organizations? Provide details in Part VI.
3a
 
 
b
Did the organization exercise a substantial degree of direction over the policies, programs and activities of each of its supported organizations? If "Yes," describe in Part VI. the role played by the organization in this regard.
3b
 
 
Schedule A (Form 990 or 990-EZ) 2019

Schedule A (Form 990 or 990-EZ) 2019
Page 6
Part V
Type III Non-Functionally Integrated 509(a)(3) Supporting Organizations
1
Section A - Adjusted Net Income (A) Prior Year (B) Current Year
(optional)
1 Net short-term capital gain 1    
2 Recoveries of prior-year distributions 2    
3 Other gross income (see instructions) 3    
4 Add lines 1 through 3 4    
5 Depreciation and depletion 5    
6 Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) 6    
7 Other expenses (see instructions) 7    
8 Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) 8    
Section B - Minimum Asset Amount (A) Prior Year (B) Current Year
(optional)
1 Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): 1
a Average monthly value of securities 1a    
b Average monthly cash balances 1b    
c Fair market value of other non-exempt-use assets 1c    
d Total (add lines 1a, 1b, and 1c) 1d    
e Discount claimed for blockage or other factors
(explain in detail in Part VI):  
2 Acquisition indebtedness applicable to non-exempt use assets 2    
3 Subtract line 2 from line 1d 3    
4 Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions). 4    
5 Net value of non-exempt-use assets (subtract line 4 from line 3) 5    
6 Multiply line 5 by .035 6    
7 Recoveries of prior-year distributions 7    
8 Minimum Asset Amount (add line 7 to line 6) 8    
Section C - Distributable Amount Current Year
1 Adjusted net income for prior year (from Section A, line 8, Column A) 1  
2 Enter 85% of line 1 2  
3 Minimum asset amount for prior year (from Section B, line 8, Column A) 3  
4 Enter greater of line 2 or line 3 4  
5 Income tax imposed in prior year 5  
6 Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) 6  
7
Schedule A (Form 990 or 990-EZ) 2019

Schedule A (Form 990 or 990-EZ) 2019
Page 7
Part V
Type III Non-Functionally Integrated 509(a)(3) Supporting Organizations(continued)
Section D - Distributions Current Year
1 Amounts paid to supported organizations to accomplish exempt purposes  
2 Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in
excess of income from activity		  
3 Administrative expenses paid to accomplish exempt purposes of supported organizations  
4 Amounts paid to acquire exempt-use assets  
5 Qualified set-aside amounts (prior IRS approval required)  
6 Other distributions (describe in Part VI). See instructions  
7Total annual distributions. Add lines 1 through 6.  
8 Distributions to attentive supported organizations to which the organization is responsive (provide
details in Part VI). See instructions		  
9 Distributable amount for 2019 from Section C, line 6  
10 Line 8 amount divided by Line 9 amount  
Section E - Distribution Allocations (see instructions) (i)
Excess Distributions 		(ii)
Underdistributions
Pre-2019 		(iii)
Distributable
Amount for 2019
1 Distributable amount for 2019 from Section C, line 6  
2 Underdistributions, if any, for years prior to 2019 (reasonable cause required-- explain in Part VI).
See instructions.		  
3 Excess distributions carryover, if any, to 2019:
a From 2014.......  
b From 2015.......  
c From 2016.......  
d From 2017.......  
e From 2018.......  
fTotal of lines 3a through e  
g Applied to underdistributions of prior years  
h Applied to 2019 distributable amount  
i Carryover from 2014 not applied (see
instructions) 		 
j Remainder. Subtract lines 3g, 3h, and 3i from 3f.  
4Distributions for 2019 from Section D, line 7:
$  
a Applied to underdistributions of prior years  
b Applied to 2019 distributable amount  
c Remainder. Subtract lines 4a and 4b from 4.  
5 Remaining underdistributions for years prior to
2019, if any. Subtract lines 3g and 4a from line 2.
If the amount is greater than zero, explain in Part VI.
See instructions.		  
6 Remaining underdistributions for 2019. Subtract
lines 3h and 4b from line 1. If the amount is greater
than zero, explain in Part VI. See instructions.		  
7 Excess distributions carryover to 2020. Add lines
3j and 4c.		  
8 Breakdown of line 7:
a Excess from 2015.....  
b Excess from 2016.....  
c Excess from 2017.....  
d Excess from 2018.....  
e Excess from 2019.....  
Schedule A (Form 990 or 990-EZ) (2019)

Schedule A (Form 990 or 990-EZ) 2019
Page 8
Part VI
Supplemental Information. Provide the explanations required by Part II, line 10; Part II, line 17a or 17b; Part III, line 12; Part IV, Section A, lines 1, 2, 3b, 3c, 4b, 4c, 5a, 6, 9a, 9b, 9c, 11a, 11b, and 11c; Part IV, Section B, lines 1 and 2; Part IV, Section C, line 1; Part IV, Section D, lines 2 and 3; Part IV, Section E, lines 1c, 2a, 2b, 3a and 3b; Part V, line 1; Part V, Section B, line 1e; Part V Section D, lines 5, 6, and 8; and Part V, Section E, lines 2, 5, and 6. Also complete this part for any additional information. (See instructions).
Facts And Circumstances Test
 
Return Reference Explanation
Schedule A (Form 990 or 990-EZ) 2019


Additional Data


Software ID:  
Software Version:  
Schedule B
(Form 990, 990-EZ,
or 990-PF)
Department of the Treasury
Internal Revenue Service
Schedule of Contributors

Arrow Bullet Attach to Form 990, 990-EZ, or 990-PF.
Arrow Bullet Go to www.irs.gov/Form990 for the latest information.
OMB No. 1545-0047
2019
Name of the organization
PATH
 
Employer identification number

91-1157127
Organization type (check one):
Filers of:
Section:
Form 990 or 990-EZ






Form 990-PF




Check if your organization is covered by the General Rule or a Special Rule.  
Note: Only a section 501(c)(7), (8), or (10) organization can check boxes for both the General Rule and a Special Rule. See instructions.
General Rule
Special Rules
......... Arrow Bullet $  
Caution: An organization that isn't covered by the General Rule and/or the Special Rules doesn't file Schedule B (Form 990,
990-EZ, or 990-PF), but it must answer “No” on Part IV, line 2, of its Form 990; or check the box on line H of its Form 990-EZ
or on its Form 990PF, Part I, line 2, to certify that it doesn't meet the filing requirements of Schedule B (Form 990,
990-EZ, or 990-PF).
For Paperwork Reduction Act Notice, see the Instructions
for Form 990, 990-EZ, or 990-PF.
Cat. No. 30613XSchedule B (Form 990, 990-EZ, or 990-PF) (2019)
Schedule B (Form 990, 990-EZ, or 990-PF) (2019) Page 2
Name of organization
PATH
  		Employer identification number
91-1157127
Part I
Contributors
Contributors (see instructions). Use duplicate copies of Part I if additional space is needed.
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
RESTRICTED
 
 
 
 
  ,    

$ RESTRICTED


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 
 

$  


(Complete Part II for noncash contributions.)
Schedule B (Form 990, 990-EZ, or 990-PF) (2019)
Schedule B (Form 990, 990-EZ, or 990-PF) (2019)
Page 3
Name of organization
PATH
  		Employer identification number

91-1157127
Part II
Noncash Property (see instructions). Use duplicate copies of Part II if additional space is needed.
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
(a)
No. from Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(See instructions) 		(d)
Date received
 
$    
Schedule B (Form 990, 990-EZ, or 990-PF) (2019)
Schedule B (Form 990, 990-EZ, or 990-PF) (2019)
Page 4
Name of organization
PATH
  		Employer identification number

91-1157127
Part III
Exclusively religious, charitable, etc., contributions to organizations described in section 501(c)(7), (8), or (10) that total more than $1,000 for the year from any one contributor. Complete columns (a) through (e) and the following line entry. For organizations completing Part III, enter the total of exclusively religious, charitable, etc., contributions of $1,000 or less for the year. (Enter this information once. See instructions.) Arrow Bullet$  
Use duplicate copies of Part III if additional space is needed.
(a)
No. from Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a)
No. from Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a)
No. from Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a)
No. from Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
Schedule B (Form 990, 990-EZ, or 990-PF) (2019)

Additional Data


Software ID:  
Software Version:  
SCHEDULE C
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service
Political Campaign and Lobbying Activities

For Organizations Exempt From Income Tax Under section 501(c) and section 527

SchCMd Bullet Complete if the organization is described below. SchCMd Bullet Attach to Form 990 or Form 990-EZ.
SchCMd BulletGo to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2019
Open to Public
Inspection
If the organization answered "Yes" on Form 990, Part IV, Line 3, or Form 990-EZ, Part V, line 46 (Political Campaign Activities), then
Round Bullet Section 501(c)(3) organizations: Complete Parts I-A and B. Do not complete Part I-C.
Round Bullet Section 501(c) (other than section 501(c)(3)) organizations: Complete Parts I-A and C below. Do not complete Part I-B.
Round Bullet Section 527 organizations: Complete Part I-A only.
If the organization answered "Yes" on Form 990, Part IV, Line 4, or Form 990-EZ, Part VI, line 47 (Lobbying Activities), then
Round Bullet Section 501(c)(3) organizations that have filed Form 5768 (election under section 501(h)): Complete Part II-A. Do not complete Part II-B.
Round Bullet Section 501(c)(3) organizations that have NOT filed Form 5768 (election under section 501(h)): Complete Part II-B. Do not complete Part II-A.
If the organization answered "Yes" on Form 990, Part IV, Line 5 (Proxy Tax) (see separate instructions) or Form 990-EZ, Part V, line 35c (Proxy Tax) (see separate instructions), then
Round Bullet Section 501(c)(4), (5), or (6) organizations: Complete Part III.
Name of the organization
PATH
 
Employer identification number

91-1157127
Part I-A
Complete if the organization is exempt under section 501(c) or is a section 527 organization.

1
Provide a description of the organization’s direct and indirect political campaign activities in Part IV (see instructions for definition of “political campaign activities")

2
Political campaign activity expenditures (see instructions) ....................................................................SchCMd Bullet
$  
3
Volunteer hours for political campaign activities (see instructions) ..................................................................
 

Part I-B
Complete if the organization is exempt under section 501(c)(3).
1
Enter the amount of any excise tax incurred by the organization under section 4955 ................................SchCMd Bullet
$  
2
Enter the amount of any excise tax incurred by organization managers under section 4955 .......................SchCMd Bullet
$  
3
If the organization incurred a section 4955 tax, did it file Form 4720 for this year? .........................................
4a
Was a correction made? ......................................................................................................................
b
If "Yes," describe in Part IV.
Part I-C
Complete if the organization is exempt under section 501(c), except section 501(c)(3).
1
Enter the amount directly expended by the filing organization for section 527 exempt function activities ..... SchCMd Bullet
$  
2
Enter the amount of the filing organization's funds contributed to other organizations for section 527 exempt function activities ............................................................................................................................SchCMd Bullet

$  
3
Total exempt function expenditures. Add lines 1 and 2. Enter here and on Form 1120-POL, line 17b...........SchCMd Bullet

$  
4
Did the filing organization file Form 1120-POL for this year? ...................................................................
5
Enter the names, addresses and employer identification number (EIN) of all section 527 political organizations to which the filing
organization made payments. For each organization listed, enter the amount paid from the filing organization’s funds. Also enter the amount of political contributions received that were promptly and directly delivered to a separate political organization, such as a separate segregated fund or a political action committee (PAC). If additional space is needed, provide information in Part IV.
(a) Name (b) Address (c) EIN (d) Amount paid from filing organization's funds. If none, enter -0-. (e) Amount of political contributions received and promptly and directly delivered to a separate political organization. If none, enter -0-.
1
2
3
4
5
6
For Paperwork Reduction Act Notice, see the instructions for Form 990 or 990-EZ.
Cat. No. 50084S
Schedule C (Form 990 or 990-EZ) 2019

Schedule C (Form 990 or 990-EZ) 2019
Page 2
Part II-A
Complete if the organization is exempt under section 501(c)(3) and filed Form 5768 (election under section 501(h)).
A Check SchCMd Bulletexpenses, and share of excess lobbying expenditures).
B Check SchCMd Bullet
Limits on Lobbying Expenditures
(The term "expenditures" means amounts paid or incurred.) 		(a) Filing
organization's
totals 		(b) Affiliated group totals
1a Total lobbying expenditures to influence public opinion (grass roots lobbying) ......................    
b Total lobbying expenditures to influence a legislative body (direct lobbying) ........................ 163,912  
c Total lobbying expenditures (add lines 1a and 1b) ............................................................ 163,912  
d Other exempt purpose expenditures ............................................................................... 292,144,927  
e Total exempt purpose expenditures (add lines 1c and 1d) .................................................. 292,308,839  
f Lobbying nontaxable amount. Enter the amount from the following table in both
columns.		 1,000,000  
If the amount on line 1e, column (a) or (b) is:The lobbying nontaxable amount is:
Not over $500,00020% of the amount on line 1e.
Over $500,000 but not over $1,000,000$100,000 plus 15% of the excess over $500,000.
Over $1,000,000 but not over $1,500,000$175,000 plus 10% of the excess over $1,000,000.
Over $1,500,000 but not over $17,000,000$225,000 plus 5% of the excess over $1,500,000.
Over $17,000,000$1,000,000.
g Grassroots nontaxable amount (enter 25% of line 1f) ................................................. 250,000  
h Subtract line 1g from line 1a. If zero or less, enter -0-. ................................................ 0  
i Subtract line 1f from line 1c. If zero or less, enter -0-. ................................................ 0  
j If there is an amount other than zero on either line 1h or line 1i, did the organization file Form 4720 reporting
section 4911 tax for this year? ...................................................................................................................

4-Year Averaging Period Under Section 501(h)
(Some organizations that made a section 501(h) election do not have to complete all of the five
columns below. See the separate instructions for lines 2a through 2f.)
Lobbying Expenditures During 4-Year Averaging Period
Calendar year (or fiscal year
beginning in) 		(a) 2016 (b) 2017 (c) 2018 (d) 2019 (e) Total
2a Lobbying nontaxable amount 1,000,000 1,000,000 1,000,000 1,000,000 4,000,000
b Lobbying ceiling amount
(150% of line 2a, column(e)) 		6,000,000
c Total lobbying expenditures 168,991 294,096 224,944 163,912 851,943
d Grassroots nontaxable amount 250,000 250,000 250,000 250,000 1,000,000
e Grassroots ceiling amount
(150% of line 2d, column (e))		 1,500,000
f Grassroots lobbying expenditures 470 127,336 7,856   135,662
Schedule C (Form 990 or 990-EZ) 2019


Schedule C (Form 990 or 990-EZ) 2019
Page 3
Part II-B
Complete if the organization is exempt under section 501(c)(3) and has NOT filed Form 5768 (election under section 501(h)).
For each "Yes" response on lines 1a through 1i below, provide in Part IV a detailed description of the lobbying activity.
(a)
Yes|No
(b)
Amount
1
During the year, did the filing organization attempt to influence foreign, national, state or local legislation, including any attempt to influence public opinion on a legislative matter or referendum, through the use of:
a
Volunteers? ...........................................................................................................
 
 
b
Paid staff or management (include compensation in expenses reported on lines 1c through 1i)? ........
 
 
c
Media advertisements? ...................................................................................................
 
 
 
d
Mailings to members, legislators, or the public? .............................................................................
 
 
 
e
Publications, or published or broadcast statements? ...........................................................
 
 
 
f
Grants to other organizations for lobbying purposes? ..........................................................
 
 
 
g
Direct contact with legislators, their staffs, government officials, or a legislative body? .......................
 
 
 
h
Rallies, demonstrations, seminars, conventions, speeches, lectures, or any similar means? ..................
 
 
 
i
Other activities? ...................................................................................................................
 
 
 
j
Total. Add lines 1c through 1i ....................................................................................................
 
2a
Did the activities in line 1 cause the organization to be not described in section 501(c)(3)? .....
 
 
b
If "Yes," enter the amount of any tax incurred under section 4912 ...........................................
 
c
If "Yes," enter the amount of any tax incurred by organization managers under section 4912 ...................
 
d
If the filing organization incurred a section 4912 tax, did it file Form 4720 for this year? ........................
 
 
Part III-A
Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6).
Yes
No
1
Were substantially all (90% or more) dues received nondeductible by members? ...............................................
1
 
 
2
Did the organization make only in-house lobbying expenditures of $2,000 or less? ............................................
2
 
 
3
Did the organization agree to carry over lobbying and political expenditures from the prior year? .................................
3
 
 
Part III-B
Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6) and if either (a) BOTH Part III-A, lines 1 and 2, are answered "No" OR (b) Part III-A, line 3, is answered “Yes."
1
Dues, assessments and similar amounts from members ......................................................................
1
 
2
Section 162(e) nondeductible lobbying and political expenditures (do not include amounts of political expenses for which the section 527(f) tax was paid).
a
Current year .............................................................................................................................
2a
 
b
Carryover from last year ............................................................................................................
2b
 
c
Total ...........................................................................................................................................
2c
 
3
Aggregate amount reported in section 6033(e)(1)(A) notices of nondeductible section 162(e) dues .
3
 
4
If notices were sent and the amount on line 2c exceeds the amount on line 3, what portion of the excess does the organization agree to carryover to the reasonable estimate of nondeductible lobbying and political expenditure next year? ......................................................................................................................
4
 
5
Taxable amount of lobbying and political expenditures (see instructions) .........................................
5
 
Part IV
Supplemental Information
Provide the descriptions required for Part l-A, line 1; Part l-B, line 4; Part l-C, line 5; Part II-A (affiliated group list); Part II-A, lines 1 and 2 (see instructions), and Part ll-B, line 1. Also, complete this part for any additional information.
Return Reference Explanation
Schedule C (Form 990 or 990EZ) 2019


Additional Data


Software ID:  
Software Version:  

SCHEDULE D
(Form 990)
Department of the Treasury
Internal Revenue Service
Supplemental Financial Statements
SchDMd Bullet Complete if the organization answered "Yes," on Form 990,
Part IV, line 6, 7, 8, 9, 10, 11a, 11b, 11c, 11d, 11e, 11f, 12a, or 12b.
SchDMd Bullet Attach to Form 990.
SchDMd Bullet Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2019
Open to Public Inspection
Name of the organization
PATH
 
Employer identification number

91-1157127
Part I
Organizations Maintaining Donor Advised Funds or Other Similar Funds or Accounts. Complete if the organization answered "Yes" on Form 990, Part IV, line 6.
(a) Donor advised funds (b) Funds and other accounts
1 Total number at end of year .........    
2 Aggregate value of contributions to (during year)    
3 Aggregate value of grants from (during year)    
4 Aggregate value at end of year ........    
5
Did the organization inform all donors and donor advisors in writing that the assets held in donor advised funds are the organization’s property, subject to the organization’s exclusive legal control? ............
6
Did the organization inform all grantees, donors, and donor advisors in writing that grant funds can be used only for charitable purposes and not for the benefit of the donor or donor advisor, or for any other purpose conferring impermissible private benefit? ...................................
Part II
Conservation Easements.
Complete if the organization answered "Yes" on Form 990, Part IV, line 7.
1
Purpose(s) of conservation easements held by the organization (check all that apply).
2
Complete lines 2a through 2d if the organization held a qualified conservation contribution in the form of a conservation easement on the last day of the tax year.
Held at the End of the Year
a Total number of conservation easements ...................... 2a  
b Total acreage restricted by conservation easements .................... 2b  
c Number of conservation easements on a certified historic structure included in (a) ..... 2c  
d Number of conservation easements included in (c) acquired after 7/25/06, and not on a historic structure listed in the National Register ... 2d  
3
Number of conservation easements modified, transferred, released, extinguished, or terminated by the organization during the
tax year SchDMd Bullet  
4
Number of states where property subject to conservation easement is located SchDMd Bullet  
5
Does the organization have a written policy regarding the periodic monitoring, inspection, handling of violations, and enforcement of the conservation easements it holds? ............
6
Staff and volunteer hours devoted to monitoring, inspecting, handling of violations, and enforcing conservation easements during the year
SchDMd Bullet  
7
Amount of expenses incurred in monitoring, inspecting, handling of violations, and enforcing conservation easements during the year
SchDMd Bullet $  
8
Does each conservation easement reported on line 2(d) above satisfy the requirements of section 170(h)(4)(B)(i) and section 170(h)(4)(B)(ii)? .............................
9
In Part XIII, describe how the organization reports conservation easements in its revenue and expense statement, and
balance sheet, and include, if applicable, the text of the footnote to the organization’s financial statements that describes
the organization’s accounting for conservation easements.
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets.
Complete if the organization answered "Yes" on Form 990, Part IV, line 8.
1a
If the organization elected, as permitted under FASB ASC 958, not to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide, in Part XIII, the text of the footnote to its financial statements that describes these items.
b
If the organization elected, as permitted under FASB ASC 958, to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide the following amounts relating to these items:
(i)
Revenue included on Form 990, Part VIII, line 1 .........................SchDMd Bullet $  
(ii)
Assets included in Form 990, Part X ...............................SchDMd Bullet $  
2
If the organization received or held works of art, historical treasures, or other similar assets for financial gain, provide the
following amounts required to be reported under FASB ASC 958 relating to these items:
a
Revenue included on Form 990, Part VIII, line 1 ..........................SchDMd Bullet $  
b
Assets included in Form 990, Part X ...............................SchDMd Bullet $  
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 52283D
Schedule D (Form 990) 2019

Schedule D (Form 990) 2019
Page 2
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets (continued)
3
Using the organization’s acquisition, accession, and other records, check any of the following that are a significant use of its collection items (check all that apply):
a
d
b
e
 
c
4
Provide a description of the organization’s collections and explain how they further the organization’s exempt purpose in
Part XIII.
5
During the year, did the organization solicit or receive donations of art, historical treasures or other similar
assets to be sold to raise funds rather than to be maintained as part of the organization’s collection?...
Part IV
Escrow and Custodial Arrangements. Complete if the organization answered "Yes" on Form 990, Part IV, line 9, or reported an amount on Form 990, Part X, line 21.
1a
Is the organization an agent, trustee, custodian or other intermediary for contributions or other assets not
included on Form 990, Part X? ....................................
b If "Yes," explain the arrangement in Part XIII and complete the following table: Amount
c Beginning balance ............................. 1c  
d Additions during the year ............................ 1d  
e Distributions during the year .......................... 1e  
f Ending balance ................................ 1f  
2a
Did the organization include an amount on Form 990, Part X, line 21, for escrow or custodial account liability? ...
b
If "Yes," explain the arrangement in Part XIII. Check here if the explanation has been provided in Part XIII ....
Part V
Endowment Funds.
Complete if the organization answered "Yes" on Form 990, Part IV, line 10.
(a) Current year (b) Prior year (c) Two years back (d) Three years back (e) Four years back
1a Beginning of year balance .... 9,095,917 10,056,545 9,339,249 8,897,224 9,404,188
b Contributions ... 2,100 1,240 3,410 4,256 2,665
c Net investment earnings, gains, and losses 1,691,617 -494,491 1,159,282 907,978 -58,783
d Grants or scholarships ...          
e Other expenditures for facilities
and programs ... 		502,521 467,377 445,396 470,209 450,846
f Administrative expenses ....          
g End of year balance ...... 10,287,113 9,095,917 10,056,545 9,339,249 8,897,224
2
Provide the estimated percentage of the current year end balance (line 1g, column (a)) held as:
a
Board designated or quasi-endowment SchDMd Bullet36.000 %
b
Permanent endowment SchDMd Bullet33.000 %
c
Term endowment SchDMd Bullet31.000 %
The percentages on lines 2a, 2b, and 2c should equal 100%.
3a
Are there endowment funds not in the possession of the organization that are held and administered for the
organization by:

Yes
No
(i) Unrelated organizations .................
3a(i)
 
No
(ii) Related organizations .................
3a(ii)
 
No
b
If "Yes" on 3a(ii), are the related organizations listed as required on Schedule R? .........
3b
 
 
4
Describe in Part XIII the intended uses of the organization's endowment funds.
Part VI
Land, Buildings, and Equipment.
Complete if the organization answered "Yes" on Form 990, Part IV, line 11a. See Form 990, Part X, line 10.
Description of property (a) Cost or other basis
(investment) 		(b) Cost or other basis (other) (c) Accumulated depreciation (d) Book value
1a Land .....      
b Buildings ....        
c Leasehold improvements   20,566,785 14,121,217 6,445,568
d Equipment ....   10,413,970 6,867,909 3,546,061
e Other .....   5,991,156 5,991,155 1
Total. Add lines 1a through 1e. (Column (d) must equal Form 990, Part X, column (B), line 10(c).)..SchDMdBullet 9,991,630
Schedule D (Form 990) 2019

Schedule D (Form 990) 2019
Page 3
Part VII
Investments—Other Securities.
Complete if the organization answered "Yes" on Form 990, Part IV, line 11b. See Form 990, Part X, line 12.
(a) Description of security or category
(including name of security)		 (b) Book value (c) Method of valuation:
Cost or end-of-year market value
(1) Financial derivatives.........    
(2) Closely-held equity interests........    
(3)Other
(B)
(C)
(D)
(E)
(F)
(G)
(H)
(I)
Total. (Column (b) must equal Form 990, Part X, col. (B) line 12.)Small Bullet  
Part VIII
Investments—Program Related. Complete if the organization answered 'Yes' on Form 990, Part IV, line 11c. See Form 990, Part X, line 13.
(a) Description of investment (b) Book value (c) Method of valuation:
Cost or end-of-year market value
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 13.)Small Bullet  
Part IX
Other Assets.
Complete if the organization answered 'Yes' on Form 990, Part IV, line 11d. See Form 990, Part X, line 15.
(a) Description (b) Book value
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 15.)...........Small Bullet  
Part X
Other Liabilities.
Complete if the organization answered 'Yes' on Form 990, Part IV, line 11e or 11f. See Form 990, Part X, line 25.
1.(a) Description of liability (b) Book value
(1) Federal income taxes  
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 25.)Small Bullet  
2. Liability for uncertain tax positions. In Part XIII, provide the text of the footnote to the organization's financial statements that reports the organization's liability for uncertain tax positions under FIN 48 (ASC 740). Check here if the text of the footnote has been provided in Part XIII
Schedule D (Form 990) 2019

Schedule D (Form 990) 2019
Page 4
Part XI Reconciliation of Revenue per Audited Financial Statements With Revenue per Return. Complete if the organization answered 'Yes' on Form 990, Part IV, line 12a.
1 Total revenue, gains, and other support per audited financial statements ....... 1  
2 Amounts included on line 1 but not on Form 990, Part VIII, line 12:
a Net unrealized gains (losses) on investments .... 2a  
b Donated services and use of facilities ......... 2b  
c Recoveries of prior year grants ........... 2c  
d Other (Describe in Part XIII.) ............ 2d  
e Add lines 2a through 2d ..................... 2e  
3 Subtract line 2e from line 1.................. 3  
4 Amounts included on Form 990, Part VIII, line 12, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b . 4a  
b Other (Describe in Part XIII.) ........... 4b  
c Add lines 4a and 4b.................... 4c  
5 Total revenue. Add lines 3 and 4c. (This must equal Form 990, Part I, line 12.) ...... 5  
Part XII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return. Complete if the organization answered 'Yes' on Form 990, Part IV, line 12a.
1 Total expenses and losses per audited financial statements ........... 1  
2 Amounts included on line 1 but not on Form 990, Part IX, line 25:
a Donated services and use of facilities ......... 2a  
b Prior year adjustments ............ 2b  
c Other losses ................ 2c  
d Other (Describe in Part XIII.) ............ 2d  
e Add lines 2a through 2d.................... 2e  
3 Subtract line 2e from line 1................... 3  
4 Amounts included on Form 990, Part IX, line 25, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b .. 4a  
b Other (Describe in Part XIII.) ............ 4b  
c Add lines 4a and 4b..................... 4c  
5 Total expenses. Add lines 3 and 4c. (This must equal Form 990, Part I, line 18.) ...... 5  
Part XIII
Supplemental Information
Provide the descriptions required for Part II, lines 3, 5, and 9; Part III, lines 1a and 4; Part lV, lines 1b and 2b; Part V, line 4; Part X, line 2; Part XI, lines 2d and 4b; and Part XII, lines 2d and 4b. Also complete this part to provide any additional information.
Return Reference Explanation
PART V, LINE 4: PATH UTILIZES THE INVESTED INTREST EARNINGS FROM THE ENDOWMENT AS AN IMPORTANT FUNDING SOURCE TO FUND NEW OPPORTUNITIES TO EXPAND ITS REACH AND IMPACT AS AN ORGANIZATION IN THE FIELD OF GLOBAL HEALTH, IN ACCORDANCE WITH PATH'S ENDOWMENT SPENDING POLICY.
Schedule D (Form 990) 2019


Additional Data


Software ID:  
Software Version:  




SCHEDULE F(Form 990)
Department of the Treasury
Internal Revenue Service
Statement of Activities Outside the United States
Right pointing arrow large image Complete if the organization answered "Yes" to Form 990, Part IV, line 14b, 15, or 16.Right pointing arrow large image Attach to Form 990.Right pointing arrow large image Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2019
Open to Public Inspection
Name of the organization
PATH
 
Employer identification number

91-1157127
Part I
General Information on Activities Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 14b.
1
For grantmakers. Does the organization maintain records to substantiate the amount of its grants and
other assistance, the grantees’ eligibility for the grants or assistance, and the selection criteria used
to award the grants or assistance? . . . . . . . . . . . . . . . . . . . . . . . . .
2
For grantmakers. Describe in Part V the organization’s procedures for monitoring the use of its grants and other assistance outside the United States.
3
Activites per Region. (The following Part I, line 3 table can be duplicated if additional space is needed.)
(a) Region (b) Number of offices in the region (c) Number of employees, agents, and independent contractors in the region (d) Activities conducted in region (by type) (such as, fundraising, program services, investments, grants to recipients located in the region) (e) If activity listed in (d) is a program service, describe specific type of
service(s) in the region		 (f) Total expenditures
for and investments
in the region
CENTRAL AMERICA AND THE CARIBBEAN 0 0 MANAGEMENT & GENERAL   1,337,651
CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES GLOBAL HEALTH PROGRAM 256,127
CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES ESSENTIAL MEDICINE 77,366
CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 214,517
CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES OTHER 49,145
CENTRAL AMERICA AND THE CARIBBEAN 0 0 FUNDRAISING   116,688
CENTRAL AMERICA AND THE CARIBBEAN 0 0 GRANTMAKING   240,108
EAST ASIA AND THE PACIFIC 5 89 MANAGEMENT & GENERAL   1,166,381
EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES GLOBAL HEALTH PROGRAM 4,770,576
EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES ESSENTIAL MEDICINE 278,686
EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 76,122
EAST ASIA AND THE PACIFIC 0 0 FUNDRAISING   35,433
EAST ASIA AND THE PACIFIC 0 0 GRANTMAKING   5,952,808
EUROPE 1 6 MANAGEMENT & GENERAL   117,977
EUROPE 0 0 PROGRAM SERVICES GLOBAL HEALTH PROGRAM 4,594,053
EUROPE 0 0 PROGRAM SERVICES ESSENTIAL MEDICINE 7,399,289
EUROPE 0 0 PROGRAM SERVICES TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 412,185
EUROPE 0 0 PROGRAM SERVICES OTHER 118,911
EUROPE 0 0 GRANTMAKING   17,408,213
MIDDLE EAST AND NORTH AFRICA 0 0 MANAGEMENT & GENERAL   28,381
MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES GLOBAL HEALTH PROGRAM 2,116
MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 7,000
NORTH AMERICA 0 0 MANAGEMENT & GENERAL   75,082
NORTH AMERICA 0 0 PROGRAM SERVICES GLOBAL HEALTH PROGRAM 115,188
NORTH AMERICA 0 0 PROGRAM SERVICES ESSENTIAL MEDICINE 160,628
NORTH AMERICA 0 0 PROGRAM SERVICES TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 1,975
NORTH AMERICA 0 0 PROGRAM SERVICES OTHER 6,704
NORTH AMERICA 0 0 FUNDRAISING   11,176
NORTH AMERICA 0 0 GRANTMAKING   400,353
RUSSIA AND NEIGHBORING STATES 1 24 MANAGEMENT & GENERAL   238,347
RUSSIA AND NEIGHBORING STATES 0 0 PROGRAM SERVICES GLOBAL HEALTH PROGRAM 2,653,697
RUSSIA AND NEIGHBORING STATES 0 0 GRANTMAKING   1,042,939
SOUTH AMERICA 1 2 MANAGEMENT & GENERAL   76,277
SOUTH AMERICA 0 0 PROGRAM SERVICES GLOBAL HEALTH PROGRAM 275,814
SOUTH AMERICA 0 0 PROGRAM SERVICES ESSENTIAL MEDICINE 3,083
SOUTH AMERICA 0 0 PROGRAM SERVICES TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 27,772
SOUTH AMERICA 0 0 PROGRAM SERVICES OTHER 1,360
SOUTH AMERICA 0 0 GRANTMAKING   333,947
SOUTH ASIA 6 122 MANAGEMENT & GENERAL   1,889,812
SOUTH ASIA 0 0 PROGRAM SERVICES GLOBAL HEALTH PROGRAM 5,241,530
SOUTH ASIA 0 0 PROGRAM SERVICES ESSENTIAL MEDICINE 1,161,152
SOUTH ASIA 0 0 PROGRAM SERVICES TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 601,147
SOUTH ASIA 0 0 GRANTMAKING   2,673,505
SUB-SAHARAN AFRICA 48 728 MANAGEMENT & GENERAL   10,720,815
SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES GLOBAL HEALTH PROGRAM 45,897,726
SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES ESSENTIAL MEDICINE 2,174,274
SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES TECHNOLOGY, ANALYTICS AND MARKET INNOVATION 1,383,395
SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES OTHER 2,069,259
SUB-SAHARAN AFRICA 0 0 FUNDRAISING   3,389
SUB-SAHARAN AFRICA 0 0 GRANTMAKING   11,415,702
3a Sub-total .... 5 89 3,457,983
b Total from continuation sheets to Part I ... 57 882 131,857,798
c Totals (add lines 3a and 3b) 62 971 135,315,781
For Paperwork Reduction Act Notice, see the Instructions for Form 990.Cat. No. 50082W Schedule F (Form 990) 2019
Schedule F (Form 990) 2019
Page 2
Part II
Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 15, for any recipient who received more than $5,000. Part II can be duplicated if additional space is needed.
1 (a) Name of organization (b) IRS code section
and EIN (if applicable)		 (c) Region (d) Purpose of
grant 		(e) Amount of
cash grant 		(f) Manner of
cash
disbursement 		(g) Amount
of noncash
assistance 		(h) Description
of noncash
assistance 		(i) Method of
valuation
(book, FMV,
appraisal, other)
CENTRAL AMERICA & THE CARIBBEAN GLOBAL HEALTH PROGRAMS 93,018 CHECK/WIRE      
CENTRAL AMERICA & THE CARIBBEAN GLOBAL HEALTH PROGRAMS 147,089 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 8,618 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 38,912 CHECK/WIRE      
EAST ASIA & THE PACIFIC ESSENTIAL MEDICINE 42,710 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 6,425 CHECK/WIRE      
EAST ASIA & THE PACIFIC ESSENTIAL MEDICINE 1,151,570 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 33,612 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 57,928 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 226,137 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 23,793 CHECK/WIRE      
EAST ASIA & THE PACIFIC ESSENTIAL MEDICINE 91,336 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 39,494 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 28,123 CHECK/WIRE      
EAST ASIA & THE PACIFIC ESSENTIAL MEDICINE 25,120 CHECK/WIRE      
EAST ASIA & THE PACIFIC ESSENTIAL MEDICINE 14,241 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 17,369 CHECK/WIRE      
EAST ASIA & THE PACIFIC TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS 38,380 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 86,964 CHECK/WIRE      
EAST ASIA & THE PACIFIC ESSENTIAL MEDICINE 36,332 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 124,085 CHECK/WIRE      
EAST ASIA & THE PACIFIC ESSENTIAL MEDICINE 10,222 CHECK/WIRE      
EAST ASIA & THE PACIFIC ESSENTIAL MEDICINE & GLOBAL HEALTH PROGRAMS 330,992 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 16,142 CHECK/WIRE      
EAST ASIA & THE PACIFIC ESSENTIAL MEDICINE 2,291,621 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 48,002 CHECK/WIRE      
EAST ASIA & THE PACIFIC ESSENTIAL MEDICINE 126,000 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 144,834 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 7,547 CHECK/WIRE      
EAST ASIA & THE PACIFIC TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS 28,627 CHECK/WIRE      
EAST ASIA & THE PACIFIC ESSENTIAL MEDICINE 685,400 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 97,367 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 50,000 CHECK/WIRE      
EAST ASIA & THE PACIFIC GLOBAL HEALTH PROGRAMS 8,411 CHECK/WIRE      
EAST ASIA & THE PACIFIC ESSENTIAL MEDICINE 16,000 CHECK/WIRE      
EUROPE TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS 198,045 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS 147,352 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS 224,690 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 4,356,625 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS 5,432 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS 44,714 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 184,293 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 276,301 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS 82,353 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS 142,750 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 749,227 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 833,318 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS 46,131 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 412,846 CHECK/WIRE      
EUROPE TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS 488,750 CHECK/WIRE      
EUROPE TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS 123,201 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 43,490 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS 59,982 CHECK/WIRE      
EUROPE TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS 297,425 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 467,701 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 32,000 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS 93,195 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 801,088 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 260,307 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS 26,615 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 225,000 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS 2,176,178 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE 236,406 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS 32,721 CHECK/WIRE      
EUROPE GLOBAL HEALTH PROGRAMS AND TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS 270,500 CHECK/WIRE      
EUROPE ESSENTIAL MEDICINE, GLOBAL HEALTH PROGRAMS, TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS, AND OTHER 4,069,578 CHECK/WIRE      
NORTH AMERICA ESSENTIAL MEDICINE 81,238 CHECK/WIRE      
NORTH AMERICA ESSENTIAL MEDICINE 285,226 CHECK/WIRE      
NORTH AMERICA ESSENTIAL MEDICINE 33,889 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 5,395 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 10,480 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 6,999 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 38,615 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 9,724 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 367,763 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 16,506 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 62,480 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 57,489 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 34,092 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 13,915 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 15,472 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 6,241 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 32,000 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 149,600 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 56,952 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 53,665 CHECK/WIRE      
RUSSIA & NEIGHBORING STATES GLOBAL HEALTH PROGRAMS 96,640 CHECK/WIRE      
SOUTH AMERICA GLOBAL HEALTH PROGRAMS 98,107 CHECK/WIRE      
SOUTH AMERICA GLOBAL HEALTH PROGRAMS 7,000 CHECK/WIRE      
SOUTH AMERICA GLOBAL HEALTH PROGRAMS 14,000 CHECK/WIRE      
SOUTH AMERICA GLOBAL HEALTH PROGRAMS 19,038 CHECK/WIRE      
SOUTH AMERICA TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS 115,115 CHECK/WIRE      
SOUTH AMERICA GLOBAL HEALTH PROGRAMS 80,687 CHECK/WIRE      
SOUTH ASIA GLOBAL HEALTH PROGRAMS 10,659 CHECK/WIRE      
SOUTH ASIA GLOBAL HEALTH PROGRAMS AND TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS 67,201 CHECK/WIRE      
SOUTH ASIA GLOBAL HEALTH PROGRAMS 73,580 CHECK/WIRE      
SOUTH ASIA GLOBAL HEALTH PROGRAMS 13,650 CHECK/WIRE      
SOUTH ASIA GLOBAL HEALTH PROGRAMS 49,523 CHECK/WIRE      
SOUTH ASIA TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS 29,364 CHECK/WIRE      
SOUTH ASIA ESSENTIAL MEDICINE & GLOBAL HEALTH PROGRAMS 82,005 CHECK/WIRE      
SOUTH ASIA GLOBAL HEALTH PROGRAMS 242,361 CHECK/WIRE      
SOUTH ASIA GLOBAL HEALTH PROGRAMS 14,893 CHECK/WIRE      
SOUTH ASIA ESSENTIAL MEDICINE 231,749 CHECK/WIRE      
SOUTH ASIA GLOBAL HEALTH PROGRAMS 11,391 CHECK/WIRE      
SOUTH ASIA ESSENTIAL MEDICINE 1,730,177 CHECK/WIRE      
SOUTH ASIA GLOBAL HEALTH PROGRAMS 19,090 CHECK/WIRE      
SOUTH ASIA ESSENTIAL MEDICINE 96,782 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 30,892 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 10,396 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 192,598 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 23,691 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 99,655 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 8,927 CHECK/WIRE      
SUB-SAHARAN AFRICA ESSENTIAL MEDICINE 1,432,181 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 70,504 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 41,751 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 18,034 CHECK/WIRE      
SUB-SAHARAN AFRICA ESSENTIAL MEDICINE 2,034,653 CHECK/WIRE      
SUB-SAHARAN AFRICA ESSENTIAL MEDICINE 257,028 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 387,808 CHECK/WIRE      
SUB-SAHARAN AFRICA TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS 57,101 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 29,457 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 7,376 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 50,404 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 12,553 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 28,010 CHECK/WIRE      
SUB-SAHARAN AFRICA OTHER 126,000 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 38,507 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 149,500 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 379,662 CHECK/WIRE      
SUB-SAHARAN AFRICA TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS 44,465 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 23,267 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS & OTHER 95,460 CHECK/WIRE      
SUB-SAHARAN AFRICA ESSENTIAL MEDICINE 272,190 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 1,172,007 CHECK/WIRE      
SUB-SAHARAN AFRICA TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS 67,200 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 12,209 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 74,257 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS & OTHER 69,137 CHECK/WIRE      
SUB-SAHARAN AFRICA TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS 45,948 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 24,312 CHECK/WIRE      
SUB-SAHARAN AFRICA OTHER 10,077 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 17,753 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 7,248 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 19,057 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 17,678 CHECK/WIRE      
SUB-SAHARAN AFRICA ESSENTIAL MEDICINE 378,060 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 48,221 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 14,281 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 87,115 CHECK/WIRE      
SUB-SAHARAN AFRICA TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS 30,755 CHECK/WIRE      
SUB-SAHARAN AFRICA TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS 376,205 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 18,278 CHECK/WIRE      
SUB-SAHARAN AFRICA ESSENTIAL MEDICINE 25,000 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 5,380 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 698,318 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 17,912 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 13,305 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 534,664 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 184,587 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 268,453 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 23,391 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 1,088,928 CHECK/WIRE      
SUB-SAHARAN AFRICA ESSENTIAL MEDICINE 25,207 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 57,468 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 18,179 CHECK/WIRE      
SUB-SAHARAN AFRICA GLOBAL HEALTH PROGRAMS 24,960 CHECK/WIRE      
2 Enter total number of recipient organizations listed above that are recognized as charities by the foreign country, recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter .......MediumBullet
128
3 Enter total number of other organizations or entities .......................MediumBullet
39
Schedule F (Form 990) 2019
Schedule F (Form 990) 2019Page 3
Part III
Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 16.
Part III can be duplicated if additional space is needed.
(a) Type of grant or assistance (b) Region (c) Number of recipients (d) Amount of
cash grant 		(e) Manner of cash
disbursement 		(f) Amount of
noncash
assistance 		(g) Description
of noncash
assistance 		(h) Method of
valuation
(book, FMV,
appraisal, other)
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
Schedule F (Form 990) 2019
Schedule F (Form 990) 2019
Page 4
Part IV
Foreign Forms
1 Was the organization a U.S. transferor of property to a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 926, Return by a U.S. Transferor of Property to a Foreign Corporation (see Instructions for Form 926). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2 Did the organization have an interest in a foreign trust during the tax year? If "Yes," the organization may be required to separately file Form 3520, Annual Return to Report Transactions with Foreign Trusts and Receipt of Certain Foreign Gifts, and/or Form 3520-A, Annual Information Return of Foreign Trust With a U.S. Owner (see Instructions for Forms 3520 and 3520-A; don't file with Form 990). . . . . . . . . . . . . . . . . . . . . . . .
3 Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 5471, Information Return of U.S. Persons with Respect to Certain Foreign Corporations. (see Instructions for Form 5471). . . . . . . . . . . . . . . . . . . . . . . . . . . .
4 Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? If “Yes,” the organization may be required to file Form 8621, Information Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund. (see Instructions for Form 8621) .
5 Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization may be required to file Form 8865, Return of U.S. Persons with Respect to Certain Foreign Partnerships (see Instructions for Form 8865). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6 Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the organization may be required to separately file Form 5713, International Boycott Report (see Instructions for Form 5713; don't file with Form 990).. . . . . . . . . . . . . . . . . . . . . . . . . . . .
Schedule F (Form 990) 2019
Schedule F (Form 990) 2019
Page 5
Part V
Supplemental Information
Provide the information required by Part I, line 2 (monitoring of funds); Part I, line 3, column (f) (accounting method; amounts of investments vs. expenditures per region); Part II, line 1 (accounting method); Part III (accounting method); and Part III, column (c) (estimated number of recipients), as applicable. Also complete this part to provide any additional information. See instructions.
ReturnReference Explanation
PART I, LINE 2: PATH HAS A SUBRECIPIENT POLICY AND PROCEDURES IN PLACE TO GUIDE THE WAY OUR PROJECT TEAMS MONITOR SUBRECIPIENTS. THIS INCLUDES BOTH FINANCIAL AND TECHNICAL MONITORING. PATH USES RISK ASSESSMENTS, REPORTING, SITE VISITS, REGULAR CONTACT, AND OTHER MEANS TO PROVIDE THE MONITORING REQUIRED BY FUNDERS AND TO ENSURE GOOD PROJECT STEWARDSHIP. THESE ACTIVITIES ALSO PROVIDE RESPONSIBLE ASSURANCE THAT THE SUBRECIPIENT ADMINISTERS FUNDS IN COMPLIANCE WITH LAWS, REGULATIONS, AND PRIME AWARD TERMS AND ACHIEVES PERFORMANCE GOALS. PATH HAS ESTABLISHED COMPREHENSIVE POLICIES AND PROCEDURES TO PROMOTE BEST BUSINESS PRACTICES AND ENSURE EFFICIENT AND EFFECTIVE INTERNAL CONTROL. THESE ARE COMBINED WITH AN INTERNAL AUDIT FUNCTION THROUGH WHICH PATH CONDUCTS AUDITS ON GRANT-FUNDED PROGRAMS TO ENSURE COMPLIANCE WITH REGULATORY REQUIREMENTS.
PART III ACCOUNTING METHOD:  
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
Schedule F (Form 990) 2019
Additional Data


Software ID:  
Software Version:  




Note: To capture the full content of this document, please select landscape mode (11" x 8.5") when printing.

Schedule I
(Form 990)
Department of the Treasury
Internal Revenue Service
Grants and Other Assistance to Organizations,
Governments and Individuals in the United States
Complete if the organization answered "Yes," on Form 990, Part IV, line 21 or 22.
lBullet Attach to Form 990.
lBullet Go to www.irs.gov/Form990 for the latest information.
OMB No. 1545-0047
2019
Open to Public
Inspection
Name of the organization
PATH
 
Employer identification number
91-1157127
Part I
General Information on Grants and Assistance
1
Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees' eligibility for the grants or assistance, and
the selection criteria used to award the grants or assistance? ........................
2
Describe in Part IV the organization's procedures for monitoring the use of grant funds in the United States.
Part II
Grants and Other Assistance to Domestic Organizations and Domestic Governments. Complete if the organization answered "Yes" on Form 990, Part IV, line 21, for any recipient
that received more than $5,000. Part II can be duplicated if additional space is needed.
(a) Name and address of organization
or government		 (b) EIN (c) IRC section
(if applicable)		 (d) Amount of cash grant (e) Amount of non-cash
assistance		 (f) Method of valuation
(book, FMV, appraisal,
other)		 (g) Description of
noncash assistance		 (h) Purpose of grant
or assistance
(1) ADARA DEVELOPMENT (USA)
300 ADMIRAL WAY SUITE 106
EDMONDS,WA98020 		98-0634789 501(C)(3)   11,392     TECHNOLOGY, ANALYTICS AND MARKET INNOVATION
(2) AJINOMOTO ALTHEA INC (DBA AJINOMOTO BIO-PHARMA SERVICES)
11040 ROSELLE STREET
SAN DIEGO,CA92121 		33-0788907 501(C)(3)   20,340     ESSENTIAL MEDICINE
(3) APIJECT SYSTEMS CORP
2 HIGH RIDGE PARK
STAMFORD,CT06905 		83-2211917 501(C)(3)   538,000     TECHNOLOGY, ANALYTICS AND MARKET INNOVATION
(4) BAO SYSTEMS LLC
2900 K STREET SUITE 507
WASHINGTON,DC20007 		27-2316349 501(C)(3)   94,009     GLOBAL HEALTH PROGRAMS
(5) BECTON DICKINSON & COMPANY
ONE BECTON DRIVE
FRANKLIN LAKES,NJ07417 		22-0760120 OTHER   360,513     TECHNOLOGY, ANALYTICS AND MARKET INNOVATION
(6) BEHAVIORAL IDEAS LAB INC (DBA IDEAS42)
80 BROAD STREET 30TH FLOOR
NEW YORK,NY10004 		27-1678009 501(C)(3)   25,000     GLOBAL HEALTH PROGRAMS
(7) BENEVOLENT HEALTHCARE FOUNDATION DBA PROJECT CURE
10377 E GEDDES AVENUE SUITE 200
CENTENNIAL,CO80112 		84-1568566 501(C)(3)   92,495     GLOBAL HEALTH PROGRAMS
(8) BIOIVT LLC
123 FROST STREET STE 115
WESTBURY,NY11590 		27-1867431 OTHER   77,775     TECHNOLOGY, ANALYTICS AND MARKET INNOVATION
(9) CARDNO EMERGING MARKETS
2107 WILSON BLVD STE 800
ARLINGTON,VA22201 		52-1788060 OTHER   47,831     GLOBAL HEALTH PROGRAMS
(10) CASCADE DESIGNS INC
4000 1ST AVE SOUTH
SEATTLE,WA98134 		91-0969695 OTHER   26,209     TECHNOLOGY, ANALYTICS AND MARKET INNOVATION
(11) CENTERS FOR DISEASE CONTROL AND PREVENTION ( CDC )
1600 CLIFTON ROAD
ATLANTA,GA30333 		58-6051157 GOV   142,650     ESSENTIAL MEDICINE
(12) CHILDREN'S HOSPITAL BOSTON
RESEARCH FINANCE PO BOX 414413
BOSTON,MA022414413 		04-2774441 501(C)(3)   118,856     ESSENTIAL MEDICINE
(13) CINCINNATI CHILDREN'S HOSPITAL
MEDICAL CENTER 3333 BURNET AVE ML
6014
CINCINNATI,OH452293039 		31-0833936 501(C)(3)   90,987     ESSENTIAL MEDICINE
(14) DIMAGI INC
585 MASSACHUSETTS AVE SUITE 4
CAMBRIDGE,MA02139 		83-0343298 501(C)(3)   21,794     GLOBAL HEALTH PROGRAMS
(15) DUKE UNIVERSITY
BOX 104132
DURHAM,NC27708 		56-0532129 501(C)(3)   61,225     ESSENTIAL MEDICINE
(16) FINA BIOSOLUTIONS LLC
9430 KEY WEST AVE SUITE 200
ROCKVILLE,MD20850 		20-5448275 OTHER   83,000     ESSENTIAL MEDICINE
(17) FOOD AND DRUG ADMINISTRATION
5600 FISHERS LANEHFA-140 ROOM 11-40
11-40
ROCKVILLE,MD20857 		53-0196965 GOV   50,000     ESSENTIAL MEDICINE
(18) FRED HUTCHINSON CANCER RESEARCH CENTER
1100 FAIRVIEW AVE N PO BOX 19024
SEATTLE,WA981091024 		23-7156071 501(C)(3)   142,705     TECHNOLOGY, ANALYTICS AND MARKET INNOVATION
(19) GHP SOLUTIONS LLC
220 EAST 42ND STREET SUITE 710
NEW YORK,NY10017 		06-1652595 OTHER   204,243     GLOBAL HEALTH PROGRAMS
(20) GLOBAL HEALTH CORPS
318 WEST 39TH STREET ROOM 9L
NEW YORK,NY10018 		80-0512336 501(C)(3)   5,564     GLOBAL HEALTH PROGRAMS
(21) GLOBAL HEALTH STRATEGIES LLC
27 WEST 24TH STREET SUITE 900
NEW YORK,NY10010 		27-2494697 501(C)(3)   292,818     TECHNOLOGY, ANALYTICS AND MARKET INNOVATION
(22) HARVARD SCHOOL OF PUBLIC HEALTH
677 HUNTINGTON AVENUE
BOSTON,MA02215 		04-2103580 501(C)(3)   1,015,118     ESSENTIAL MEDICINE
(23) HARVARD UNIVERSITY
1033 MASSACHUSETTS AVE 2ND FLOOR
CAMBRIDGE,MA02115 		04-2103580 501(C)(3)   45,101     ESSENTIAL MEDICINE
(24) HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE INC
6720-A ROCKLEDGE DRIVE STE 100
BETHESDA,MD20817 		52-1317896 501(C)(3)   30,841     ESSENTIAL MEDICINE
(25) ICF MACRO INC
9300 LEE HIGHWAY
FAIRFAX,VA22031 		22-3661438 501(C)(3)   1,433,641     GLOBAL HEALTH PROGRAMS
(26) INITIATIVES INC
264 BEACON STREET
BOSTON,MA02116 		04-2961350 OTHER   30,481     GLOBAL HEALTH PROGRAMS
(27) INTRAHEALTH INTERNATIONAL INC
6340 QUADRANGLE DRIVE SUITE 200
CHAPEL HILL,NC27517 		55-0825466 501(C)(3)   370,237     GLOBAL HEALTH PROGRAMS
(28) INVENTPRISE LLC
18133 NE 68TH STREET SUITE D 150
REDMOND,WA98052 		45-4927373 OTHER   229,593     ESSENTIAL MEDICINE
(29) JHPIEGO
1615 THAMES STREET SUITE 200
BALTIMORE,MD212313447 		23-7424444 501(C)(3)   14,823     GLOBAL HEALTH PROGRAMS
(30) JOHNS HOPKINS UNIVERSITY
BLOOMBERG SCHL OF PUB HLTH 615 N
WOLFE STREET
BALTIMORE,MD21205 		52-0595110 501(C)(3)   813,659     ESSENTIAL MEDICINE & GLOBAL HEALTH PROGRAMS
(31) JSI RESEARCH AND TRAINING INSTITUTE INC
1616 NORTH FORT MYER DR 16TH FLOOR
ARLINGTON,VA222093100 		04-2679824 OTHER   1,187,106     GLOBAL HEALTH PROGRAMS
(32) KYBELE INC
3524 YADKINVILLE ROAD 124
WINSTONSALEM,NC27106 		90-0759003 501(C)(3)   91,391     GLOBAL HEALTH PROGRAMS
(33) LINKSBRIDGE SPC
101 TAYLOR AVE N 105
SEATTLE,WA98109 		26-3067893 OTHER   43,873     ESSENTIAL MEDICINE
(34) MANAGEMENT SCIENCES FOR HEALTH
200 RIVERS EDGE DRIVE SUITE 320
MEDFORD,MA02155 		04-2482188 501(C)(3)   63,998     GLOBAL HEALTH PROGRAMS
(35) MASSACHUSETTS GENERAL HOSPITAL
DEPT OF EMERGENCY MEDICINE
BOSTON,MA02139 		04-1564655 501(C)(3)   50,000     ESSENTIAL MEDICINE
(36) MASSACHUSETTS INSTITUTE OF TECHNOLOGY ( MIT )
77 MASSACHUSETTS AVENUE
CAMBRIDGE,MA02139 		04-2103594 501(C)(3)   70,000     ESSENTIAL MEDICINE
(37) MASSBIOLOGICS INC
460 WALK HILL STREET
BOSTON,MA02126 		04-3167352 501(C)(3)   7,250     ESSENTIAL MEDICINE
(38) NAT'L INST OF ALLERGY & INFECTIOUS DISEASES ( NIAID )
6610 ROCKLEDGE DR ROOM 2800
BETHESDA,MD208926606 		52-0858115 GOV   824,068     ESSENTIAL MEDICINE
(39) NICHOLAS INSTITUTE FOR ENVIRONMENTAL POLICY SOLUTIONS AT DUKE UNIVERSITY
2117 CAMPUS DRIVE
DURHAM,NC27708 		56-0532129 501(C)(3)   46,666     GLOBAL HEALTH PROGRAMS
(40) NYAYA HEALTH (DBA POSSIBLE HEALTH)
30 BROAD STREET FLOOR 9
NEW YORK,NY10004 		20-3055055 501(C)(3)   81,185     GLOBAL HEALTH PROGRAMS
(41) ONA SYSTEMS INC
126 E 12TH ST SUITE 4A
NEW YORK,NY100035320 		38-3940780 OTHER   116,731     GLOBAL HEALTH PROGRAMS
(42) OPENMRS INC
10425 COMMERCE DR STE 110
CARMEL,IN460327643 		45-5316647 501(C)(3)   94,054     GLOBAL HEALTH PROGRAMS
(43) PANORAMA GLOBAL
2101 FOURTH AVENUE STE 2100
SEATTLE,WA98121 		81-4204119 501(C)(3)   10,000     GLOBAL HEALTH PROGRAMS
(44) PATHFINDER INTERNATIONAL
9 GALEN STREET SUITE 217
WATERTOWN,MA02472 		53-0235320 501(C)(3)   100,867     GLOBAL HEALTH PROGRAMS
(45) PHARMARON CPC INC
800 W BALTIMORE STREET 5TH FLOOR
BALTIMORE,MD21201 		20-8419781 501(C)(3)   687,836     ESSENTIAL MEDICINE
(46) POPULATION COUNCIL
ONE DAG HAMMARSKJOLD PLAZA
NEW YORK,NY10017 		13-1687001 501(C)(3)   146,121     TECHNOLOGY, ANALYTICS AND MARKET INNOVATION
(47) POPULATION SERVICES INTERNATIONAL INC
1120 19TH ST NW STE 600
WASHINGTON,DC20036 		56-0942853 501(C)(3)   63,300     GLOBAL HEALTH PROGRAMS
(48) ROSTROPOVICH-VISHNEVSKAYA FOUNDATION
1776 K STREET NW SUITE 700
WASHINGTON,DC20006 		52-1752473 501(C)(3)   152,378     ESSENTIAL MEDICINE
(49) SOLAR ELECTRIC LIGHT FUND
1612 K STREET NW SUITE 300
WASHINGTON,DC20006 		52-1701564 501(C)(3)   46,778     TECHNOLOGY, ANALYTICS AND MARKET INNOVATION
(50) TECHCHANGE INC
2001 13TH ST NW 2ND FLOOR
WASHINGTON,DC20009 		27-3358772 OTHER   64,664     GLOBAL HEALTH PROGRAMS
(51) THE NATURE CONSERVANCY
4245 FAIRFAX DRIVE
ARLINGTON,VA22203 		53-0242652 501(C)(3)   9,500     GLOBAL HEALTH PROGRAMS
(52) THE SCRIPPS RESEARCH INSTITUTE ( TSRI )
10550 N TORREY PINES ROAD
LA JOLLA,CA92037 		33-0435954 501(C)(3)   131,834     ESSENTIAL MEDICINE
(53) THE STATE UNIVERSITY OF NEW YORK
35 STATE STREET
ALBANY,NY122072826 		14-6013200 501(C)(3)   143,437     ESSENTIAL MEDICINE
(54) THE UNIVERSITY OF TEXAS AT AUSTIN
110 INNER CAMPUS DRIVE STOP K5300
AUSTIN,TX78712 		74-6000203 GOV   82,294     ESSENTIAL MEDICINE
(55) THE WILLIAM DAVIDSON INST AT THE UNIV OF MICHIGAN ( WDI )
724 E UNIVERSITY AVE WYLY HALL
FIRST FLOOR
ANN ARBOR,MI48109 		38-3048086 501(C)(3)   20,178     GLOBAL HEALTH PROGRAMS
(56) TULANE UNIVERSITY
6823 ST CHARLES AVE
NEW ORLEANS,LA70112 		72-0423889 501(C)(3)   372,590     GLOBAL HEALTH PROGRAMS
(57) UNIVERSITY OF MARYLAND BALTIMORE
PO BOX 41428
BALTIMORE,MD21203 		52-6002033 501(C)(3)   87,010     ESSENTIAL MEDICINE
(58) UNIVERSITY OF MASSACHUSETTS
MEDICAL SCHOOL 55 LAKE AVENUE NORTH
NORTH
WORCESTER,MA01655 		04-3167352 GOV   137,500     ESSENTIAL MEDICINE
(59) UNIVERSITY OF VERMONT AND STATE
AGRICULTURAL COLLEGE 85 SOUTH
PROSPECT STREET
BURLINGTON,VT05405 		03-0179440 501(C)(3)   57,854     ESSENTIAL MEDICINE
(60) UNIVERSITY OF WASHINGTON ( UW )
12455 COLLECTIONS DRIVE
CHICAGO,IL60693 		91-6001537 501(C)(3)   1,673,811     ESSENTIAL MEDICINE, GLOBAL HEALTH PROGRAMS, OTHER, AND TECHNOLOGY, ANALYTICS AND MARKET INNOVATION
(61) VILLAGEREACH
2900 EASTLAKE AVE E SUITE 230
SEATTLE,WA981023012 		91-2088484 501(C)(3)   1,271,766     GLOBAL HEALTH PROGRAMS
(62) WALTER REED ARMY INSTITUTE OF RESEARCH
US TREASURY 503 ROBERT GRANT AVE
SILVER SPRING,MD20910 		52-0664528 GOV   1,550,593     ESSENTIAL MEDICINE
(63) YALE UNIVERSITY
GRANT AND CONTRACT FINANCIAL ADMIN
PO BOX 1873
NEW HAVEN,CT065081873 		06-0646973 501(C)(3)   64,471     GLOBAL HEALTH PROGRAMS
(64) PVS
2201 WESTLAKE AVE SUITE 200
SEATTLE,WA98121 		83-0431851 501(C)(3)   92,478     OTHER
2
Enter total number of section 501(c)(3) and government organizations listed in the line 1 table ................. Bullet Image
52
3
Enter total number of other organizations listed in the line 1 table ........................ . Bullet Image
13
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50055P
Schedule I (Form 990) 2019

Schedule I (Form 990) 2019
Page 2
Part III
Grants and Other Assistance to Domestic Individuals. Complete if the organization answered "Yes" on Form 990, Part IV, line 22.
Part III can be duplicated if additional space is needed.
(a) Type of grant or assistance (b) Number of
recipients		 (c) Amount of
cash grant		 (d) Amount of
noncash assistance		 (e) Method of valuation (book,
FMV, appraisal, other)		 (f) Description of noncash assistance
(1) GRANT 1 10,313      
(1)
(2)
(3)
(4)
(5)
(6)
(7)
Part IV
Supplemental Information. Provide the information required in Part I, line 2; Part III, column (b); and any other additional information.
Return Reference Explanation
PART I, LINE 2: PATH HAS A SUBRECIPIENT POLICY AND PROCEDURES IN PLACE TO GUIDE THE WAY OUR PROJECT TEAMS MONITOR SUBRECIPIENTS. THIS INCLUDES BOTH FINANCIAL AND TECHNICAL MONITORING. PATH USES RISK ASSESSMENTS, REPORTING, SITE VISITS, REGULAR CONTACT, AND OTHER MEANS TO PROVIDE THE MONITORING REQUIRED BY FUNDERS AND TO ENSURE GOOD PROJECT STEWARDSHIP. THESE ACTIVITIES ALSO PROVIDE RESPONSIBLE ASSURANCE THAT THE SUBRECIPIENT ADMINISTERS FUNDS IN COMPLIANCE WITH LAWS, REGULATIONS, AND PRIME AWARD TERMS AND ACHIEVES PERFORMANCE GOALS. PATH HAS ESTABLISHED COMPREHENSIVE POLICIES AND PROCEDURES TO PROMOTE BEST BUSINESS PRACTICES AND ENSURE EFFICIENT AND EFFECTIVE INTERNAL CONTROL. THESE ARE COMBINED WITH AN INTERNAL AUDIT FUNCTION THROUGH WHICH PATH CONDUCTS AUDITS ON GRANT-FUNDED PROGRAMS TO ENSURE COMPLIANCE WITH REGULATORY REQUIREMENTS.
Schedule I (Form 990) 2019



Additional Data


Software ID:  
Software Version:  


Schedule J
(Form 990)
Department of the Treasury
Internal Revenue Service
Compensation Information
For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
SchJMediumBullet Complete if the organization answered "Yes" on Form 990, Part IV, line 23.
SchJMediumBullet Attach to Form 990.
SchJMediumBullet Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2019
Open to Public Inspection
Name of the organization
PATH
 
Employer identification number

91-1157127
Part I
Questions Regarding Compensation
Yes
No
1a
Check the appropiate box(es) if the organization provided any of the following to or for a person listed on Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.
b
If any of the boxes on Line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain .........
1b
Yes
 
2
Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
directors, trustees, officers, including the CEO/Executive Director, regarding the items checked on Line 1a? ..
2
Yes
 
3
Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.
4
During the year, did any person listed on Form 990, Part VII, Section A, line 1a, with respect to the filing organization or a related organization:
a
Receive a severance payment or change-of-control payment? .............
4a
Yes
 
b
Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........
4b
 
No
c
Participate in, or receive payment from, an equity-based compensation arrangement? .........
4c
 
No
If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.
Only 501(c)(3), 501(c)(4), and 501(c)(29) organizations must complete lines 5-9.
5
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:
a
The organization? ....................
5a
 
No
b
Any related organization? .......................
5b
 
No
If "Yes," on line 5a or 5b, describe in Part III.
6
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:
a
The organization? ..................
6a
 
No
b
Any related organization? ......................
6b
 
No
If "Yes," on line 6a or 6b, describe in Part III.
7
For persons listed on Form 990, Part VII, Section A, line 1a, did the organization provide any nonfixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............
7
Yes
 
8
Were any amounts reported on Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III ..........................
8
 
No
9
If "Yes" on line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................
9
 
 
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50053T
Schedule J (Form 990) 2019

Schedule J (Form 990) 2019
Page 2
Part II
Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.
For each individual whose compensation must be reported on Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.
(A) Name and Title (B) Breakdown of W-2 and/or 1099-MISC compensation (C) Retirement and other deferred compensation (D) Nontaxable
benefits		 (E) Total of columns
(B)(i)-(D) 		(F) Compensation in column (B) reported as deferred on prior Form 990
(i) Base
compensation 		(ii) Bonus & incentive
compensation 		(iii) Other reportable compensation
1STEPHEN BROWN DAVIS
PRESIDENT AND CEO 		(i)

(ii)		 480,557
-------------
0 		78,315
-------------
0 		1,800
-------------
0 		33,600
-------------
0 		30,402
-------------
0 		624,674
-------------
0 		0
-------------
0
2OLIVIA D POLIUS
CHIEF FINANCIAL OFFICER 		(i)

(ii)		 177,827
-------------
0 		0
-------------
0 		171,006
-------------
0 		21,972
-------------
0 		9,995
-------------
0 		380,800
-------------
0 		0
-------------
0
3JERRY KUO
CHIEF OF STRATEGIC FINANCE 		(i)

(ii)		 215,187
-------------
0 		0
-------------
0 		400
-------------
0 		26,848
-------------
0 		29,105
-------------
0 		271,540
-------------
0 		0
-------------
0
4BRIAN N NEVILLE
CHIEF OF ACCOUNTING 		(i)

(ii)		 222,837
-------------
0 		0
-------------
0 		840
-------------
0 		25,743
-------------
0 		8,967
-------------
0 		258,387
-------------
0 		0
-------------
0
5PRAVEEN RAJA
CHIEF OPERATING OFFICER 		(i)

(ii)		 372,545
-------------
0 		0
-------------
0 		35,995
-------------
0 		28,983
-------------
0 		10,854
-------------
0 		448,377
-------------
0 		0
-------------
0
6DAVID C KASLOW
VP - ESSENTIAL MEDICNES 		(i)

(ii)		 381,740
-------------
0 		0
-------------
0 		1,800
-------------
0 		33,600
-------------
0 		32,581
-------------
0 		449,721
-------------
0 		0
-------------
0
7JEFFREY D BERNSON
VP - TECH, ANALYTICS, & MRKT INNOV. 		(i)

(ii)		 250,526
-------------
0 		48,088
-------------
0 		74,760
-------------
0 		30,428
-------------
0 		26,919
-------------
0 		430,721
-------------
0 		0
-------------
0
8DAVID W FLEMING
VP - PUBLIC HEALTH 		(i)

(ii)		 299,264
-------------
0 		0
-------------
0 		2,419
-------------
0 		33,600
-------------
0 		14,712
-------------
0 		349,995
-------------
0 		0
-------------
0
9ELAINE L GIBBONS
VP - GLOBAL ENGAGEMENT 		(i)

(ii)		 248,319
-------------
0 		0
-------------
0 		1,720
-------------
0 		32,171
-------------
0 		40,044
-------------
0 		322,254
-------------
0 		0
-------------
0
10MOLLI M BARNES
CHIEF PEOPLE OFFICER 		(i)

(ii)		 216,617
-------------
0 		0
-------------
0 		220
-------------
0 		24,805
-------------
0 		23,067
-------------
0 		264,709
-------------
0 		0
-------------
0
11ERICA JANE SESSLE
CHIEF OF STAFF 		(i)

(ii)		 213,096
-------------
0 		0
-------------
0 		1,800
-------------
0 		25,647
-------------
0 		11,234
-------------
0 		251,777
-------------
0 		0
-------------
0
12SABRINA L POWERS
GENERAL COUNSEL 		(i)

(ii)		 160,935
-------------
0 		0
-------------
0 		700
-------------
0 		19,552
-------------
0 		12,187
-------------
0 		193,374
-------------
0 		0
-------------
0
13TRAD M HATTON
COUNTRY DIRECTOR 		(i)

(ii)		 135,223
-------------
0 		0
-------------
0 		198,189
-------------
0 		17,214
-------------
0 		32,569
-------------
0 		383,195
-------------
0 		0
-------------
0
14JAMES B MCKENNA
DEPUTY DIRECTOR 		(i)

(ii)		 164,480
-------------
0 		0
-------------
0 		125,801
-------------
0 		23,317
-------------
0 		54,308
-------------
0 		367,906
-------------
0 		0
-------------
0
15ASHLEY J BIRKETT
GLOBAL HEAD, MALARIA VACCINES 		(i)

(ii)		 309,050
-------------
0 		0
-------------
0 		990
-------------
0 		30,310
-------------
0 		29,092
-------------
0 		369,442
-------------
0 		0
-------------
0
16BRUCE LAMONT INNIS
GLOBAL HEAD, RESPIRATORY INFECTIONS 		(i)

(ii)		 319,784
-------------
0 		0
-------------
0 		840
-------------
0 		33,600
-------------
0 		-708
-------------
0 		353,516
-------------
0 		0
-------------
0
17JOHN O KONZ
GLOBAL HEAD, FINANCIAL MANAGEMENT 		(i)

(ii)		 312,128
-------------
0 		0
-------------
0 		840
-------------
0 		33,600
-------------
0 		27,568
-------------
0 		374,136
-------------
0 		0
-------------
0
Schedule J (Form 990) 2019

Schedule J (Form 990) 2019
Page 3
Part III
Supplemental Information
Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II. Also complete this part for any additional information.
Return Reference Explanation
PART I, LINE 1A HOUSING ALLOWANCES & TAX INDEMNIFICATIONS ARE ONLY PROVIDED TO THOSE INDIVIDUALS WHO ARE EXPATRIATE EMPLOYEES. ALL BENEFIT PAYMENTS ARE MADE ACCORDING TO OUR EXPATRIATE POLICY. PART I, LINE 3: PATH ENGAGES WITH A CONSULTING FIRM TO REVIEW THE COMPENSATION FOR EACH OF THE SENIOR MANAGEMENT POSITIONS. PATH PROVIDES AN ANNUAL SALARY ADJUSTMENT EACH JANUARY BASED ON THE OVERALL LABOR MARKET MOVEMENT.
PART I, LINE 4A THE FOLLOWING EMPLOYEES RECEIVED SEVERANCE PAYMENTS IN 2019: - OLIVIA POLIUS $163,910
PART I, LINE 7 BONUS COMPENSATION HAS BEEN REFLECTED IN PART II, COLUMN (B)(II).
Schedule J (Form 990) 2019

Additional Data


Software ID:  
Software Version:  
SCHEDULE M
(Form 990)

Department of the Treasury
Internal Revenue Service
Noncash Contributions
Right pointing arrow large imageComplete if the organizations answered "Yes" on Form 990, Part IV, lines 29 or 30.
Right pointing arrow large image Attach to Form 990.
Right pointing arrow large imageGo to www.irs.gov/Form990 for the latest information.
OMB No. 1545-0047
2019
Open to Public Inspection
Name of the organization
PATH
 
Employer identification number

91-1157127
Part I
Types of Property
(a)
Check if applicable 		(b)
Number of contributions or items contributed 		(c)
Noncash contribution amounts reported on
Form 990, Part VIII, line 1g 		(d)
Method of determining
noncash contribution amounts
1 Art—Works of art ....        
2 Art—Historical treasures .        
3 Art—Fractional interests ..        
4 Books and publications ..      
5 Clothing and household
goods ....... 		     
6 Cars and other vehicles ..        
7 Boats and planes ....        
8 Intellectual property ...        
9 Securities—Publicly traded . X 18 219,075 FMV
10 Securities—Closely held stock .        
11 Securities—Partnership, LLC,
or trust interests .... 		       
12 Securities—Miscellaneous ..        
13 Qualified conservation
contribution—Historic
structures ..... 		       
14 Qualified conservation
contribution—Other ... 		       
15 Real estate—Residential .        
16 Real estate—Commercial ..        
17 Real estate—Other ...        
18 Collectibles .....        
19 Food inventory ...        
20 Drugs and medical supplies .        
21 Taxidermy ......        
22 Historical artifacts ....        
23 Scientific specimens ..        
24 Archeological artifacts ...        
25 Other Right pointing arrow large image ( SOFTWARE/SUPP. ) X 5 4,124,378 COST
26 Other Right pointing arrow large image ( )
27 Other Right pointing arrow large image ( )
28 Other Right pointing arrow large image ( )
29
Number of Forms 8283 received by the organization during the tax year for contributions
for which the organization completed Form 8283, Part IV, Donee Acknowledgement
29
 
Yes
No
30a
During the year, did the organization receive by contribution any property reported in Part I, lines 1 through 28, that it must hold for at least three years from the date of the initial contribution, and which isn't required to be used for exempt purposes for the entire holding period? ...................
30a
 
No
b
If "Yes," describe the arrangement in Part II.
31
Does the organization have a gift acceptance policy that requires the review of any nonstandard contributions?
31
Yes
 
32a
Does the organization hire or use third parties or related organizations to solicit, process, or sell noncash
contributions? ..........................
32a
 
No
b
If "Yes," describe in Part II.
33
If the organization didn't report an amount in column (c) for a type of property for which column (a) is checked,
describe in Part II.
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 51227J
Schedule M (Form 990) (2019)
Schedule M (Form 990) (2019)
Page 2
Part IISupplemental Information. Provide the information required by Part I, lines 30b, 32b, and 33, and whether the organization is reporting in Part I, column (b), the number of contributions, the number of items received, or a combination of both. Also complete this part for any additional information.
Return Reference Explanation
PART I, COLUMN (B): THIS COLUMN REFLECTS THE NUMBER OF CONTRIBUTIONS.
Schedule M (Form 990) (2019)

Additional Data


Software ID:  
Software Version:  
SCHEDULE O
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service
Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or 990-EZ or to provide any additional information.
MediumBullet Attach to Form 990 or 990-EZ.
MediumBullet Go to www.irs.gov/Form990 for the latest information.
OMB No. 1545-0047
2019
Open to Public
Inspection
Name of the organization
PATH
 
Employer identification number

91-1157127
Return Reference Explanation
FORM 990, PART III, LINE 1, DESCRIPTION OF ORGANIZATION MISSION: PATH IS A GLOBAL ORGANIZATION THAT WORKS TO ACCELERATE HEALTH EQUITY BY BRINGING TOGETHER PUBLIC INSTITUTIONS, BUSINESSES, SOCIAL ENTERPRISES, AND INVESTORS TO SOLVE THE WORLD'S MOST PRESSING HEALTH CHALLENGES. WITH EXPERTISE IN SCIENCE, HEALTH, ECONOMICS, TECHNOLOGY, ADVOCACY, AND DOZENS OF OTHER SPECIALTIES, PATH DEVELOPS AND SCALES UP SOLUTIONS-INCLUDING VACCINES, DRUGS, DEVICES, DIAGNOSTICS, AND INNOVATIVE APPROACHES TO STRENGTHENING HEALTH SYSTEMS WORLDWIDE. SINCE 2011, PATH AND OUR PARTNERS AND SUPPORTERS HAVE IMPROVED HEALTH FOR MORE THAN 150 MILLION PEOPLE ON AVERAGE EACH YEAR. THE LARGEST INVESTMENTS IN PATH'S PROGRAMMATIC WORK IN 2019 WERE ORGANIZED INTO THREE PRIMARY PORTFOLIOS: GLOBAL HEALTH PROGRAMS; ESSENTIAL MEDICINES; AND TECHNOLOGY, ANALYTICS, AND MARKET INNOVATION. SEE BELOW FOR DESCRIPTIONS OF THESE PROGRAMS.
FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICE: IN UKRAINE, PATH LEADS THE USAID-FUNDED SERVING LIFE PROJECT, WHICH REDUCES TB, HIV, AND HEPATITIS C TRANSMISSION IN PRETRIAL DETENTION CENTERS, PRISONS, POST-PRISON SETTINGS, AND THE COMMUNITY. STRATEGIES INCLUDE INCREASING CASE DETECTION, STRENGTHENING LINKAGES TO CARE, AND EMPLOYING A CASE-MANAGEMENT APPROACH TO ENSURE TREATMENT COMPLETION. IN 2019, WE WORKED IN 12 REGIONS IN 75 PRETRIAL DETENTION CENTERS, PRISON COLONIES, AND CORRECTIONAL CENTERS, AND 12 PROBATION CENTERS. WE TESTED APPROXIMATELY 30,000 PEOPLE FOR HIV, LINKED AROUND 3,000 NEWLY IDENTIFIED PLHIV TO TREATMENT, AND SUPPORTED ABOUT 2,500 PEOPLE IN PRISON ON HIV TREATMENT. IN 2019, WE ALSO PARTNERED WITH THE MINISTRY OF JUSTICE TO LAUNCH A PILOT PROGRAM TO PROVIDE OPIOID-SUBSTITUTION THERAPY TO PEOPLE WHO INJECT DRUGS, THE FIRST TIME THIS INTERVENTION HAS BEEN PROVIDED IN A PRISON IN UKRAINE. IN ANOTHER ADVANCEMENT, WE ROLLED OUT THE USE OF A SMART PILL BOX THAT REMINDS PATIENTS TO TAKE THEIR TB MEDICATION AND NOTIFIES PROVIDERS IF DOSES ARE MISSED, RESULTING IN 90% TREATMENT COMPLETION AMONG PATIENTS USING THIS TECHNOLOGY. WE WILL CONTINUE TO BUILD ON THESE SUCCESSES AS A PARTNER UNDER THE UNITAID-FUNDED ADHERENCE SUPPORT COALITION TO END TB PROJECT, LAUNCHED IN 2019. FOR MORE INFORMATION ON OUR WORK IN UKRAINE, SEE THE COUNTRY PROGRAMS SECTION. IN VIETNAM, PATH CONTINUED TO PILOT INNOVATIONS IN HIV. IN 2019, WE EQUIPPED SOCIAL ENTERPRISES AND PRIVATE CLINICS LED BY KEY POPULATIONS TO GENERATE DEMAND FOR AND PROVIDE HIV SERVICES. INNOVATIVE ONLINE CHAT BOTS OFFERED INFORMATION ON HIV SELF TESTING (HIVST) AND PRE-EXPOSURE PROPHYLAXIS (PREP); CARE PROVIDERS THEN SERVED THESE CLIENTS OFFLINE IN COMMUNITIES OR AT CLINICS. PATH ALSO ENGAGED THE GOVERNMENT OF VIETNAM TO SCALE UP NEW MODELS OF HIV TESTING, INCLUDING EXPANDING ACCESS TO HIV LAY- AND SELF-TESTING AND PARTNER NOTIFICATION SERVICES. THE PROJECT TESTED APPROXIMATELY 50,000 PEOPLE IN 2019. WORKING AGAIN WITH THE GOVERNMENT AND KEY POPULATION SERVICE PROVIDERS, PATH INTRODUCED A VARIETY OF SERVICE MODELS TO RAPIDLY SCALE UP PREP NATIONWIDE; IN 2019 ALONE, WE DOUBLED THE NUMBER OF PEOPLE ON PREP. PATH ALSO FOCUSED ON TB CONTROL. IN 2019, THE BREATH FOR LIFE PROJECT WORKED WITH VIETNAM'S NATIONAL TUBERCULOSIS PROGRAM TO DEVELOP AND TEST STANDARD OPERATING PROCEDURES TO ADDRESS THE SPECIMEN COLLECTION CHALLENGES THAT CONTRIBUTE TO LOW DETECTION OF TB IN CHILDREN. OUR EFFORTS RESULTED IN UPDATED NATIONAL GUIDELINES THAT FACILITATED COUNTRYWIDE SCALE-UP OF STOOL XPERT TESTING FOR TB DIAGNOSIS AMONG CHILDREN. IN INDIA, PATH DEVELOPED TOOLS AND APPLICATIONS TO ENHANCE MONITORING OF HIV SERVICE DELIVERY THROUGH IMPROVED DATA QUALITY AND AUTOMATED DATA COMPILATION. TO IMPROVE TB SERVICES, WE PILOTED ARTIFICIAL INTELLIGENCE TO STREAMLINE CHEST X-RAY READINGS, ENABLING QUICKER DIAGNOSIS AND INITIATION ON TB TREATMENT. FURTHER, WE WORKED CLOSELY WITH THE NATIONAL TB PROGRAM TO DEVELOP PUBLIC-PRIVATE PARTNERSHIP GUIDELINES, AND WE CONTINUED ENGAGING THE PRIVATE SECTOR TO LINK DRUG-RESISTANT TB PATIENTS TO PUBLIC-SECTOR CARE. IN TANZANIA, PATH AND OUR PARTNERS DEVELOPED A MOBILE PHONE APPLICATION THAT ENABLED ALMOST 229,900 PEOPLE TO SELF-SCREEN FOR TB. IN ZAMBIA, PATH CONTINUED TO IMPLEMENT THE ERADICATE TB PROJECT, SUPPORTING 249 HEALTH FACILITIES ACROSS SIX PROVINCES. THE PROJECT TESTED MORE THAN 125,000 PEOPLE FOR TB AND INITIATED MORE THAN 8,000 PEOPLE ON TREATMENT. FOR MORE INFORMATION, SEE THE COUNTRY PROGRAMS SECTION. ALSO IN 2019, PATH BEGAN WORK ON A NEW TB PROJECT IN CENTRAL ASIA THAT PROVIDES CLINICAL TECHNICAL SUPPORT AND DRUG SAFETY MONITORING TO NATIONAL TB PROGRAMS IN TAJIKISTAN, KAZAKHSTAN, AND UZBEKISTAN. MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION: PATH WORKS WITH PARTNERS TO IMPROVE MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION AROUND THE WORLD. TOGETHER WE DEVELOP, ADAPT, AND SCALE TECHNOLOGIES AND APPROACHES TO REDUCE ILLNESS AND DEATH AND GIVE CHILDREN THE BEST POSSIBLE START IN LIFE. IN 2019, PATH CONTINUED TO EXPAND OUR GLOBAL AND NATIONAL LEADERSHIP IN EARLY CHILDHOOD DEVELOPMENT (ECD). WITH PATH SUPPORT, THE GOVERNMENTS OF ETHIOPIA, KENYA, MOZAMBIQUE, AND ZAMBIA CONTINUED TO INCORPORATE ECD SERVICES INTO BASIC HEALTH CARE. THIS PIONEERING WORK FOCUSES ON BUILDING AN ENABLING LEADERSHIP AND POLICY ENVIRONMENT WHILE SUPPORTING AND STRENGTHENING THE CAPACITY OF HEALTH SYSTEMS AND HEALTH SERVICE PROVIDERS. ALONG WITH WHO, UNICEF, THE WORLD BANK, AND OTHERS, PATH HELPED ADVANCE THE NURTURING CARE FOR ECD FRAMEWORK, WHICH OFFERS A STRUCTURE FOR COUNTRIES TO ADOPT, ADAPT, AND SCALE ECD SERVICES. IN PARTNERSHIP WITH THE AFRICAN POPULATION AND HEALTH RESEARCH CENTER, WE LAUNCHED A RANDOMIZED CONTROL TRIAL OF ECD INTERVENTIONS IN KENYA. WITH HARVARD UNIVERSITY, WE DESIGNED A LARGE-SCALE EVALUATION IN MOZAMBIQUE. PATH CONTINUED EFFORTS TO ENSURE THAT ALL INFANTS RECEIVE HUMAN MILK. OUR WORK CENTERS AROUND BREASTFEEDING PROMOTION, INCLUDING THE PROVISION OF SAFE DONOR MILK THROUGH HUMAN MILK BANKS. IN 2019, PATH LAUNCHED STRENGTHENING HUMAN MILK BANKING: A RESOURCE TOOLKIT FOR ESTABLISHING AND OPERATING HUMAN MILK BANK PROGRAMS, THE FIRST-EVER STANDARD TO ENSURE QUALITY AND SAFETY. AMONG OTHER EFFORTS, PATH WORKED WITH THE MINISTRY OF HEALTH (MOH) IN KENYA TO LAUNCH THE FIRST HUMAN MILK BANK IN THE EAST AFRICAN REGION AND CONDUCTED AN EVALUATION TO ASSESS OUTCOMES. IN GHANA, THE MAKING EVERY BABY COUNT INITIATIVE STRENGTHENED LEADERSHIP AND CAPACITY AT THE NATIONAL AND LOCAL LEVELS TO MANAGE AND SUSTAIN BEST PRACTICES IN NEWBORN CARE. BY 2019, PATH HAD TRAINED MORE THAN 3,600 FRONTLINE HEALTH WORKERS IN IMPROVED NEWBORN CARE, HELPED DRIVE ADVOCACY AND POLICY THROUGH THE GHANA NATIONAL NEWBORN SUBCOMMITTEE, AND PARTNERED WITH THE GHANA HEALTH SERVICE ON ITS NEWBORN ACTION PLAN TO REDUCE NEONATAL MORTALITY RATES. RECOGNIZING THAT NUTRITION IS AFFECTED BY A VARIETY OF ECONOMIC AND ENVIRONMENTAL FACTORS, PATH'S NUTRITION TEAM CONTINUED TO DRIVE NOVEL APPROACHES TO ADDRESS THE MASSIVE BURDEN OF MALNUTRITION IN COMMUNITIES AROUND THE WORLD. WE ENGAGED STAKEHOLDERS WITH EXPERTISE SPANNING GLOBAL HEALTH, DEVELOPMENT, AND THE ENVIRONMENT, FROM BOTH THE PUBLIC AND PRIVATE SECTORS. PATH CONTINUED TO LEAD A CONSORTIUM OF FIVE ORGANIZATIONS IN A PROJECT KNOWN AS MAXIMISING THE QUALITY OF SCALING UP NUTRITION PLUS (MQSUN+). IN 2019, MQSUN+ SUPPORTED THE DEVELOPMENT OF A MULTISECTORAL NUTRITION PLAN FOR TAJIKISTAN AND COSTED MULTISECTORAL NUTRITION PLANS FOR AFGHANISTAN, GUINEA, SOMALIA, TOGO, AND YEMEN. MQSUN+ ALSO SUPPORTED EFFORTS TO PROVIDE STRATEGIC DIRECTION TOWARD THE NEXT PHASE OF THE "SCALING UP NUTRITION" MOVEMENT AND CONTINUED TO ADVANCE AND SUPPORT THE TRACKING OF FINANCIAL AND NONFINANCIAL COMMITMENTS TO NUTRITION. OTHER ACTIVITIES IN 2019 INCLUDED PARTNERING WITH THE NATURE CONSERVANCY, DUKE UNIVERSITY, AND THE INTERNATIONAL FOOD POLICY RESEARCH INSTITUTE ON USE OF ALTERNATIVE PROTEINS; THIS WORK WAS FUNDED BY THE ROCKEFELLER FOUNDATION. WE ALSO WORKED WITH HARVEST PLUS TO EXPAND THE REACH OF BIOFORTIFIED CROPS. WE CONTINUED TO DRIVE MULTISECTORAL COLLABORATION IN 2019 THROUGH THE BRIDGE COLLABORATIVE, A TRAILBLAZING, CROSS-DISCIPLINARY EFFORT TO ENGAGE MORE THAN 150 LEADING TECHNICAL EXPERTS FROM THE HEALTH, DEVELOPMENT, AND ENVIRONMENTAL SECTORS TO ADDRESS HUMAN AND PLANETARY HEALTH. IN CONJUNCTION WITH THE WILDLIFE CONSERVATION SOCIETY AND THE NATURE CONSERVANCY, THE BRIDGE COLLABORATIVE PUBLISHED SEVERAL NEW PAPERS AND HELD SEVERAL MEETINGS ON FOOD SYSTEMS AND THE INTERSECTION OF HUMAN AND PLANETARY HEALTH. IN 2019, PATH STAFF MEMBERS PRESENTED AT KEY GLOBAL AND NATIONAL MEETINGS AND AUTHORED, EDITED, AND CONTRIBUTED TO VARIOUS HIGH-PROFILE PEER-REVIEWED JOURNAL ARTICLES, BOOK CHAPTERS, GLOBAL REPORTS, AND SYSTEMATIC REVIEWS. THESE EFFORTS ADVANCED THINKING ON BROAD, EFFECTIVE SOLUTIONS TO THE MOST PRESSING CHALLENGES IN MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION. SEXUAL AND REPRODUCTIVE HEALTH: PATH'S WORK IN SEXUAL AND REPRODUCTIVE HEALTH IS GUIDED BY THE KEY PRINCIPLES OF CHOICE, EQUITY, AND DIGNITY FOR ALL WOMEN. BECAUSE WE UNDERSTAND THE COMPLEX SOCIAL, BEHAVIORAL, AND GENDER DIMENSIONS OF WOMEN'S REPRODUCTIVE HEALTH, WE BUILD EVIDENCE AROUND TOOLS AND SERVICES THAT ARE BEST SUITED TO ADDRESS WOMEN'S DIVERSE NEEDS AND CIRCUMSTANCES. WE SPECIALIZE IN REDUCING BARRIERS TO ACCESS.
FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICE: IN 2019, PATH CONTINUED TO CHAMPION THE RIGHT OF WOMEN TO MANAGE THEIR OWN SEXUAL AND REPRODUCTIVE HEALTH BY CREATING AND ADVANCING IMPROVED TOOLS AND PRACTICES THAT MAKE WOMEN'S SELF-CARE POSSIBLE. AN INTEGRATED APPROACH TO WOMEN'S HEALTH INCLUDES ATTENTION TO CONTRACEPTION, CERVICAL AND BREAST CANCER, SEXUALLY TRANSMITTED INFECTIONS, AND A WOMAN'S RIGHT TO DECIDE WHETHER AND WHEN TO BECOME A MOTHER. AMONG THE RECENT WOMAN-INITIATED PRODUCTS INTRODUCED BY PATH ARE AN ALL-IN-ONE INJECTABLE CONTRACEPTIVE THAT CAN BE SELF-ADMINISTERED AND A VAGINAL SELF-SAMPLING KIT FOR HUMAN PAPILLOMAVIRUS (HPV) TESTING IN CERVICAL CANCER SCREENING PROGRAMS, AS DESCRIBED BELOW. PATH'S RESEARCH AND COORDINATION TO EXPAND ACCESS TO THE INJECTABLE CONTRACEPTIVE SUBCUTANEOUS DMPA (DMPA-SC, OR SAYANA PRESS) CONTINUED IN 2019, PRIMARILY THROUGH THE SELF-INJECTION BEST PRACTICES AND DMPA-SC ACCESS COLLABORATIVE PROJECTS. OUR SELF-INJECTION PROJECT IN UGANDA TOOK A USER-CENTERED APPROACH TO DEVELOP AND INTRODUCE MODELS FOR CONTRACEPTIVE SELF-INJECTION AND DISSEMINATED INFORMATION ON HOW THE PRACTICE CAN BE IMPLEMENTED AT SCALE. MORE THAN 7,000 WOMEN SELF-INJECTED DMPA-SC ACROSS FOUR DISTRICTS THROUGH THIS PROGRAM. THE DMPA-SC ACCESS COLLABORATIVE CONTINUED WORKING WITH MINISTRIES OF HEALTH AND PARTNERS ACROSS SECTORS IN SEVEN COUNTRIES TO FACILITATE DMPA-SC INTRODUCTION AS WELL AS SCALE-UP PLANNING FOR A RANGE OF CONTRACEPTIVE OPTIONS. IN 2019, THE COLLABORATIVE PROVIDED TECHNICAL ASSISTANCE TO ENSURE IMPLEMENTATION OF EACH COUNTRY'S TOTAL MARKET PLAN. THE COLLABORATIVE FACILITATED LEARNING ACROSS COUNTRIES BY EXCHANGING INFORMATION, RESULTS, AND LESSONS LEARNED; TROUBLESHOOTING CHALLENGES; AND ACCELERATING THE ADOPTION OF BEST PRACTICES. PATH WORKED WITH GLOBAL AND COUNTRY PARTNERS TO IMPROVE THE PREVENTION, DETECTION, AND TREATMENT OF CERVICAL PRECANCER, WHICH IS CAUSED BY INFECTION WITH HPV. WE CONTINUED OUR PARTNERSHIP WITH THE MINISTRIES OF HEALTH IN GUATEMALA AND HONDURAS TO SUPPORT THE SCALE-UP OF HPV TESTING IN THE PUBLIC SECTOR. WE PROVIDED TECHNICAL SUPPORT FOR PROCUREMENT OF TESTS, SUPPORTED ADVOCACY AND DISSEMINATION EVENTS, AND MADE PROGRESS TOWARD TRANSITIONING LEADERSHIP OF THE PROGRAM TO THE MINISTRIES AS THE PROJECT WAS IN ITS FINAL YEAR. WE ALSO EVALUATED FOLLOW-UP AND TREATMENT STRATEGIES TO ENSURE WOMEN RECEIVE APPROPRIATE, COMPREHENSIVE CARE. PATH PARTICIPATED IN WHO'S CALL FOR GLOBAL CERVICAL CANCER ELIMINATION BY HELPING SHAPE STRATEGIES FOR LOW- AND MIDDLE-INCOME COUNTRIES. IN MYANMAR, WE ENGAGED WITH THE MOH AND OTHER STAKEHOLDERS TO DESIGN A CERVICAL CANCER CONTROL PLAN. A PATH-LED CONSORTIUM ALSO WORKED CLOSELY WITH THE MOH TO STRENGTHEN THE KNOWLEDGE, CAPACITY, AND COORDINATION OF DECISION-MAKERS, SERVICE PROVIDERS, AND COMMUNITY MEMBERS TO UNDERSTAND SEXUAL AND REPRODUCTIVE HEALTH SERVICES AND RIGHTS AND TO INFLUENCE THE DEVELOPMENT AND IMPLEMENTATION OF RELATED POLICIES. TO COMBAT BREAST CANCER, WE WORKED IN PERU WITH THE NATIONAL AND REGIONAL CANCER INSTITUTES AND OTHER STAKEHOLDERS TO IMPLEMENT A MODEL FOR EARLY DETECTION OF BREAST CANCER APPROPRIATE AND FEASIBLE FOR LOW- AND MIDDLE-RESOURCE SETTINGS. WE BUILT THE CAPACITY OF HEALTH PROFESSIONALS TO IMPLEMENT THIS MODEL AND SHARED EVIDENCE WITH MOH REPRESENTATIVES FROM EL SALVADOR, GUATEMALA, HONDURAS, AND NICARAGUA. WE ALSO CONDUCTED ADVOCACY AMONG HEALTH OFFICIALS TO ENSURE BREAST CANCER REMAINS ON THE AGENDA AND WOMEN RECEIVE SCREENING AND TREATMENT EVEN IN THE ABSENCE OF MAMMOGRAPHY SERVICES. PATH CONTINUED TO SERVE AS THE SECRETARIAT FOR THE REPRODUCTIVE HEALTH SUPPLIES COALITION, A GLOBAL PARTNERSHIP OF MORE THAN 400 PUBLIC AND PRIVATE ENTITIES AND NGOS WORKING TO EXPAND ACCESS TO CRITICAL SEXUAL AND REPRODUCTIVE HEALTH AND FAMILY PLANNING SUPPLIES AND SERVICES. NONCOMMUNICABLE DISEASES: PATH IS AT THE FOREFRONT OF THE FIGHT AGAINST NONCOMMUNICABLE DISEASES (NCDS), INCLUDING DIABETES AND CARDIOVASCULAR DISEASE, IN LOW-RESOURCE SETTINGS WORLDWIDE. THE BURDEN OF THESE DISEASES IS RISING DISPROPORTIONATELY AMONG LOW- AND MIDDLE-INCOME COUNTRIES AND POPULATIONS. IN 2019, PATH CONTINUED TO SERVE AS THE SECRETARIAT OF THE COALITION FOR ACCESS TO NCD MEDICINES AND PRODUCTS. THIS GLOBAL, MULTISECTORAL COALITION IS DEDICATED TO INCREASING ACCESS TO NCD MEDICINES AND HEALTH PRODUCTS IN LOW- AND MIDDLE-INCOME COUNTRIES. IN ADDITION TO GLOBAL ADVOCACY EFFORTS, THE COALITION FOCUSED ON EAST AFRICA. AMONG OTHER ACTIVITIES, PATH CO-LED A MEETING WITH THE EAST AFRICA COMMUNITY SECRETARIAT TO BEGIN DEVELOPING A REGIONAL FRAMEWORK FOR NCDS. IN COLLABORATION WITH THE KENYA MOH AND LOCAL STAKEHOLDERS, PATH CONTINUED TO REFINE THE NCD NAVIGATOR, A FIRST-OF-ITS-KIND DIGITAL MANAGEMENT INFORMATION SYSTEM THAT PROVIDES REAL-TIME DATA ON NCD PROGRAMMING. OTHER ACHIEVEMENTS INCLUDED AN END-TO-END NCD SUPPLY CHAIN ASSESSMENT IN KENYA THAT WILL INFORM SUPPLY CHAIN STRENGTHENING EFFORTS. IN 2019, PATH BEGAN ADDRESSING THE GROWING NCD BURDEN IN GHANA BY LEVERAGING THE WORK DONE IN KENYA AND APPLYING THE NCD NAVIGATOR TO THE LOCAL CONTEXT. WE CONDUCTED A SITUATIONAL ANALYSIS AND DEVELOPED A PROTOCOL FOR A SUPPLY CHAIN ASSESSMENT (TO BE IMPLEMENTED IN 2020). ALSO IN GHANA, PATH LAUNCHED THE HEALTHY HEART AFRICA PROJECT. IN PARTNERSHIP WITH THE GHANA HEALTH SERVICE, THE PROJECT WORKS IN THE ASHANTI REGION TO SUPPORT HYPERTENSION SCREENING AND LINKAGES TO CARE. IN 2019, THE PROGRAM CONDUCTED MORE THAN 20,000 BLOOD PRESSURE SCREENINGS AND DIAGNOSED MORE THAN 1,200 PEOPLE WITH HYPERTENSION, CONTRIBUTING TO NATIONAL TESTING EFFORTS. IN VIETNAM, PATH BUILT ON THE PREVIOUS COMMUNITIES FOR HEALTHY HEARTS PROJECT AND ADAPTED THE MODEL IN 2019 TO INCLUDE DIABETES AND HYPERTENSION. USING LESSONS LEARNED AND CAPACITY STRENGTHENING ACTIVITIES, THE MODEL WAS SCALED UP NATIONALLY. WORKING CLOSELY WITH THE MOH AND A PROVINCIAL GOVERNMENT, WE SCREENED 10,000 PEOPLE AND LINKED 6,000 PEOPLE TO CARE. PATH ALSO COLLABORATED WITH THE MOH TO CREATE A DIGITAL ROAD MAP FOR MANAGING NCDS IN VIETNAM. IN SENEGAL, PATH IMPLEMENTED THE BETTER HEARTS BETTER CITIES PROJECT TO IMPROVE THE HYPERTENSION CONTROL RATE IN DAKAR. MORE INFORMATION CAN BE FOUND IN THE COUNTRY PROGRAMS SECTION. PATH ALSO IMPLEMENTED A HYPERTENSION SCREENING PROJECT IN MUMBAI, INDIA, IN PARTNERSHIP WITH RESOLVE TO SAVE LIVES. THE PROJECT USES A PRIVATE-SECTOR ENGAGEMENT MODEL. FINALLY, PATH LED AND CONTRIBUTED TO CONVENINGS TO RAISE AWARENESS OF NCDS AND ORCHESTRATE ACTION TO IMPROVE ACCESS TO PREVENTION AND CARE. HEALTH SYSTEMS INNOVATION AND DELIVERY: PATH'S HEALTH SYSTEMS INNOVATION AND DELIVERY PROGRAM STRENGTHENS HEALTH SYSTEMS AND ENHANCES COUNTRY CAPACITY FOR DATA-DRIVEN DECISION-MAKING. OUR PORTFOLIO SERVES AS AN ORGANIZING MECHANISM FOR PATH PROJECTS, INITIATIVES, AND UNITS THAT STRENGTHEN HEALTH SYSTEMS. THE HEALTH SYSTEMS ANALYTICS UNIT PROMOTES SYSTEMS THINKING; WITHIN AND OUTSIDE OF PATH, THIS UNIT LEADS COMPLEX EVALUATIONS OF HEALTH PROGRAMS, ENGAGES IN IMPLEMENTATION SCIENCE RESEARCH, FACILITATES HEALTH TECHNOLOGY INTRODUCTION AND SCALE-UP, AND WORKS TO IMPROVE DATA QUALITY AND USE FOR DECISION-MAKING. IN 2019, AS PART OF THE GLOBAL FUND'S PROSPECTIVE COUNTRY EVALUATIONS, THE UNIT EVALUATED THE GLOBAL FUND'S BUSINESS MODEL IN THE DRC, GUATEMALA, AND UGANDA. STAFF ENGAGED IN NETWORK ANALYSES TO INFORM THE OPTIMAL STRUCTURE AND FUNCTION OF VARIOUS COALITIONS AND INFORMAL AND FORMAL NETWORKS. THE HEALTH SYSTEMS STRENGTHENING IMPACT TEAM CONTINUED TO SERVE AS A HUB FOR STAFF WORKING IN HEALTH SYSTEMS. THE TEAM PLANNED FUTURE WORK IN STRENGTHENING URBAN HEALTH SYSTEMS, IMPROVING COMMUNITY-LEVEL DATA USE, AND DEVELOPING RESOURCES FOR SUCCESSFUL INTRODUCTION AND SCALE-UP OF INTERVENTIONS AND TECHNOLOGIES. THIS TEAM ALSO DEVELOPED PATH'S PRIMARY HEALTH CARE STRATEGY. THE GLOBAL HEALTH SECURITY TEAM CONTINUED TO INNOVATE FOR THE PREVENTION, DETECTION, AND CONTROL OF INFECTIOUS DISEASE OUTBREAKS. WITH SUPPORT FROM THE US CENTERS FOR DISEASE CONTROL AND PREVENTION, THE TEAM WORKED WITH NATIONAL LEADERS IN THE DRC, SENEGAL, TANZANIA, AND VIETNAM TO STRENGTHEN THEIR PUBLIC HEALTH SYSTEMS AND BUILD THEIR CAPACITY IN EPIDEMIC PREPAREDNESS AND RESPONSE. THE TEAM ALSO WORKED AS A MAJOR SUBGRANTEE ON THE USAID-SUPPORTED INFECTIOUS DISEASE DETECTION & SURVEILLANCE PROJECT. THIS PROJECT WORKS TO IMPROVE THE DETECTION OF HIGH-PRIORITY INFECTIOUS DISEASES AND IDENTIFICATION OF ANTIMICROBIAL RESISTANCE THROUGH IMPROVED DIAGNOSTIC AND SURVEILLANCE SYSTEMS. OUR CROSS-ORGANIZATIONAL IMPACT TEAM FOR EPIDEMIC PREPAREDNESS AND RESPONSE CONTINUED TO BE AT THE FOREFRONT OF THE EBOLA RESPONSE IN THE DRC, ENHANCING SURVEILLANCE, DETECTION, AND RESOURCE MOBILIZATION. OTHER EFFORTS INCLUDED STRENGTHENING ELECTRONIC HEALTH INFORMATION SYSTEMS, ADVANCING NOVEL VACCINE PLATFORMS, PREPARING MEDICAL COUNTERMEASURES FOR PANDEMIC INFLUENZA, AND DEFINING PATH'S ROLE IN COMBATING ANTIMICROBIAL RESISTANCE.
FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICE: COUNTRY PROGRAMS: PATH'S COUNTRY PROGRAMS SUPPORT WORK RANGING FROM SMALL-SCALE PILOTS TO LARGE, MULTICOUNTRY EFFORTS. IN 2019, WE OPERATED FULL-SCALE "COUNTRY" OFFICES IN THE DRC, ETHIOPIA, INDIA, KENYA, MYANMAR, SENEGAL, TANZANIA, UGANDA, UKRAINE, VIETNAM, AND ZAMBIA, AS WELL AS SMALLER "PROJECT" OFFICES IN MANY OTHER COUNTRIES. EXAMPLES THIS YEAR FOCUS ON SENEGAL, UKRAINE, AND ZAMBIA. IN SENEGAL, PATH WORKS CLOSELY WITH THE GOVERNMENT TO ACCELERATE PROGRESS TOWARD HEALTH SYSTEM MILESTONES. WE DO THIS IN PART BY BUILDING A CULTURE OF DATA USE. THE MACEPA PROGRAM, DESCRIBED EARLIER, HAS WORKED WITH SENEGAL'S MINISTRY OF HEALTH AND SOCIAL ACTION (MOHSA) AND NATIONAL MALARIA CONTROL PROGRAM SINCE 2010. IN 2019, MACEPA PROVIDED TECHNICAL ASSISTANCE IN DATA QUALITY AND DATA-DRIVEN DECISION-MAKING, OPERATIONAL RESEARCH, DEVELOPMENT OF NATIONAL POLICIES, AND COLLABORATION ON CROSS-BORDER ISSUES WITH NEIGHBORING COUNTRIES; FOR INSTANCE, PATH SUPPORTED COORDINATED PLANNING BETWEEN SENEGAL AND THE GAMBIA FOR THE DEVELOPMENT OF A SHARED DATA PLATFORM AND THE MASS DISTRIBUTION OF LONG-LASTING INSECTICIDE-TREATED BEDNETS. DURING 2019, PATH'S GLOBAL HEALTH SECURITY TEAM, ALSO DESCRIBED EARLIER, FOCUSED IN SENEGAL ON STRENGTHENING LABORATORY, SURVEILLANCE, AND INFORMATION SYSTEMS, AND ON PREVENTING ANTIMICROBIAL RESISTANCE. IN 2019, PATH SUPPORTED THE MOHSA TO IMPROVE ELECTRONIC REPORTING FROM HOSPITALS. WE ALSO SUPPORTED PUBLICATION OF KEY POLICY DOCUMENTS RELATED TO THE NATIONAL LABORATORY SYSTEM, INCLUDING A QUALITY ASSURANCE ACTION PLAN AND FIVE-YEAR STRATEGIC PLAN. WE ALSO STRENGTHENED REAL-TIME, COMMUNITY-BASED SURVEILLANCE FOR PRIORITY HUMAN AND ZOONOTIC DISEASES WITH EPIDEMIC POTENTIAL. AS PART OF THE DOSE PER CONTAINER PARTNERSHIP, PATH CONDUCTED FORMATIVE RESEARCH THAT CONTRIBUTED TO THE VACCINE INNOVATION PRIORITIZATION STRATEGY WORK LED BY GAVI. PATH ALSO CONDUCTED A REFRIGERATOR TEMPERATURE MONITORING STUDY IN PRIVATE PHARMACIES IN TWO URBAN DISTRICTS AND ORGANIZED COLD CHAIN MANAGEMENT TRAINING WORKSHOPS FOR THE CHIEF REGIONAL SUPPLY PHARMACISTS IN ALL 14 REGIONS OF THE COUNTRY. IN 2019, PATH PROVIDED TECHNICAL ASSISTANCE TO THE GOVERNMENT OF SENEGAL TO SCALE UP SAFE OXYGEN DELIVERY. ACTIVITIES INCLUDED QUANTIFYING THE DEMAND FOR, AND THE EXISTING IN-COUNTRY SUPPLY OF, OXYGEN. IN ADDITION, WE PROVIDED TECHNICAL ASSISTANCE TO A COALITION OF PARTNERS LED BY THE MOHSA TO COLLECT DATA ON THE AVAILABILITY OF MEDICAL DEVICES, INCLUDING OXYGEN AND PULSE OXIMETERS, WITHIN ALL PUBLIC HEALTH FACILITIES. THROUGH THE BETTER HEARTS BETTER CITIES PROJECT, PATH PUT IN PLACE AN ACTION PLAN FOR THE MOHSA AND NATIONAL SUPPLY PHARMACY TO IMPROVE THE AVAILABILITY AND ACCESSIBILITY OF HYPERTENSION MEDICATIONS. WE ALSO ESTABLISHED A COALITION OF PRIVATE COMPANIES TO RAISE AWARENESS AND INCREASE HEALTH LITERACY AROUND NONCOMMUNICABLE DISEASES. THE GOAL WAS TO CHANGE THE MINDSET FROM TREATMENT TO PREVENTION, WITH A BUSINESS CASE DEVELOPED TO DEMONSTRATE THE GAIN FOR BOTH COMPANIES AND EMPLOYEES. PATH HAS BEEN A KEY PARTNER TO THE GOVERNMENT OF SENEGAL SINCE THE INCEPTION OF ITS HPV VACCINATION DEMONSTRATION PROGRAM IN 2013. PROVIDING SUPPORT EACH YEAR, ACTIVITIES IN 2019 INCLUDED MULTI-AGE COHORT VACCINATIONS OF 9- TO 14-YEAR-OLD GIRLS. PER THE GOVERNMENT'S REQUEST, PATH CONTINUED TO ASSIST WITH PROGRAM PLANNING AND PREPARATION, SOCIAL MOBILIZATION, VACCINE DELIVERY, MONITORING AND EVALUATION, AND GRANT RENEWALS. FINALLY, AS PART OF A PROJECT FUNDED BY THE CLINTON HEALTH ACCESS INITIATIVE, PATH AND THE MOHSA WORKED TOGETHER TO TRAIN 1,672 PROVIDERS (ABOUT 200 MORE THAN ANTICIPATED) ON SELF-INJECTION OF THE CONTRACEPTIVE DMPA-SC. THE PROJECT EXCEEDED TRAINING TARGETS ACROSS ALL CADRES OF HEALTH WORKERS AND SIGNIFICANTLY CONTRIBUTED TO THE MOHSA'S OBJECTIVE OF SCALING UP DMPA-SC SELF-INJECTION NATIONWIDE. PATH IN UKRAINE ENGAGES DIRECTLY WITH KEY MOH AND NATIONAL CENTER FOR PUBLIC HEALTH (NCPH) STAKEHOLDERS TO ENSURE THAT THE PROGRAMS WE IMPLEMENT ARE ADAPTED TO THE CONTEXT OF THE COUNTRY'S ONGOING HEALTH SYSTEM REFORM. WE PROVIDE TECHNICAL ASSISTANCE TO CENTRAL-, OBLAST-, AND MUNICIPAL-LEVEL INSTITUTIONS IN DEVELOPING TB AND TB/HIV PLANS, PROTOCOLS, AND OTHER GUIDING DOCUMENTS. THE AIM IS TO ENSURE RAPID AND EFFECTIVE UPTAKE OF SUSTAINABLE, COMPREHENSIVE, HIGH-QUALITY CARE FOR ALL PATIENTS. PATH ALSO MAINTAINS STRONG RELATIONSHIPS WITH UKRAINE'S NGO AND CIVIL-SOCIETY SECTOR, ESSENTIAL PARTNERS IN REACHING MARGINALIZED GROUPS. WE WORK ACROSS THE COUNTRY, BUILDING THIS SECTOR'S CAPACITY TO PROVIDE PREVENTION, SCREENING, AND TREATMENT SUPPORT SERVICES TO TB PATIENTS, PLHIV, AND OTHER KEY POPULATIONS. NGOS AND CIVIL-SOCIETY ORGANIZATIONS FILL IMPORTANT GAPS IN THE CONTINUUM OF CARE FOR A RANGE OF CONDITIONS AND ARE OFTEN MORE TRUSTED THAN FORMAL HEALTH SERVICES. UNDER THE USAID-FUNDED SERVING LIFE PROJECT, PATH COLLABORATES WITH THE MINISTRY OF JUSTICE, MOH, AND A BROAD RANGE OF HIV, TB, AND PENITENTIARY HEALTH STAKEHOLDERS TO STRENGTHEN HIV, TB, AND HEPATITIS C SCREENING, DIAGNOSIS, TREATMENT, AND LINKAGES TO CARE (POST-RELEASE), AS DESCRIBED IN THE HIV AND TUBERCULOSIS SECTION. THIS WORK BUILDS ON A PREVIOUS PROGRAM FUNDED THROUGH TB REACH THAT LED TO A TEN-FOLD INCREASE IN TB CASE DETECTION AMONG PRETRIAL DETAINEES AND PRISONERS OVER TWO YEARS. IN 2019, PATH CLOSED OUT CHALLENGE TB (CTB) AND BEGAN A NEW PROJECT: SUPPORT TB CONTROL EFFORTS IN UKRAINE (STBCEU). CTB'S ACTIVITIES IMPROVED CASE DETECTION AND ADHERENCE TO TREATMENT AND CONTRIBUTED TOWARD NATIONWIDE CONTROL OF THE DRUG-RESISTANT TB EPIDEMIC. AMONG OTHER ACHIEVEMENTS, CTB HELPED UKRAINE INTRODUCE NEW DRUG REGIMENS THAT DRAMATICALLY IMPROVED CARE AND OUTCOMES FOR THESE PATIENTS. STBCEU PICKED UP WHERE CTB LEFT OFF AND WILL CONTINUE TO IMPROVE SERVICES AND INTRODUCE INNOVATIONS FOR TB CONTROL. THE UNITAID-FUNDED ADHERENCE SUPPORT COALITION TO END TB (ASCENT) PROJECT, FOR WHICH PATH IS A LEAD PARTNER IN UKRAINE, USES DIGITAL INNOVATIONS SUCH AS MOBILE COMMUNICATION TECHNOLOGIES TO HELP PATIENTS SUCCEED IN TREATMENT. THE ASCENT PROJECT IS GENERATING CRUCIAL EVIDENCE FOR OPTIMAL USE AND SCALE. THE LONG-TERM VISION IS A WORLD WHERE THESE DIGITAL TOOLS CAN BE AVAILABLE TO ALL TB PATIENTS, NO MATTER WHERE THEY LIVE. OVER THE LAST DECADE AND A HALF, PATH HAS ESTABLISHED ITSELF IN ZAMBIA AS A KEY AND ALL-WEATHER PARTNER FOR THE MOH. THROUGH MACEPA AND PAMO (SEE THE MALARIA AND NEGLECTED TROPICAL DISEASES SECTION), PATH SUPPORTS THE EXPANSION OF MALARIA SURVEILLANCE AND TREATMENT SERVICES. AMONG OTHER ACTIVITIES, THESE PROGRAMS STRENGTHEN IN-COUNTRY CAPACITY FOR EFFECTIVE ANALYSIS AND USE OF DATA FOR EVIDENCE-BASED DECISION-MAKING. PATH'S MALARIA WORK IN ZAMBIA SPANS SIX PROVINCES; IN 2019, EASTERN PROVINCE REACHED A NEW THRESHOLD OF LOW MALARIA PREVALENCE. IN RESPONSE, PATH, WITH ADDITIONAL FUNDING, TRAINED 1,401 COMMUNITY HEALTH WORKERS AND SET UP INTENSIFIED SURVEILLANCE SYSTEMS IN AN EFFORT TO REDUCE MALARIA INCIDENCE TO ITS LOWEST POSSIBLE LEVEL AND ACHIEVE PRE-ELIMINATION STATUS. MACEPA ALSO INTRODUCED THE CONCEPT OF COMMUNITY-BASED REACTIVE INDOOR RESIDUAL SPRAYING TO EXTEND VECTOR CONTROL COVERAGE THROUGHOUT THE YEAR IN PERENNIAL MALARIA TRANSMISSION AREAS OF SOUTHERN PROVINCE. VECTOR CONTROL IS A PROVEN AND PRIORITY INTERVENTION OF THE GOVERNMENT OF ZAMBIA TO REDUCE MALARIA. TO THIS END, PAMO SUPPORTED DEVELOPMENT OF GUIDELINES FOR EFFECTIVE AND CONTINUOUS DISTRIBUTION OF LONG-LASTING INSECTICIDE-TREATED NETS. IN 2019, PAMO DISTRIBUTED 115,416 OF THESE NETS ACROSS THE COUNTRY; 63% THROUGH A "MOP-UP" CAMPAIGN AND 37% THROUGH SCHOOLS. PATH'S EFFORTS TO ELIMINATE MALARIA EXPANDED IN 2019 TO INCLUDE RESEARCH ON A NOVEL TOOL: ATTRACTIVE TARGETED SUGAR BAITS, WHICH ARE DEPLOYED OUTSIDE OF HOMES TO ATTRACT MOSQUITOES AND PROVIDE THEM WITH A LETHAL DOSE OF INSECTICIDE. ACHIEVEMENTS IN ZAMBIA INCLUDED PRODUCT TESTING AND OPTIMIZATION BOTH IN THE LAB AND IN SEMI-FIELD SETTINGS. PATH ALSO SUPPORTED THE INTRODUCTION, TESTING, AND DOCUMENTATION OF DIGITAL TOOLS TO IMPROVE OPERATIONAL PERFORMANCE OF MASS DRUG ADMINISTRATION AND INDOOR RESIDUAL SPRAYING CAMPAIGNS IN SOUTHERN AND WESTERN PROVINCES. TB IS ANOTHER MAJOR CHALLENGE IN ZAMBIA. FOR THE PAST THREE YEARS, PATH HAS BEEN IMPLEMENTING USAID'S FLAGSHIP TB PROJECT, ERADICATE TB. OVER THE LIFE OF THE PROJECT, THE TB CURE RATE IN ZAMBIA HAS IMPROVED FROM 65% TO 70%, AND THE PROPORTION OF TB/HIV PATIENTS ON ANTIRETROVIRAL TREATMENT HAS INCREASED FROM 84% TO 93%. ALSO IN ZAMBIA, PATH CONTINUED TO ADVANCE THE AVAILABILITY OF DMPA-SC, AN INJECTABLE CONTRACEPTIVE. (SEE THE SEXUAL AND REPRODUCTIVE HEALTH SECTION.) IN 2019, PATH ROLLED OUT TRAININGS ON SELF-INJECTION TO SEVEN OUT OF TEN PROVINCES. THE TRAININGS REACHED 1,790 HEALTH CARE PROVIDERS FROM 625 HEALTH FACILITIES IN 62 DISTRICTS WHO ARE NOW ABLE TO OFFER SELF-INJECTION AS PART OF THE FAMILY PLANNING PACKAGE.
FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICE: PATH ALSO BUILT UPON THE BETTER IMMUNIZATION DATA PROJECT BY BRINGING TOGETHER A CONSORTIUM OF TECHNICAL EXPERTS AND PARTNERS WORKING WITH THE GOVERNMENT OF ZAMBIA TOWARD A COMMON GOAL: ACCURATE, IMPROVED, AND EQUITABLE VACCINE COVERAGE RATES. THIS WORK IS FUNDED BY GAVI. KEY ACHIEVEMENTS IN 2019 INCLUDED REFRESHER TRAININGS FOR 562 HEALTH CARE WORKERS IN 320 HEALTH FACILITIES.
FORM 990, PART III, LINE 4B, DESCRIPTION OF PROGRAM SERVICE: DRUG DEVELOPMENT: THROUGH OUR WORK ON DRUG DEVELOPMENT AND INTRODUCTION, PATH HELPS ENSURE THAT PEOPLE AROUND THE WORLD, ESPECIALLY CHILDREN IN LOW-RESOURCE SETTINGS, HAVE RELIABLE ACCESS TO LIFESAVING MEDICINES. OVER THE YEARS, OUR WORK HAS ADVANCED SOLUTIONS FOR A RANGE OF URGENT GLOBAL HEALTH CHALLENGES, INCLUDING ENTERIC AND DIARRHEAL DISEASES, NEGLECTED TROPICAL DISEASES, HIV/AIDS, AND MALARIA. DRAWING ON AN ENDURING COMMITMENT TO HEALTH EQUITY AND A UNIQUE PARTNERSHIP APPROACH THAT SPANS THE ACADEMIC, PRIVATE, NONPROFIT, AND GOVERNMENT SECTORS, OUR WORK OVERTURNS BARRIERS TO HEALTH AT EVERY STAGE OF DRUG DEVELOPMENT AND USE-FROM EARLY RESEARCH TO POLICY INTRODUCTION. IN 2019, THE DIARRHEA INNOVATIONS GROUP, AN INTERNATIONAL NETWORK OF CHILD HEALTH STAKEHOLDERS HOUSED WITHIN AND CO-CHAIRED BY PATH, MOVED FORWARD A CRITICAL GUIDANCE FOR DIARRHEA MANAGEMENT AMONG CHILDREN: THE ADDITION OF CO-PACKAGED ORS AND ZINC TO THE WHO ESSENTIAL MEDICINES LISTS. CO-PACKAGED ADMINISTRATION, NOW RECOGNIZED AS ESSENTIAL, COULD INCREASE ACCESS TO THIS LIFESAVING TREATMENT AND ACCELERATE PROGRESS TOWARD CHILD HEALTH GOALS. ALSO IN 2019, WE CONTINUED OUR WORK ON DEVELOPING NEW THERAPEUTICS FOR CRYPTOSPORIDIUM, A DEADLY DIARRHEA-CAUSING PARASITE FOR WHICH NO HIGHLY EFFECTIVE TREATMENT IS AVAILABLE. ADDITIONALLY, WE BEGAN ENROLLMENT IN A PHASE 2 PROOF-OF-CONCEPT CLINICAL TRIAL OF IOWH032, A NOVEL ANTISECRETORY DRUG FOR THE TREATMENT OF CHOLERA. WE ALSO CONTINUED TO ADVANCE OUR WORK ON A NEW ASSESSMENT TOOL FOR ENVIRONMENTAL ENTERIC DYSFUNCTION (EED)-AN INTESTINAL DISORDER RESPONSIBLE FOR A SIGNIFICANT PORTION OF THE GROWTH STUNTING OF APPROXIMATELY 140 MILLION CHILDREN WORLDWIDE. KNOWN AS THE "MICRONUTRIENT AND ENVIRONMENTAL ENTERIC DYSFUNCTION ASSESSMENT TOOL" (MEEDAT), THE TOOL IS DESIGNED TO MEASURE MULTIPLE BIOMARKERS, INCLUDING THOSE OF EED, SYSTEMIC INFLAMMATION, GROWTH HORMONE RESISTANCE, AND MICRONUTRIENTS.
FORM 990, PART III, LINE 4C, DESCRIPTION OF PROGRAM SERVICE: MARKET DYNAMICS: PATH'S MARKET DYNAMICS PROGRAM ENCOMPASSES EFFORTS TO EVALUATE MARKETS, ASSESS SHORTCOMINGS, AND DESIGN MARKET-BASED INTERVENTIONS TO IMPROVE HEALTH OUTCOMES. THIS WORK COMPLEMENTS PATH'S OTHER EFFORTS, SUCH AS PRODUCT DEVELOPMENT AND INTRODUCTION. IT BUILDS UPON OUR EXISTING STRENGTH IN COMMERCIALIZATION, ALIGNS EXPERTISE ACROSS TEAMS, AND EXPANDS OUR CAPACITY TO ADDRESS MARKET-BASED ISSUES. IN 2019, OUR WORK FOCUSED ON ASSESSING MARKETS AND IMPROVING MARKET FUNCTIONING FOR MALARIA DRUGS AND DRUG INTERMEDIATES, MALARIA DIAGNOSTICS, AND OXYGEN THERAPY DEVICES. CENTER OF DIGITAL AND DATA EXCELLENCE: PATH USES DIGITAL TECHNOLOGIES AND DATA-LED ACTION TO IMPROVE HEALTH AND SAVE LIVES. IN 2019, THE CENTER OF DIGITAL AND DATA EXCELLENCE APPLIED ITS EXPERTISE TO SEVERAL PROJECTS. KEY ACCOMPLISHMENTS INCLUDED THE WHO-PATH STRATEGIC COLLABORATION ON INNOVATION AND GLOBAL DIGITAL HEALTH. THIS COLLABORATION BRINGS TOGETHER A CROSS-SECTOR NETWORK OF DIGITAL HEALTH EXPERTS AND INVESTORS TO SUPPORT WHO IN DEVELOPING A GLOBAL DIGITAL HEALTH DEPARTMENT AND PORTFOLIO. WORK CONTINUED UNDER DIGITAL SQUARE, A PATH-LED INITIATIVE. THIS INITIATIVE BRINGS DONORS AND PARTNERS TOGETHER TO IMPROVE HOW THE GLOBAL COMMUNITY DESIGNS, USES, AND PAYS FOR DIGITAL HEALTH TOOLS AND APPROACHES. PATH ALSO CONTINUED IMPLEMENTATION OF THE TANZANIA DATA USE PARTNERSHIP, WHICH SUPPORTS THE GOVERNMENT OF TANZANIA TO IMPROVE COUNTRYWIDE HEALTH INFORMATION SYSTEMS AND IMPLEMENT THE TANZANIA DIGITAL HEALTH INVESTMENT ROAD MAP. IN 2019, THE PARTNERSHIP SUPPORTED LAUNCH OF THE COUNTRY'S 2019-2024 NATIONAL DIGITAL HEALTH STRATEGY. THE BID INITIATIVE, A COLLABORATION BETWEEN PATH AND THE GOVERNMENTS OF TANZANIA AND ZAMBIA, HAS EMPOWERED THESE COUNTRY GOVERNMENTS TO ENHANCE IMMUNIZATION THROUGH IMPROVED DATA COLLECTION, QUALITY, AND USE. PATH CONTINUED TO SUPPORT THE SCALE-UP AND SUSTAINABILITY OF ELECTRONIC IMMUNIZATION REGISTRIES IN BOTH COUNTRIES WHILE PROVIDING MENTORSHIP AND PEER LEARNING OPPORTUNITIES TO OTHER COUNTRIES PURSUING SIMILAR DIGITAL HEALTH SOLUTIONS. IN ADDITION, PATH COLLABORATED WITH THE JOINT LEARNING NETWORK FOR UNIVERSAL HEALTH COVERAGE TO CONTINUE A PEER LEARNING MODEL THAT INCLUDES PROFESSIONALS FROM MINISTRIES OF HEALTH AND NATIONAL HEALTH INSURANCE AGENCIES IN TEN COUNTRIES. PATH ALSO INCREASED PARTICIPATION IN HIGH-LEVEL COALITIONS, INCLUDING THE DIGITAL TRANSFORMATION FOR UHC 2030 COALITION, THE LANCET/FINANCIAL TIMES JOINT COMMISSION ON GOVERNING HEALTH FUTURES 2030, AND THE DIGITAL CONNECTED CARE COALITION.
FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 WAS PREPARED BY AN OUTSIDE ACCOUNTING FIRM USING INFORMATION PROVIDED BY PATH ACCOUNTING SERVICES STAFF. PATH SENIOR MANAGEMENT REVIEWED THE DRAFT FORM. A COPY OF THE DRAFT WAS SENT TO THE BOARD OF DIRECTORS FOR COMMENT. AFTER THE COMMENT PERIOD, THE CHIEF OF ACCOUNTING SIGNED THE FORM.
FORM 990, PART VI, SECTION B, LINE 12C PATH HAS POLICIES AND PROCEDURES TO ADDRESS CONFLICTS OF INTEREST. PATH MANAGEMENT AND ALL STAFF AT A DESIGNATED LEVEL OR HIGHER WITHIN THE ORGANIZATION MUST COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM EACH YEAR. ALL FORMS ARE REVIEWED AND KEPT ON FILE. A CONFLICT MANAGEMENT PLAN IS DEVELOPED FOR ANY EMPLOYEE WITH A SIGNIFICANT ACTUAL OR PERCEIVED CONFLICT OF INTEREST. PATH ALSO HAS A WELL-DEFINED PROCEDURE FOR IDENTIFYING AND REPORTING ACTUAL AND POTENTIAL CONFLICTS OF INTEREST AMONG BOARD MEMBERS. NEW BOARD MEMBERS ARE ASKED TO COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM WITHIN 30 DAYS OF JOINING THE BOARD AND TO COMPLETE A NEW FORM ANNUALLY THEREAFTER. IN ADDITION, MEMBERS ARE REMINDED TO REPORT ANY NEW ISSUES THAT ARISE OUTSIDE OF THE ANNUAL DISCLOSURE PERIOD. THE DISCLOSURE FORMS ARE REVIEWED BY PATH'S GENERAL COUNSEL, AND IF ANY ACTUAL OR POTENTIAL CONFLICTS ARE IDENTIFIED, GENERAL COUNSEL MAKES A RECOMMENDATION TO THE CHAIR OF THE GOVERNANCE COMMITTEE AND THE CHAIR OF THE BOARD FOR A MANAGEMENT PLAN TO PROPERLY MANAGE ANY CONFLICTS. A FORMAL MANAGEMENT PLAN IS THEN AGREED UPON WITH THE BOARD MEMBER, AND THE ENTIRE BOARD OF DIRECTORS IS INFORMED AT THE NEXT REGULARLY SCHEDULED BOARD MEETING.
FORM 990, PART VI, SECTION B, LINE 15 THE BOARD'S EXECUTIVE COMPENSATION COMMITTEE ANNUALLY REVIEWS SALARIES AND BENEFITS FOR EXECUTIVE EMPLOYEE POSITIONS AND PROVIDES GUIDANCE TO THE PRESIDENT/CHIEF EXECUTIVE OFFICER (CEO) ON COMPENSATION DECISIONS FOR EXECUTIVE POSITIONS. THE COMPENSATION AND BENEFITS FOR PATH'S PRESIDENT/CEO ARE REVIEWED AND APPROVED BY THE ENTIRE BOARD OF DIRECTORS EACH YEAR. PATH ROUTINELY USES THE SERVICES OF EXTERNAL FIRMS TO ASSESS AND BENCHMARK EXECUTIVE COMPENSATION (PRESIDENT/CEO, VICE PRESIDENTS, AND EXECUTIVE TEAM MEMBERS). THE MOST RECENT MAJOR REVIEW WAS COMPLETED BY THE BOARD COMPENSATION COMMITTEE IN 2017. AT THE REQUEST OF THE BOARD, PATH ENGAGED MERCER (A COMPENSATION, BENEFITS, AND HUMAN RESOURCES CONSULTING FIRM) TO REVIEW CURRENT AND PROPOSED BASE SALARIES OF PATH'S PRESIDENT/CEO, VICE PRESIDENTS, AND EXECUTIVE TEAM MEMBERS. MERCER USED DATA FROM MULTIPLE SOURCES TO EVALUATE CURRENT AND PROPOSED BASE SALARIES FOR THESE POSITIONS. THE BOARD'S EXECUTIVE COMPENSATION COMMITTEE REVIEWED THE MERCER REPORT AND APPROVED THE USE OF THE REPORT TO ESTABLISH A FRAMEWORK WITHIN WHICH THE PRESIDENT/CEO IS DELEGATED AUTHORITY TO ESTABLISH THE TOTAL COMPENSATION PACKAGES OF THE VICE PRESIDENTS AND EXECUTIVE TEAM MEMBERS. ADDITIONALLY, MERCER REVIEWED THE PROPOSED TOTAL COMPENSATION AND BENEFITS PACKAGE FOR THE PRESIDENT/CEO POSITION AND OBTAINED A SIGNIFICANT NUMBER OF DATA POINTS TO ASCERTAIN ITS REASONABLENESS AND APPROPRIATENESS. THE BOARD APPROVED THE COMMITTEE'S RECOMMENDATION FOR THE PRESIDENT/CEO'S TOTAL COMPENSATION PACKAGE.
FORM 990, PART VI, SECTION C, LINE 19 PATH GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST; MOST DOCUMENTS ARE ALSO AVAILABLE ONLINE.
For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.
Cat. No. 51056K
Schedule O (Form 990 or 990-EZ) 2019


Additional Data


Software ID:  
Software Version:  
SCHEDULE R
(Form 990)
Department of the Treasury
Internal Revenue Service
Related Organizations and Unrelated Partnerships
MediumBulletComplete if the organization answered "Yes" on Form 990, Part IV, line 33, 34, 35b, 36, or 37.
MediumBulletAttach to Form 990.
MediumBullet Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047
2019
Open to Public Inspection
Name of the organization
PATH
 
Employer identification number

91-1157127
Part I
Identification of Disregarded Entities. Complete if the organization answered "Yes" on Form 990, Part IV, line 33.
(a)
Name, address, and EIN (if applicable) of disregarded entity


(b)
Primary activity


 		(c)
Legal domicile (state
or foreign country)

 		(d)
Total income


 		(e)
End-of-year assets


 		(f)
Direct controlling
entity










Part II
Identification of Related Tax-Exempt Organizations. Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related tax-exempt organizations during the tax year.
(a)
Name, address, and EIN of related organization


(b)
Primary activity


 		(c)
Legal domicile (state
or foreign country)

 		(d)
Exempt Code section


 		(e)
Public charity status
(if section 501(c)(3))

 		(f)
Direct controlling
entity

 		(g)
Section 512(b)(13) controlled entity?
Yes No
(1)PATH VACCINE SOLUTIONS
2201 WESTLAKE AVENUE

SEATTLE,WA98109
83-0431851 		ADVANCE DEVELOPMENT OF VACCINES TO IMPROVE THE HEALTH OF CHILDREN WA 501(C)(3) LINE 12A, I PATH
 
Yes
 
(2)FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND
207 ROUTE DE FERNEY 1218 LE GRAND-S
GENEVA    
SZ
EDUCATIONAL AND SCIENTIFIC PROMOTION OF HEALTH SZ 501(C)(3)   PATH
 
Yes
 
(3)PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH -KENYA
ACS PLAZA 4TH FL LENANA RD PO BOX
NAIROBI    
KE
EDUCATIONAL AND SCIENTIFIC PROMOTION OF HEALTH KE 501(C)(3)   PATH
 
Yes
 
(4)ORGANIZATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH-NIGERIA
9TH FL ST NICHOLAS HOUSE CATHOLI
LAGOS    
NI
EDUCATIONAL AND SCIENTIFIC PROMOTION OF HEALTH NI 501(C)(3)   PATH
 
Yes
 






For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50135Y
Schedule R (Form 990) 2019
Schedule R (Form 990) 2019
Page 2
Part III
Identification of Related Organizations Taxable as a Partnership. Complete if the organization answered "Yes" on Form 990, Part IV, line 34, because it had one or more related organizations treated as a partnership during the tax year.
(a)
Name, address, and EIN of
related organization



 		(b)
Primary activity




 		(c)
Legal
domicile
(state or foreign
country)


 		(d)
Direct controlling
entity



 		(e)
Predominant income(related, unrelated, excluded from tax under sections 512-514)

(f)
Share of total income




 		(g)
Share of end-of-year
assets



 		(h)
Disproprtionate allocations?




 		(i)
Code V-UBI
amount in box 20 of
Schedule K-1
(Form 1065)
 		(j)
General or
managing
partner?



 		(k)
Percentage
ownership
Yes No Yes No












Part IV
Identification of Related Organizations Taxable as a Corporation or Trust. Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a corporation or trust during the tax year.
(a)
Name, address, and EIN of
related organization
 		(b)
Primary activity
 		(c)
Legal
domicile
(state or foreign
country)
 		(d)
Direct controlling
entity
 		(e)
Type of entity
(C corp, S corp,
or trust) 		(f)
Share of total income
 		(g)
Share of end-of-year
assets
 		(h)
Percentage
ownership
 		(i)
Section 512(b)(13) controlled entity?
Yes No












Schedule R (Form 990) 2019
Schedule R (Form 990) 2019
Page 3
Part V
Transactions With Related Organizations. Complete if the organization answered "Yes" on Form 990, Part IV, line 34, 35b, or 36.
Note. Complete line 1 if any entity is listed in Parts II, III, or IV of this schedule.
Yes
No
1 During the tax year, did the orgranization engage in any of the following transactions with one or more related organizations listed in Parts II-IV?
a Receipt of (i) interest, (ii) annuities, (iii) royalties, or (iv) rent from a controlled entity .....................
1a
 
No
b Gift, grant, or capital contribution to related organization(s) ............................
1b
Yes
 
c Gift, grant, or capital contribution from related organization(s) ............................
1c
Yes
 
d Loans or loan guarantees to or for related organization(s) ............................
1d
 
No
e Loans or loan guarantees by related organization(s) ............................
1e
 
No
f Dividends from related organization(s) ............................
1f
 
No
g Sale of assets to related organization(s) ............................
1g
 
No
h Purchase of assets from related organization(s) ............................
1h
 
No
i Exchange of assets with related organization(s) ............................
1i
 
No
j Lease of facilities, equipment, or other assets to related organization(s) .......................
1j
 
No
k Lease of facilities, equipment, or other assets from related organization(s) ......................
1k
 
No
l Performance of services or membership or fundraising solicitations for related organization(s) .....................
1l
 
No
m Performance of services or membership or fundraising solicitations by related organization(s) .................
1m
 
No
n Sharing of facilities, equipment, mailing lists, or other assets with related organization(s) ...................
1n
 
No
o Sharing of paid employees with related organization(s) ............................
1o
 
No
p Reimbursement paid to related organization(s) for expenses ............................
1p
 
No
q Reimbursement paid by related organization(s) for expenses ............................
1q
 
No
r Other transfer of cash or property to related organization(s) ............................
1r
 
No
s Other transfer of cash or property from related organization(s) ............................
1s
 
No
2
If the answer to any of the above is "Yes," see the instructions for information on who must complete this line, including covered relationships and transaction thresholds.
(a)
Name of related organization 		(b)
Transaction
type (a-s) 		(c)
Amount involved 		(d)
Method of determining amount involved
(1) PATH VACCINE SOLUTIONS

 C 4,265,711 FMV
(2) FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND

 B 4,069,578 FMV
(3) PATH VACCINE SOLUTIONS

 B 92,478  



Schedule R (Form 990) 2019
Schedule R (Form 990) 2019
Page 4
Part VI
Unrelated Organizations Taxable as a Partnership. Complete if the organization answered "Yes" on Form 990, Part IV, line 37.
Provide the following information for each entity taxed as a partnership through which the organization conducted more than five percent of its activities (measured by total assets or gross revenue) that was not a related organization. See instructions regarding exclusion for certain investment partnerships.
(a)
Name, address, and EIN of entity 		(b)
Primary activity 		(c)
Legal domicile
(state or foreign
country) 		(d)
Predominant income (related, unrelated, excluded from tax under sections 512-514)

(e)
Are all partners
section
501(c)(3)
organizations? 		(f)
Share of total income




 		(g)
Share of
end-of-year
assets 		(h)
Disproprtionate allocations? 		(i)
Code V-UBI
amount in box 20
of Schedule K-1
(Form 1065) 		(j)
General or
managing
partner? 		(k)
Percentage
ownership
Yes No Yes No Yes No






























Schedule R (Form 990) 2019
Schedule R (Form 990) 2019
Page 5
Part VII
Supplemental Information
Provide additional information for responses to questions on Schedule R. (see instructions).
Return Reference Explanation
Schedule R (Form 990) 2019

Additional Data


Software ID:  
Software Version: